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Abstract
Intracellular oxidative stress is induced by oxidised low density lipoprotein (oxLDL) in
macrophages. In the atherosclerotic lesions, this oxLDL dependent oxidative stress
appears to cause macrophage cell death, a key process in the development of the necrotic
core within the complex plaque. Macrophages are activated by γ-interferon to synthesise
and release a potent antioxidant, 7,8-dihydroneopterin (7,8-NP), which has been
previously shown to protect human monocyte-like U937 cells and human monocyte-
derived macrophage (HMDM) cells from oxLDL cytotoxicity. This study examined
whether oxLDL causes the loss of cellular metabolic function and whether 7,8-
dihydroneopterin can prevent this loss of metabolic activity in U937 cells and HMDM
cells.
OxLDL prepared by copper oxidation caused cell death in both U937 and HMDM cells at
concentrations of 0.5 and 2.0 mg/ml, respectively. Cell morphology showed the oxLDL
caused a necrotic like death in both cells as indicated by cell swelling and lysis. The
decrease in cell viability was only observed after the loss of intracellular glutathione
(GSH) which occurred in the first 3 hours in U937 cells following oxLDL addition. The
loss of GSH appeared to be due to the production of intracellular oxidants generated in
response to the presence of the oxLDL.
Within 3 hours of oxLDL addition to both cell types, there was a rapid and progressive
shutdown of cell metabolism indicated by a significant decrease in the enzymatic activity
of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and a
fall in lactate production and intracellular ATP levels. GAPDH activity was found to be
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inactivated rather than being lost from the cell. Gel electrophoresis with specific staining
for oxidised proteins showed that the GAPDH had been oxidatively inactivated in the
cells when oxLDL was present. Unlike GAPDH, lactate dehydrogenase (LDH) was not
inactivated by the oxidation but was lost from the cells due to cell lysis. The observed
rate of glycolysis failure was similar in both cell types except the HMDM cells did not
lose lactate, LDH activity and cell viability until 6 hours compared to 3 hours with the
U937 cells.
The rate of oxygen consumption (VO2) was measured in U937 cells by taking cells at set
time points and placing them in the respirometers to measure the VO2. U937 cells were
found to increase their VO2 with incubation but this increase was inhibited in the
presence of oxLDL within 3 hours.
The addition of the 7,8-dihydroneopterin above 100 μM to both the U937 and HMDM
cells significantly inhibited the oxLDL-induced loss of cell viability. GAPDH activity
loss was also inhibited while lactate production was maintained. The 7,8-
dihydroneopterin also prevented the decrease in the VO2 in oxLDL-treated U937 cells.
OxLDL was labelled with fluorescent DiI to measure the uptake of oxLDL by HMDM
cells. The incorporation of DiI into oxLDL was found to make it non-cytotoxic, possibly
due to DiI’s antioxidant properties. Studies were therefore conducted using either a
mixture of oxLDL and DiI labelled oxLDL (DiI-oxLDL) at non-protective concentrations
or low concentration of DiI-oxLDL alone. These studies showed that 7,8-
dihydroneopterin downregulated the oxLDL uptake in oxLDL-treated HMDM cells.
Surprisingly the uptake rates also suggested that there was no relationship between
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oxLDL uptake and cell death assuming oxLDL and DiI-oxLDL are taken up by the same
mechanism.
This research showed that oxLDL-induced oxidative stress in macrophage cells causes a
rapid oxidative loss of GAPDH activity which leads to the loss of glycolytic activity and
a fall in ATP levels. The failure of cell metabolism appears to be a key event in the death
mechanism triggered by the oxLDL. The radical scavenging activity of 7,8-
dihydroneopterin appears to prevent the oxidative stress as indicated by the protection of
the GSH pool. Without the oxidative stress, GAPDH remains functioning, glycolytic
activity is maintained and both the U937 cells and HMDM cells did not die.  This
suggests that within the atherosclerotic plaque, 7,8-dihydroneopterin may act to stabilise
the metabolism of macrophage cells in the presence of oxLDL and downregulate the
oxLDL uptake.
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1 Introduction
1.1 Atherosclerosis
Atherosclerosis is a chronic inflammatory disease, often linked to high plasma
concentrations of cholesterol, in particular low-density lipoprotein (LDL) cholesterol
(Carpenter et al., 1991, Blasi, 2008). High concentrations of plasma LDL appear to
be linked to the accumulation of cholesterol filled macrophages in the artery wall.
The macrophage is the predominant cell type in the atherosclerotic plaque making up
66% of the inner plaque region, but is also elevated in concentration in the media
region of a carotid plaques where 13% of the cells are monocyte/macrophage with
endothelial cells making up 20%, smooth muscle (44.0%) and T cells (14%) (Rekhter
& Gordon, 1995). This high percentage of immune/inflammatory cells clearly shows
atherosclerotic plaques are a site of inflammation. The macrophage cells generate
significant amounts of oxidants as part of the inflammatory process as well as
absorbing lipids, mainly cholesterol, from the oxidatively modified lipoproteins,
within the artery wall. The resulting high intracellular content of cholesterol lipid
transforms these lipid-loaded macrophages into foam cells, which then remain stuck
in the artery wall. It is the collection of these foam cells in the artery wall that causes
the narrowing of the artery and is called an atherosclerotic plaque (Figure 1.1). In
extreme cases these plaques can eventually block the artery stopping the flow of
blood. The death of the macrophage foam cells leads to plaque rupture, resulting in
thrombosis (Takahashi et al., 2002).
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Figure 1.1 A cross section of atherosclerotic plaque.
Cross section of a plaque (4.0mm diameter) removed from the left common carotid
artery of an 84 year old non-smoking patient who presented with transient ischemic
attacks. Ultrasound analysis showed 85% stenosis (narrowing) of the vessel. This is
the classic type of advanced, lipid-filled plaque with a large necrotic core region and
significant levels of calcification. Adapted from (Gieseg et al., 2009a).
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In humans, oxidised low density lipoprotein (oxLDL) within atherosclerotic lesions is
strongly associated with coronary artery disease, acute coronary syndromes, and
vulnerable plaques (Tsimikas et al., 2005). The death of the foam cells and resulting
plaque instability, is thought to be driven in part by the cytotoxicity of oxLDL. The
mechanism of oxLDL cytotoxicity is not clear with membrane/cellular instability,
kinase activation, metabolic failure and oxidative mechanisms being proposed (Asmis
et al., 2005). OxLDL has been shown to cause the shutdown of endothelial cells
metabolism through oxidative modification of key metabolic enzymes (Chisolm &
Chai, 2000). Whether this happens in the more oxidant resistant macrophage and
whether the macrophages own antioxidant can count the oxidative stress of oxLDL
will be explored in the research described in this thesis.
1.1.1 Development of atherosclerosis
Atherosclerotic plaque development is a progressive process usually taking many
years. It is characterised by the acquirement and differentiation of a variety of
inflammatory cells, mainly monocytes and T-cells. Smooth muscle cells (SMCs)
become a major component in advanced plaques. The developing plaque also
contains significant amounts of extracellular matrix and lipoprotein. Cholesterol and
cholesterol crystal deposition has also been described (Libby et al., 2002, Lusis,
2000). The process of formation plaque and growth is summarised in the following
sections and in Figure 1.2.  The figure outlines the events leading to the earliest
stages of atherosclerosis, with foam cells differentiation and the fatty streak lesion
formation (Steinberg, 1997).
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Figure 1.2 The sequence of events in atherosclerosis.
Adapted from (Steinberg, 1997).
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This progresses to advanced plaques through cell growth, matrix deposition, cell
migration, cell death and necrosis (Ross, 1993).
1.1.2 Foam cell formation
Modifications of LDL (discussed in section 1.2.2) appear to release inflammatory
lipids that induce endothelial cells to express leukocyte adhesion molecules. It has
also been proposed that mechanical stress on the artery wall (Hansson et al., 2006)
also contributes to the expression of inflammatory cell surface markers which cause
the requirement of monocytes/macrophages into the artery walls intima layer. The
oxLDL particles are taken up by specific scavenger receptors (section 1.2.4) on
macrophages, resulting in the formation of foam cells (Figure 1.3) (Hansson, 2005).
Foam cells are characterised as macrophage cells loaded with cholesterol esters
(Steinberg et al., 1989). OxLDL taken up by macrophages consists of free cholesterol
and cholesterol esters that are hydrolysed in lysosomes. The free cholesterol
undergoes esterification which is catalysed by acyl coenzyme A:cholesterol
acyltransferase (ACAT). The free cholesterol is also stored in the lipid droplets that
characterise foam cells (Ouimet & Marcel, 2011). Endothelial cells (ECs) and SMCs
in lesions also accumulate lipid droplets, but monocyte-derived macrophage foam
cells predominate (Steinberg, 2009). Cholesterol esters within these lipid droplets can
in turn be hydrolysed by cholesteryl ester hydrolase (acid lipase) and proteases
generating free cholesterol and fatty acids, for incorporation into membranes and
transport out of the cells (Ouimet & Marcel, 2011).
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Figure 1.3 Scavenger receptors-mediated macrophage foam cell formation.
Inflammatory stimuli of ECs and macrophage cause the secretion of oxidative
enzymes (lipoxygenases) and reactive oxygen species including NO, O2●-, H2O2, and
HOCl. These oxidants cause LDL oxidation generating oxLDL in the artery wall. The
uptake of oxLDL by ECs, SMCs and macrophages cells via scavenger receptors
CD36, SR-A and other oxLDL receptors is not downregulated in response to
increasing intracellular cholesterol levels causing the macrophage cells to form large
lipid loaded foam cells.
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Mechanisms mediating excess cholesterol efflux are critical for the maintenance of
cholesterol homeostasis in macrophages since the build-up of excess cholesterol is
cytotoxic to the cells (Warner et al., 1995). Therefore, in the presence of an
appropriate extracellular acceptor, mainly high density lipoprotein (HDL), and in
particular the apolipoprotein A1 containing lipoproteins (apoA1), excess cholesterol
can be exported from the cell via the plasma membrane ABCA1 and ABCG1
transports (Moore & Tabas, 2011). This process appears to be partially impaired in
foam cells by oxysterols within oxLDL (Kritharides et al., 1995, Maor & Aviram,
1994). In the absence of extracellular acceptors, excess free cholesterol in the cytosol
undergoes re-esterification to detoxify the excess cholesterol before storage as
cholesterol ester in the cytosol (Van Reyk & Jessup, 1999). OxLDL also inhibit
normal processing of lipids through the endosomes and lysosomes. The oxysterols
and oxLDL appear to resist processing by the lysosomal esterase and proteases (Maor
& Aviram, 1994, Van Reyk & Jessup, 1999). This leads to intra-cytoplasmic
accumulation of cholesterol ester as membrane-free lipid droplets and transformation
of macrophages into foam cell (Maor & Aviram, 1994). The formation of foam cells
has been cited as a key process in plaque development (Steinberg et al., 1989). It is
the clustering of the foam cells that leads to the development of the fatty streak.
Thereafter, continued cell influx and proliferation leads to more advanced lesions,
distinguished by their complex structures, fibrous character with areas of lipid
deposition and often calcification (Mendis et al., 2005).
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1.1.3 Cell death mechanisms
Cell death occurs either by necrosis or apoptosis or both together (Halliwell &
Gutteridge, 2007). Necrotic cell death is characterised by swelling of the cell and
internal organelles, rupture of the plasma membrane, loss of integrity of
mitochondrial, peroxisomal and lysosomal membranes. The cells content is released
as a result of this lysis to the surrounding environment and so will affect the nearby
cells. This cellular content can contain pro-oxidants such as copper iron, antioxidants
such as glutathione (GSH) and  degradative molecules such as activated calpains
(Halliwell, 2003). Collectively the internal cellular contents can trigger cellular
inflammation. In contrast apoptotic cell death is characterised by cell shrinkage and
bleb formation on the surface of the cell membrane without the membrane losing its
integrity. Internal organelles retain their structure, but chromatin condensation and
nuclear fragmentation occur (Yuan et al., 2000). The cell breaks into small
membrane-surrounded fragments (called apoptotic bodies), without rupture of
organelle membranes (Haunstetter & Izumo, 1998). The apoptotic bodies are then
cleared by phagocytosis without inciting an inflammatory response. The
redistribution of phosphatidylserine (PS) to the outer surface of plasma membrane is
also a hallmark of apoptosis, which enables the recognition of apoptotic bodies by
phagocytic cells (Van Engeland et al., 1998). If the apoptotic bodies are not
phagocytosed, a process known as secondary necrosis will occur, in which the
membranes of apoptotic bodies lyse and the contents of the bodies are released
(Tabas, 2005).
CHAPTER 1 9
___________________________________________________________
1.1.4 Lesion progression, immunological response and
inflammation
Macrophages, T cells, mast cells, ECs and SMCs play a key role in the formation and
progression of atherosclerotic lesions (Hansson, 2005). All stages of atherosclerosis,
from initiation to progression, have an involvement of the immune system (including
both innate immunity and adaptive immunity). In atherosclerotic plaques there is an
accumulation of immune cells, such as monocytes/macrophages, dendritic cells
(DCs), and numerous lymphocytes, which include different subpopulations of
leukocytes (Shimada, 2009). In the sub-endothelial space, there are complexes of
antibodies and antigens also present (Prohaszka & Fust, 2004, Binder et al., 2007).
In response to inflammatory signals, circulating monocytes near the artery wall attach
to endothelial cells of the artery wall by cell adhesion molecules. Monocytes migrate
through the endothelial layer into the intima (Li & Glass, 2002). In the sub-
endothelial space, the activation of monocytes, ECs and mast cells together with
mononuclear cells, such as CD4+ T cells occurs (Prohaszka & Fust, 2004, Mandal et
al., 2004). Endothelium activation is induced by a chemoattractants and cytokines or
growth factor (macrophage-colony stimulating factor, M-CSF) released in the intima.
This causes the stimulation of monocytes to enter the artery wall and undergo
differentiation into macrophages. These inflammatory markers also cause the
proliferation and migration of SMCs, net matrix deposition, and fibrous cap
formation in advanced lesions (Newby & Zaltsman, 1999).
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Circulating LDL can diffuse through the endothelial layer into the intima where they
can become trapped by proteoglycans at the artery wall. In the intima LDL appears to
be modified to various forms of oxLDL including the laboratory defined minimally
oxidised LDL (mLDL) and heavily oxidised oxLDL (section 1.2.2). It has been
proposed that the oxidation of LDL in the arterial wall is catalysed by transition metal
ions through the release of iron from transferrin, due to low pH environment of the
intima (Lamb & Leake, 1994). There is also evidence that the oxidation also occurs
by oxidative enzymes including lipoxygenases and oxidative products produced by
specific enzymes such as nitric oxide synthase generating nitric oxide (NO),
NADPH-oxidase (NOX) generating superoxide (O2●-), and hydrogen peroxide
(H2O2), and myeloperoxidase (MPO) generating hypochlorite (HOCl). These
oxidants are secreted from ECs and macrophages during inflammatory stimuli and
are thought to generate oxLDL in the artery wall. Superoxide production from both
the plasma membrane and cytoplasm has been reported in macrophage, ECs and
SMCs. Some of this oxidant production appears to be due to the release of
cytochrome c from the mitochondria as a result of cell death and lysis (Harada-Shiba
et al., 1998, Kinscherf et al., 1998, Zmijewski et al., 2005, Sukhanov et al., 2006).
The resulting oxLDL can be taken up by macrophages via scavenger receptors CD36,
SR-A and other oxLDL scavenger receptors (section 1.2.4) which results in the
accumulation of cholesterol ester in the macrophages, leading to the formation of
foam cells (section1.1.2). At the same time SMCs migration from the media region
into the intima causes irregular thickening of arterial intima and migration along
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endothelial layer. SMCs synthesise extracellular matrix leading to formation of
fibrous plaque lesion (Newby & Zaltsman, 1999).
The interaction oxLDL and other oxidative products with the various cells within the
artery wall leads to release of additional inflammatory cytokines (e.g., γ-interferon
and tumour necrosis factor-α, TNF-α), chemokines, oxygen and nitrogen radicals, and
other inflammatory molecules (Hansson, 2005). Antigens presented by macrophages
and DCs (antigen-presenting cells) also may trigger the activation of antigen-specific
T cells in the artery. Most of the activated T cells produce Th-1 cytokines (e.g. γ-
interferon), which activate macrophages and vascular cells, leading to inflammation
(Hansson, 2005). Interferon-γ improves the efficiency of antigen presentation and
augments synthesis of the inflammatory cytokines such as TNF-α and interleukin-
1(IL-1) (Szabo et al., 2003). Regulatory T cells modulate the process by secreting
anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth
factor-β (TGF-β). The balance between inflammatory and anti-inflammatory activity
controls the progression of atherosclerosis. Metabolic factors may affect this process
in several ways, by contributing to lipid deposition in the artery and initiating new
rounds of immune-cell involvement (Hansson, 2005).
In early and advanced lesions oxLDL appears to induce foam cells death by
apoptosis/necrosis. As a result of prolonged inflammation, foam cells and SMCs have
been shown to undergo apoptosis and secondary necrosis leading to the formation of
the necrotic core. This necrotic core region contains cell debris from necrotic cells
plus insoluble protein, free cholesterol and cholesterol ester deposits (Seimon &
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Tabas, 2009). This necrotic core region can become unstable if the overlying fibrous
cap is produced forming vulnerable plaque which is prone to rupture. The release of
matrix metalloproteinases (MMPs) by macrophages is though to be a key step in the
formation of these unstable vulnerable plaques (Moore & Tabas, 2011).
1.1.5 Plaque rupture and thrombosis
The advance plaque, often refered to as a “lesion” may further increase in size and
subsequently rupture due to thining of the fibrous cap so exposing the underlying
lipid-rich necrotic debris to the blood. This appears to trigger thrombus formation and
precipitate acute vascular events (Mendis et al., 2005). Plaque rupture is a serious
clinical event because it exposes pro-thrombotic material from the core of the plaque
(phospholipids, tissue factor and platelet-adhesive matrix molecules) to the blood
(Figure 1.4) (Hansson, 2005). Plaque rupture preferentially occurs where the fibrous
cap is thin and partially destroyed. At these sites, activated immune cells are
abundant. They produce numerous inflammatory molecules and proteolytic enzymes
that can weaken the fibrous cap and activate cells in the core, transforming the stable
plaque into a vulnerable, unstable structure that can rupture, induce a thrombus, and
elicit an acute coronary event i.e. heart attack or stroke (Hansson, 2005).
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Figure 1.4 Atherosclerotic lesion thrombosis formation.
Microbes, auto-antigens, and various inflammatory molecules can activate T cells,
macrophages, and mast cells, leading to the secretion of inflammatory cytokines (e.g.,
γ-interferon and tumour necrosis factor) that reduce the stability of plaque. The
activation of macrophages and mast cells also causes the release of
metalloproteinases and cysteine proteases, which directly attack collagen and other
components of the tissue matrix. These cells may also produce prothrombotic and
procoagulant factors that directly precipitate the formation of thrombus at the site of
plaque rupture. Taken from (Hansson, 2005).
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1.2 Low density lipoprotein
Low density lipoprotein (LDL) is the main carrier of cholesterol within the plasma,
delivering cholesterol from the hepatocytes to the peripheral cells. In normolipidemic
person, the serum LDL concentration is about 3 mg/ml total mass (total mass, protein
plus lipid components with apoB portion making up 1/5 of mass) and typically this
LDL carries about 60% of the total serum cholesterol (Esterbauer et al., 1992). The
amount of cholesterol and cholesterol esters associated with LDL are typically about
two-thirds
of the total plasma cholesterol (total plasma cholesterol ranges from 1.3 to 2.6 mg/ml)
(Mathews & Van Holde, 1996). In the artery wall, the LDL concentration is higher
than that of other lipoproteins, although the range is still within that found in plasma
(Steinbrecher & Lougheed, 1992).
1.2.1 LDL Composition
LDL is a particle with a spherical shape with diameter of 19-25 nm, relative
molecular mass between 1.8 and 2.8 million and a density range of LDL is 1.090-
1.063 g/ml.  Each LDL particle has an average of 170 molecules of triglycerides, 600
molecules of cholesterol and 1600 molecules of cholesterol esters (mostly cholesterol
linoleate) forming an inner core. The core is surrounded by phospholipid monolayer
containing about 700 phospholipid molecules (mainly phosphatidylcholine) with their
polar head groups oriented towards the aqueous phase. Of the fatty acids, half are
polyunsaturated fatty acids (PUFAs) making LDL highly susceptible to free radical
mediated oxidation (Parthasarathy et al., 1990). The fatty acid contents vary
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considerably among individuals. For instance, linoleic acid content varies from 1200
to 2400 nmol/mg LDL protein. This variation in the PUFA content affects the
oxidation susceptibility of LDL in the laboratory and possibly clinically (Esterbauer
et al., 1992, Thomas et al., 1994).
The LDL particle contains only one protein called apolipoprotein B100 (apoB100)
which is made up of 4536 amino acids. Structurally apoB100 is made up of extensive
 sheet with small amount of -helices. The apoB100 protein is embedded in the
lipid phase with extensive hydrophobic and hydrophilic sections (Obama et al., 2007,
Johs et al., 2006). The interactions between apoB100 and the LDL receptor are
critical for the normal, regulated receptor-mediated endocytosis of LDL by target
cells (Brown & Goldstein, 1986).
Due to the high PUFAs content LDL contains a variety of antioxidants for protection.
On average, each molecule of LDL has 6 -tocopherol molecules and the remaining
antioxidants are each reported to be present at less than one mole per mole of LDL
and include γ-tocopherol, ubiquinol-10, retinoids and carotenoids (Esterbauer et al.,
1992). These lipid soluble antioxidants are present in both the core and phospholipid
outer layer. Since the structure of LDL is reasonably fluid, the lipid soluble
antioxidants can move freely between the core and the phospholipid coat (Schuster et
al., 1995). When LDL is exposed to oxidants, α-tocopherol is generally the first
antioxidant to be consumed while β-carotene is the last (Esterbauer et al., 1991). It is
usually only after the antioxidants are consumed that significant lipid oxidation
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occurs within the LDL particle. Under very low but extended exposure to oxidants α-
tocopherol can be involved in the lipid oxidation (Bowry et al., 1992).
1.2.2 LDL oxidation
Oxidative LDL modification, especially copper ion oxidation, involves the
peroxidation of the PUFAs in the LDL particle (Esterbauer et al., 1992). The lipid
oxidation reactions in turn oxidise and damage the apoB100 protein moiety to give a
particle that is not recognised as oxLDL by the cells scavenger receptors but is no
longer recognised as LDL by the LDL receptor. The peroxidation starts when a
reactive free radical (R●) detaches a hydrogen atom from PUFAs (LH) and yielding a
carbon-centred lipid radical (L●). This in turn reacts with oxygen and forms lipid
peroxyl radical (LOO●), which can then attack further PUFAs (LH) generating further
lipid peroxyl radicals. The lipid peroxyl radicals also attack the apoB100 to generate
protein hydroperoxides (LOOH) (Gieseg et al., 2003). The resulting chain reactions
would rapidly oxidise all the PUFAs in the particle except that the LDL antioxidant
α-tocopherol (Vitamin E) scavenges the peroxyl radical preventing the chain reaction
from occurring. In the plasma the resulting tocopherol radical is regenerated by
ascorbate. In the absence of water soluble antioxidants, like ascorbate, lipid
peroxidation occurs once all the α-tocopherol is consumed (Jessup et al., 1990). The
resulting lipid peroxides can break down via metal catalysed reactions to stable but
often reactive end-products such as lipid aldehydes, hydrocarbon gases, epoxides and
alcohols (Esterbauer et al., 1992, Gieseg et al., 2009b).
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Lipid aldehydes, in particular, 4-hydroxy-2-nonenal (HNE) and malondialdehyde
(MDA), reacted with lysine residues within the apoB100 protein of LDL. The
aldehyde binding to the lysines destroys the LDL receptor binding site on the LDL
and causes the LDL to be recognised/bound by macrophage scavenger receptors
(section 1.2.4) (Hoff et al., 1989). OxLDL is not observed in plasma. However,
antibodies against oxLDL have been detected in the plasma of patients with heart
disease (Salonen et al., 1992, Shaw et al., 2001). Antibodies against oxLDL are
present in normal animal and human plasma, but in atherosclerosis, both oxLDL and
oxLDL antibodies have been reported (Steinberg, 2009).
Several lines of evidence support the involvement of oxLDL in the development of
atherosclerosis. Plasma LDL isolated from people with extensive atherosclerosis
shows a mild degree of oxidation (Palinski et al., 1995). Components of oxLDL have
been shown to be present in human and animal models of atherosclerotic lesions.
Analysis of plaques has detected cholesterol oxidation products, linoleic and
arachidonic acid peroxides and hydroxides, and decomposition products of lipid
peroxides (HNE and MDA) (Niki, 2009). In addition, antibodies that recognise a
range of epitopes, including aldehydes and specific oxidised lipids present in oxLDL
were found in the plasma from patients with coronary artery disease (Toshima et al.,
2000). The significance of these findings was shown by two separate studies. The
first study showed that immunisation of mice or rabbits lacking LDL receptors with
MDA-treated LDL led to high plasma antibody levels, and less atherosclerosis (Soto
et al., 2012). The second study showed that antibodies recognising oxidised mouse
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LDL caused decreased atherosclerosis in LDL-receptor deficient mice (Shoenfeld et
al., 2004).
1.2.3 Types of oxLDL
There is a range of “oxidised” or high uptake LDL types all of which are taken up by
the cells in a non-LDL receptor dependent mechanism. Types described in the
literature include aggregated LDL (agLDL), minimally oxidised LDL (mLDL),
moderately (mod-LDL) or mildly oxidised LDL (although some publications
consider these as two different types), hypochlorite oxidised LDL (HOCl-oxLDL)
and heavily oxidised LDL (oxLDL) usually made with copper ions with extended
incubation periods more than 24 hours (Gieseg et al., 2009a).  The type of oxLDL
made in the laboratory and the degree of oxidation is chosen according to the type of
cells and the research. AgLDL contains little or no lipid peroxidation, less tocopherol
or coenzyme Q10 (CoQ10). Technically, it is not oxidised and apparently not
cytotoxic. AgLDL may initiate vascular disease due to low solubility, reduced
diffusion potential and ability to act as a source of lipoprotein for oxLDL formation.
Furthermore, it is rapidly taken up by macrophages (Khoo et al., 1988, Asmis et al.,
2005). mLDL contains lipid hydroperoxides and greatly reduced α-tocopherol levels
(30-50% compared with native LDL). It is not cytotoxic but has often been reported
in the literature as being cytotoxic (Sparrow et al., 1988, Massaeli et al., 1999).
Mildly oxidised LDL has been reported to be more toxic than moderately oxidised
LDL. Mildly oxidised LDL is high in hydroperoxides, but low in oxysterols (e.g. 7-
ketocholesterol, 7-KC) and MDA, contains no α-tocopherol and little protein damage
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based on overall charge. The relatively high hydroperoxide levels of mildly oxidised
LDL could be the cause of the observed increase in cell death and apoptosis. In
contrast, mod-LDL is higher in oxysterols and less toxic (Carpenter et al., 2003,
Gerry et al., 2007, Gerry & Leake, 2008). HOCl-oxLDL is characterised by heavy
oxidation of the apoB100 residues of Cys, Met, Tyr, Trp, lipid oxidation and organic
chloramine formation (Hazell et al., 1994, Vicca et al., 2003). During inflammation
HOCl-oxLDL may be a significant product within the artery wall as chlorinated
amino acid residues within atherosclerotic plaques have been detected (Hazen &
Heinecke, 1997). The resulting HOCl is cytotoxic to cells including macrophages
(Vicca et al., 2000, Vicca et al., 2003). Heavily oxLDL has the highest oxysterol
levels and is the most cytotoxic. It is characterised by its colourless appearance and
oxidation of all tocopherol and –carotene, is often aggregated during preparation,
and is high in oxysterols, protein carbonyls and isoprostanes. The resulting associated
apoB100 appears heavily fragmented on sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) analysis (Esterbauer et al., 1989, Lenz et al., 1990,
Reid et al., 1993, Baird et al., 2004, Gerry et al., 2007). In heavily oxidised LDL,
50% of total cholesterol is oxidised, predominantly to 7-ketocholesterol. Few
unoxidised sterolesters remain, all hydroperoxide-containing esters have further
oxidised as well as and up to 90% of the steryl ester acyl groups (Brown et al., 2000).
1.2.4 OxLDL uptake and scavenger receptors
Monocyte/macrophages in culture take up oxLDL much more rapidly than they take
up native LDL. OxLDL does not bind to normal LDL receptors. Instead, oxLDL
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binds with high affinity to macrophage-specific plasma membrane receptors called
scavenger receptors. Scavenger receptors appear to be important for the binding of
oxidised phospholipids for the recognision of apoptotic cells but also bind oxLDL
(Shaw et al., 2000). Macrophages possess several scavenger receptors for taking up
oxLDL, including scavenger receptor A (SR-A), scavenger receptor B1 (SR-B1),
CD36, CD68 and scavenger receptor for phosphatidylserine and oxidised lipoprotein
(Linton & Fazio, 2001, Boullier et al., 2001, Febbraio et al., 2001). SR-A and CD36
mediate the uptake of oxLDL and promote the development of atherosclerosis
(Linton & Fazio, 2001, Boullier et al., 2001, Febbraio et al., 2001). CD36 also
functions as a fatty acid transport protein in adipose tissue and muscle (Febbraio et
al., 2001). Internalisation of oxLDL via CD36 generates oxLDL products (oxidised
phospholipids and oxysterols), which is mediated by lipoxygenase (Febbraio et al.,
2001, Steinberg, 2002). These lipids provide ligands for the transcriptional regulator,
peroxisome proliferator-activated receptor-γ (PPAR-γ) and activate LXR−RXR
heterodimers, resulting in nuclear translocation and increased transcription of target
genes (Li & Glass, 2002). The increased expression of CD36 on the cell surface leads
to further internalisation of modified LDL and eventual foam cell formation
(Febbraio et al., 2001).
SR-B1 binds HDL with high affinity and mediates selective cholesterol delivery to
liver and steroidogenic tissues by a mechanism distinct from the classic LDL receptor
pathway (Acton et al., 1996). Gene encoding studies showed that SR-B1 has an anti-
atherogenic function (Braun et al., 2002). In macrophages, SR-B1 facilitates
cholesterol ester re-uptake by inhibiting net ATP-binding cassette 1 (ABCA1)-
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mediated cholesterol efflux (Chen et al., 2000). Thus, the overall actions of SR-B1 in
the arterial wall seem to be protective (Li & Glass, 2002). As the cholesterol content
of the macrophage increases, accumulation of cholesterol occurs to the point of foam
cell generation, without down regulation of these receptors (Steinberg, 2009).
Macrophages possess at least two major pathways for the uptake of oxLDL. SR-A
takes up both acetylated LDL (acLDL) and oxLDL. AcLDL was able to compete for
around 40% of oxLDL uptake (Sparrow et al., 1988). CD36 appears to only take up
oxLDL and cannot be out competed with acLDL (Lougheed & Steinbrecher, 1996).
There are also non-receptor mediated mechanisms for the uptake of oxLDL by the
cells. For example, aldehydes and oxysterols enter the cells’ plasma membrane by
partitioning from the lipid phase of oxLDL (Gotoh et al., 1993, Brown et al., 1997).
OxLDL can also be taken up by non-specific receptor-mediated endocytosis,
especially in the aggregated form (Khoo et al., 1988, Brown et al., 1997).
1.2.5 OxLDL metabolism
The oxLDL taken up by the receptor mediated endocytosis is delivered to lysosomes
where the cholesterol esters are degraded into free fatty acids and free cholesterol by
cholesteryl ester hydrolase (acid lipase) and proteases (cathepsins). Free cholesterol is
readily esterified by the endoplasmic reticulum ER enzyme ACAT, leading to intra-
cytoplasmic accumulation of cholesterol ester as membrane-free lipid droplets, so
transforming the macrophage cells into foam cells (Li & Glass, 2002). Uptake of
acLDL by macrophages leads to extensive cholesterol accumulation (Moore & Tabas,
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2011). Free cholesterol is able to leave the lysosome to relocate in all cell
membranes. Excess cholesterol in foam cells undergoes efflux onto HDL by ABCA1
and ABCG1 transporters and then is transported to the liver for excretion in the bile
(Terasaka et al., 2007). Loading foam cells with free cholesterol, oxLDL and 7-
ketocholesterol, the major oxysterol present in oxLDL induced apoptosis (Freeman et
al., 2005). HDL exerted a protective effect against this apoptosis (Terasaka et al.,
2007). Excess cellular accumulation of oxLDL and oxysterols causes disfunction in
ACAT and defect in ABCA1and ABCG1transporters lead to impaired efflux of free
cholesterol from the cells onto HDL, trapped free cholesterol in the cells and induced
cell death in advanced lesions (Moore & Tabas, 2011).
For reasons not fully understood, a portion of the cholesterol esters become resistant
to acid esterases and remain trapped in the lysosomes and represent approximately
90% of the total ester pool in oxLDL-loaded macrophages. Cholesterol esters
together with other undegradable components, such as oxidised apoB and oxidised
sterylesters remain appearently trapped within the lysosomal in the form of
particulate insoluble materials such as ceroid (Jessup & Kritharides, 2000).
1.2.6 OxLDL cytotoxicity
OxLDL triggers cell death in a wide number of different cell types such as ECs,
SMCs, human monocyte-derived macrophage (HMDM) cells and human derived
monocyte-like U937 and THP-1 cell lines (Henriksen et al., 1979, Hessler et al.,
1979, Baird et al., 2005, Gieseg et al., 2010). There is a directly proportional
relationship between oxLDL concentration and cell death. The cytotoxicity of oxLDL
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in vitro experiments generally occurs between 100 and 400 g/ml of apoB protein
(0.25 to 2.0 mg/ml total mass of LDL) depending on the LDL preparation and type of
cell (Gieseg et al., 2009a).
The exact composition of oxLDL depends on the nature and amount of oxidant used,
with the latter parameter related to oxidant concentration, duration and conditions of
exposure. These conditions appear to affect the level of oxLDL cytotoxicity. For
example, lipoxygenases catalyse peroxidation of fatty acids generating a less
cytotoxic oxLDL than oxLDL made with hypochlorite which oxidises the
apolipoprotein B100 protein (Jessup & Kritharides, 2000). Some of the oxidation
products that are present in oxLDL after exposure to copper are oxysterols (e.g. 7-
ketocholesterol), hydroperoxides (e.g. linoleyl hydroperoxide), hydroxides (e.g.
linoleyl hydroxide), ketones (e.g. oxo-octadecadienote), F2-isoprostanes (e.g. 8-epi-
prostaglandin F2), core aldehydes (e.g. 9-oxononanoate), fragmentation (e.g. 3-
chlorotyrosine), cross-linking (e.g. dityrosine), amino acid oxidation (e.g.
hydroxyleucine) and amino acid dervativatisation products (Jessup & Kritharides,
2000). Many of these compounds are cytotoxic when given directly to cells. OxLDL
is therefore thought to cause macrophage cell death due to the cytotoxic chemicals,
within the particle (Darley-Usmar et al., 1991, Clare et al., 1995). OxLDL induces
intracellular oxidant production by decreasing antioxidant enzymes or increasing
production of reactive oxygen species (ROS) such as H2O2 and HOCl (Dimmeler et
al., 1997). The binding of oxLDL to CD36 causes H2O2 release (Maxeiner et al.,
1998). Also the binding of oxLDL to CD36 activates caspase-3 to induce apoptosis in
human macrophages (Wintergerst et al., 2000). In addition, oxLDL and oxysterols
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cause loss of the intracellular antioxidant GSH (Baird et al., 2004, Rutherford &
Gieseg, 2011).
The nature of the cell death does appear to depend on the type of death mechanism
stimulated by oxLDL. Cell death induced by oxLDL can be either necrotic or
apoptotic or both depending on cell type and incubation conditions (Gieseg et al.,
2009a). Direct observations of plaque have shown foam cells dying by an apoptosis-
like mechanism as indicated by TUNEL staining (DNA fragmentation) of the cells
(Hegyi et al., 1996). Monocytes and macrophages derived from human blood showed
caspase-dependent and -independent cell death (Nhan et al., 2003, Asmis & Begley,
2003). In the absence of human serum, oxLDL induces apoptosis via the caspase-3
activation mechanism in HMDM cells (Asmis & Begley, 2003). In this laboratory, in
the presence of 10% human serum, oxLDL induces cell death via necrosis with a
rapid loss of GSH and without caspase-3 activation (Gieseg et al., 2009a, Baird et al.,
2004).
With human derived monocyte-like THP-1 cells, increasing oxLDL concentration
results in increasing activity of caspase-3 (Baird et al., 2004). THP-1 cells undergo
classic apoptosis with the appearance of annexin V staining morphology due to the
flipping of phosphatidylserine to the outer surface of the membrane, caspase-3
activation and a small reduction in cellular thiol after exposure to oxLDL (Baird et
al., 2004, Vicca et al., 2000). In U937 cells, incubation with oxLDL causes
phosphatidylserine exposure (a marker of apoptosis), but with the absence of caspase
activity. The oxLDL also causes a dramatic loss of intracellular thiol, which may
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cause the inhibition of caspase activity. The failure of caspase-3 appears to lead to
necrosis with cell swelling and lysis with no phosphatidylserine exposure on the cell
membrane (Baird et al., 2004). The difference in responses to oxLDL could be related
to the varying mechanisms of uptake of oxLDL. U937 cells uptake by CD36 scavenger
receptor four-fold higher than THP-1 cells (Nguyen-Khoa et al., 1999), which causes
oxidative stress. In contrast, THP-1cells uptake by scavenger receptors were partially
regulated by the transcriptional regulator PPAR- γ, in response to oxLDL (Inoue et al.,
2001).
OxLDL uptake via scavenger receptors is important for cell death because it alters the
cellular response to oxLDL. Antibodies to CD36 do not inhibit oxLDL uptake but do
significantly reduce the level of ROS produced, caspase activation and cell death in
human aortic smooth muscle cells (HASMCs) (Sukhanov et al., 2006) and in HMDM
cells (Wintergerst et al., 2000). OxLDL result in the generation of more ROS in U937
cells than THP-1 cells possibly because THP-1 cells have lower level of CD36
expression than U937 cells (Nguyen-Khoa et al., 1999). In THP-1 cells where oxLDL
is though to be mainly taken up via the SR-A receptor which seems to alter the type
of cell death (Liao et al., 2000). Interestingly, there is no appearent difference in the
degree of oxLDL toxicity between U937 and THP-1 cells (Baird et al., 2004).
Aggregation of oxLDL causes a decrease in macrophage injury and necrotic core
formation. Aggregation of oxLDL also causes increase in oxLDL uptake, so
increaseing cholesterol ester accumulation and foam cell formation. Aggregated
oxidised low density lipoprotein (aggoxLDL), is taken up through the SR-A receptor
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but not by the CD36 receptor. AggoxLDL enhances oxLDL clearences by
macrophages without damage to the cells (Asmis et al., 2005) which may explain
why aggoxLDL does not appear to increase free cholesterol levels.
1.3 Antioxidants
Antioxidants are substances which at at low concentrations are able to react with and
neutralise free radicals faster than the radical reaction with key biomolecules such as
proteins, lipids or DNA. Antioxidants can be enzymatic and non-enzymatic
compounds. The main antioxidant enzymes are superoxide dismutase’s (SOD),
catalases and glutathione peroxidases. The most commonly studied non-enzymatic
antioxidants are glutathione, ascorbate, α-tocopherol and β-carotene (Halliwell &
Gutteridge, 2007).
1.3.1 Oxidative stress
Oxidative stress is defined as an increase in the production of ROS due to an
imbalance between oxidants and antioxidants leading to damage of lipids, proteins,
nucleic acids, membrane and genes (Sies, 1991). Oxidative stress can result either
from low levels of antioxidants and/or from an increased production of reactive
species (Halliwell & Whiteman, 2004). Free radicals and ROS interact with other
molecules within cells inducing oxidative stress and oxidative damage. Oxidative
damage has been implicated in the cause of many diseases, such as cardiovascular
disease, cancer and Alzheimer’s disease (Sies, 1991). In this research the antioxidant
activities of two specific antioxidants, GSH and 7,8-dihydroneopterin (7,8-NP) will
be examined in oxLDL treated cells.
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1.3.2 The antioxidant effect of glutathione
Glutathione (L--glutamyl-L-cysteinylglycine, GSH) is synthesized from its
constituent amino acids by the sequential action of cytosolic enzymes, -
glutamylcysteine synthetase (-GCS) and GSH synthetase. GSH is important in
maintaining various proteins in a reduced state. GSH is the key thiol controlling the
redox potential and state of reduction within the cell. GSH plays a critical role in
cellular defenses against electrophiles, oxidative stress and nitrosating species
(Griffith, 1999, Meister, 1988). The intracellular GSH concentration, typically 1-8
mM, reflects a dynamic balance between the rate of GSH synthesis and the combined
rate of GSH consumption within the cell and loss through efflux.
Approximately 70% of the cells total antioxidant capacity is due to the presence of
free thiol, whose reduction is partially dependent on the GSH concentration
(Balcerczyk & Bartosz, 2003). Administration of L-cysteine precursors and other
strategies allow GSH levels to be maintained under conditions that would otherwise
result in GSH depletion and cytotoxicity. Conversely, inhibitors of -GCS have been
used to deplete GSH as a strategy for increasing the sensitivity of tumours and
parasites to certain therapeutic interventions (Griffith, 1999). Excessive accumulation
of lipids derived from oxLDL, induces oxidative stress in foam cells and causes a
compensatory increase in the synthesis of the endogenous antioxidant, GSH (Bea et
al., 2003, Shen & Sevanian, 2001, Darley-Usmar et al., 1991). The oxidised GSH
(GSSG) is converted back to GSH by the action of GSH-reductase using NADPH,
which means the cell can withstand a certain level of oxidative stress (Gieseg et al.,
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2009b). A number of the key enzymes in metabolism such as glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) enzyme, as well as regulatory enzymes like
caspases, require key cysteine residues to be in a reduced free thiol state for activity
(Baty et al., 2002, Hampton et al., 2002b). The interaction between ascorbate and
GSH is an essential part of the cellular defence mechanism. Ascorbate reduces the
level of GSH loss and subsequent DNA base and protein damage in human arterial
smooth muscle cells (Jenner et al., 2002).
In macrophages, depletion of intracellular GSH disables caspases and thus apoptosis
is inhibited (Boggs et al., 1998). A high GSH status in monocytes and macrophages
is important in both  controlling the foam cell formation and detoxification of oxLDL
(Gotoh et al., 1993). In HMDM cells, oxLDL depleted intracellular GSH and
inhibited glutathione reductase, resulting in a marked diminution of the GSH/GSSG
ratio (Gotoh et al., 1993). Since GSH/GSSG ratio is one of the principal determinants
of the cellular redox environment, any alteration in the redox environment can lead to
cellular dysfunction and cell death (Schafer & Buettner, 2001). In the absence of
oxLDL, an 80% depletion of intracellular GSH levels did not affect cell viability, but
GSH depletion dramatically increased oxLDL-induced cell death. Conversely,
supplementation of intracellular GSH stores with glutathione diethyl ester
substantially diminished oxLDL toxicity (Wang et al., 2006). In vitro, exposure of
macrophages and THP-1 cells to oxLDL or HNE (a reactive aldehyde formed during
LDL oxidation) causes oxidative stress and depletion of GSH, followed by re-
synthesis and elevated levels of GSH after 24 hours and in turn, increases in availbale
antioxidant (Darley-Usmar et al., 1991). Also, increases in GSH and antioxidant
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vitamins such as vitamins C and E play a central role in the antioxidant defences of
human umbilical artery smooth muscle cells (HUASMCs) and may help to prevent
oxLDL-mediated alterations in cell signalling, gene transcription and vascular
reactivity occurring during atherogenesis (Siow et al., 1998). Similarly, increasing
GSH levels by treatment with GSH-ethyl ester decreased mouse-derived IC21
macrophage death resulting from oxLDL-induced apoptosis (Rosenson-Schloss et al.,
2005). The intracellular GSH status plays an important role in the differentiation and
phagocytic activity of macrophages (Kim et al., 2004).
1.3.3 Synthesis of 7,8-dihydroneopterin
Macrophages do not just release oxidants but they also release antioxidants. As
mentioned previously, macrophages are a major source of the oxidants that can
oxidise LDL to oxLDL including O2●-, HOCl and reductants that increase the level of
Fenton active metal ions on LDL (Firth et al., 2008a). Macrophages appear to
respond to inflammatory mediators by increasing their antioxidant capacity. During
inflammation, -interferon released by Th-1 cells has been shown to stimulate
macrophages to synthesise a potent antioxidant, 7,8-dihydroneopterin, which is
generated through the enzymatic breakdown of guanosine triphosphate (GTP) by
GTP-cyclohydrolase (Figure 1.5) (Gieseg et al., 2008).
Interferon-γ generally prepares immune cells for inflammation by stimulating the
macrophages in to various cellular changes such as increasing the NOX superoxide
generating capacity (Cassatella et al., 1985, Kikuchi et al., 1994).
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Figure 1.5 Generation and oxidation of 7,8-dihydroneopterin.
Interferon-γ stimulation of macrophages causes the enzymatic breakdown of
intracellular GTP to 7,8-dihydroneopterin which can either be oxidised to the highly
fluorescent neopterin by HOCl or to 7,8-dihydroxanthopterin by peroxyl and
hydroxyl radicals. Adapted from (Gieseg et al., 2009b).
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Interferon- also up regulates synthesis of indoleamine2,3-dioxygenase (IDO) which
catalyses the breakdown of tryptophan to  3-hydroxyanthranilic acid (3HAA) which
also has antioxidant activity in vitro (Christen et al., 1994, Gieseg et al., 1995).
Together these two antioxidants appear to play a role in protecting macrophages from
oxidative stress but this research will focus solely on 7,8-dihydroneopterin (Gieseg et
al., 2008).
In vivo, 7,8-dihydroneopterin is oxidised to the highly fluorescent compound
neopterin, which has been used clinically as a marker of immune cell activation for a
number of years (Gieseg et al., 2009a, Wachter et al., 1989). During vascular disease
high levels of neopterin are detected in the plasma and at micro-molar concentrations
in atherosclerotic plaques (Firth et al., 2008a, Ray et al., 2007, Adachi et al., 2007).
1.3.4 The antioxidant effect of 7,8-dihydroneopterin
It is possible that micro-molar concentrations of  7,8-dihydroneopterin are capable of
exerting a biological effect on oxidative processes (Firth et al., 2008b). This and other
laboratories have reported that 7,8-dihydroneopterin was relatively a good antioxidant
and inhibitor of oxidant-induced cell death when added at low micro-molar
concentrations to cell culture media (Duggan et al., 2002, Gieseg et al., 1995). 7,8-
Dihydronepterin has a protective effect against oxidant damage on cells, cellular
membranes, free proteins, cellular protein and protein thiol (Gieseg et al., 2000,
Gieseg et al., 2001b, Duggan et al., 2002, Gieseg et al., 2008). The protective effect
of 7,8-dihydronepterin is due to the potent radical-scavenging ability of 7,8-
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dihydronepterin with peroxyl radical (ROO●), O2●- and HOCl (Duggan et al., 2002,
Oettl et al., 1997).
In vitro, it was shown that 7,8-dihydroneopterin neutralised lipid peroxyl radicals,
inhibited copper, 2,2'-azobis (2-amidinopropane) hydrochloride (AAPH) and cell-
mediated LDL oxidation (Gieseg et al., 2003, Gieseg et al., 1995).
It has been hypothesised that in vivo, this may slow the rate of LDL oxidation,
therefore lowering the concentration of oxLDL within plaques (Gieseg et al., 1995,
Gieseg et al., 2003, Gieseg & Cato, 2003, Firth et al., 2007b). In U937 cells but not
in THP-1 cells, 7,8-dihydroneopterin was shown to inhibit the cytotoxicity of oxLDL,
possibly by preventing the loss of the intracellular antioxidant GSH by scavenging
ROS generated in the presence of oxLDL (Baird et al., 2005). 7,8-Dihydroneopterin
has been shown to inhibit oxLDL-induced loss of GSH and cell death in HMDM cells
in this laboratory (Gieseg et al., 2010, Amit, 2008). 7,8-dihydroneopterin was unable
to reduce the oxidised protein thiol and it is unlikely that 7,8-dihydroneopterin can
regenerate or increase the intracellular GSH levels (Duggan et al., 2002).
Micro-molar concentrations of  7,8-dihydroneopterin protect U937 but not THP-1
(Baird et al., 2005, Duggan et al., 2002) or HMDM cells (Firth et al., 2007b) from
AAPH-derived peroxyl radicals (Gieseg et al., 2000). The reason for this was initially
thought to be due to the poor uptake of 7,8-dihydroneopterin in HMDM cells but
these cells have been shown to readily take up the 7,8-dihydroneopterin (Gieseg et
al., 2010). The reason for these differences in protection is still being investigated and
may be due to the speed at which oxidative stress occurs in these cells.
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7,8-Dihydroneopterin has been shown to protect U937 cells from a number of other
oxidants including H2O2, HOCl and free iron ions, which reduce cell viability loss as
well as protein and lipid hydroperoxide formation (Gieseg et al., 2001b, Duggan et
al., 2001). TNF-α-induced apoptosis in U937 cells is also inhibited by 7,8-
dihydroneopterin (Baier-Bitterlich et al., 1995).
1.3.5 The effect of other antioxidants on oxLDL induced cell
death
It has been shown in animal models that the extent and progression of atherosclerotic
plaques is decreased by the administration of antioxidants. Cardiovascular disease is
also associated with low plasma concentrations of ascorbate, tocopherol and –
carotene (Gey et al., 1991). The modification of LDL to oxLDL in atherosclerotic
plaques by macrophages can be inhibited by antioxidants such as α-tocopherol
(vitamin E) (Morel et al., 1983, Steinbrecher et al., 1984). α-Tocopherol inhibited
oxLDL-induced apoptosis in mouse mesangial cells (Tashiro et al., 1999) and in
SMCs (Guyton et al., 1995). Treatment of HASMCs with water-soluble γ-tocopherol
derivative (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, Trolox),
suppressed oxLDL-specific increase in ROS and prevented down-regulation of
GAPDH (Sukhanov et al., 2006). In human coronary artery endothelial cells
(HCAECs), γ-tocopherol significantly decreased oxLDL-induced apoptosis by
inhibiting the activation of nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-kB) (Li et al., 1999). Interestingly, α-tocopherol supplementation of
HMDM cells did not prevent foam cell formation or alter the susceptibility of foam
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cells to lysis by oxLDL (Asmis & Jelk, 2000b) suggesting that plasma membrane
oxidation is not a significant factor in oxLDL toxicity. Additionally, other
antioxidants such as GSH and vitamin C can also inhibit LDL oxidation (Siow et al.,
1998, Lizard et al., 2000). Copper-induced LDL oxidation is inhibited by vitamin C
(L-ascorbic acid, AA) and dehydro-L-ascorbic acid (DHAA), the oxidative product of
vitamin C (Retsky et al., 1999). Results with ascorbic acid inhibition of oxLDL have
been rather inconsistent. Ascorbate gave almost complete inhibition of apoptosis in
human ECs (Dimmeler et al., 1997). Ascorbic acid also protected human vascular
smooth muscle cells (HVSMCs) against apoptosis induced by “moderately oxidised
LDL” which contained high levels of lipid hydroperoxides (Siow et al., 1999).
However, later the same laboratory reported that ascorbic acid did not protect the
murine macrophage cell line J774 against moderately oxidised LDL, but produced a
modest increase in apoptosis (Harris et al., 2006). Detoxification of oxLDL by
DHAA but not ascorbic acid and isoascorbic acid completely inhibited apoptosis
induced by oxLDL. In contrast to oxLDL treated with ascorbic or isoascorbic acid,
thiobarbituric acid reactive substances (TBARS) levels and lipid peroxide levels of
oxLDL treated with DHAA were not substantially reduced. This suggests that
reduction of oxLDL is an unlikely mechanism for the inhibition of oxLDL-induced
apoptosis by DHAA. There is a possibility that the inhibitory effect of DHAA is due
to it reacting with reactive groups within apoB100 (Asmis & Wintergerst, 1998).
Results with butylated hydroxytoluene (BHT) were also varied. BHT has no
protective effect against oxLDL induced death of rabbit aortic smooth muscle cells
(RASMCs) (Liu et al., 1998), but gave partial protection in SMCs (Guyton et al.,
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1995) and gave complete protection to human umbilical vein endothelial cells
(HUVECs) (Harada-Shiba et al., 1998). BHT also blocked oxLDL-induced apoptosis
of mouse peritoneal macrophages (Niu et al., 1996).
Antioxidant thiols could also prevent oxLDL-induced apoptosis. N-Acetylcysteine
(NAC) as well as GSH were successful in protecting mouse vascular smooth muscle
cells (MVSMCs) (Hsieh et al., 2001) and mesanglia cells with oxLDL (Tashiro et
al., 1999). Also, NAC and GSH have been reported to inhibit oxLDL- and 7-
ketocholesterol-induced apoptosis by increasing the intracellular thiol pool in
macrophages and U937 cells (Kinscherf et al., 1998, Lizard et al., 2000).
Increases in putative cystine protease (CPP32-like) activity triggered by oxLDL were
drastically reduced by NAC, vitamin C and α-tocopherol. The decreased CPP32-like
protease activity correlated with a reduction in proteolytic cleavage of the CPP32 into
the active p17 subunit and therefore, probably inhibits apoptosis through inhibition of
caspase-3 activation (Dimmeler et al., 1997).
In vitro, LDL oxidation has been shown to be suppressed by several garlic
compounds (Lau, 2006). Pomegranate juice inhibits oxLDL uptake and cholesterol
biosynthesis in macrophages, which leads to a reduction in cellular cholesterol
accumulation and macrophage foam cell formation (Fuhrman et al., 2005).
Serum albumin, which is the most abundant circulating protein in the plasma
constitutes the major plasma protein target of oxidant stress (Roche et al., 2008). In
vitro, albumin acts as a multifaceted antioxidant. Albumin binds fatty acids and
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protects them from oxidation; binds copper, cysteine, GSH, bilirubin and pyridoxal-
5’-phosphate and in doing so protects them from oxidation (Kouoh et al., 1999). The
presence of serum has been shown to protect macrophages cells against the cytotoxic
effects of oxLDL (Leake & Rankin, 1990, Henriksen et al., 1979).
1.4 Metabolic functions of the cell
One of the most basic functions of a cell is energy release. Cell viability assays like
the thiazolyl blue tetrazolium bromide (MTT) reduction assay essential measure cell
viability by the activity of the metabolism. In the case of the MTT assay this is a
measure of the cells ability to maintain a reductive level of nicotinamide adenine
dinucleotide phosphate (NADPH) and nicotinamide adenine dinucleotide (NADH).
The loss of metabolism is therefore both a cause and consequence of cell death. This
research will be examining cell metabolism failure as a cause of macrophage cell
death following exposure to oxLDL. To reliably measure cell metabolism we have
focussed on key enzymes and products of glycolysis in the cells.
1.4.1 Lactate
Lactate is synthesised from the pyruvic acid derived from glycolysis. Under hypoxic
conditions the animal cells will regenerate nicotinamide adenine dinucleotide (NAD+)
from NADH by the reduction of pyruvate to lactate, which is catalysed by lactate
dehydrogenase (LDH) enzyme. Some tissues and cell types, which have no
mitochondria and thus cannot oxidise pyruvate to carbon dioxide (CO2), produce
lactate from glucose even under aerobic conditions. The resulting lactate is mainly
utilised in the liver and the kidney. During starvation and strenuous muscular activity,
CHAPTER 1 37
___________________________________________________________
lactate can also serve as one of the gluconeogenic precursors. The rate of lactate
synthesis is dependent on the activity of the glycolytic pathway relative to the
oxidative capacity of the pyruvate dehydrogenase enzymatic complex. An
acceleration of lactate synthesis may be observed in conditions of increased glucose
uptake from circulation, of increased glycogenolysis and glycolysis due to enhanced
epinephrine secretion, of inhibition of pyruvate dehydrogenase or of glycogen
synthesis in sepsis and, finally, during tissue hypoxia (Nelson & Cox, 2005). Lactate
measurement of cells such as macrophages therefore represents a very basic measure
of overall glycolytic flux within a cell.
Lactate, which is present in biological fluids as its dissociated canionic form, is
widely distributed among the pathways involved in the intermediary metabolism of
living systems. While, from the physiologists’ point of view, it is one of the most
crucial intermediates of carbohydrate metabolism, for most physicians, it is merely
considered a marker of bad prognosis significantly related to a high mortality rate in
acutely ill patients (Bakker et al., 1991, Marecaux et al., 1996). The concentration of
blood lactate is usually 1–2 mmol/L at rest, but can rise to over 20 mmol/L during
intense exertion. The increased lactate that is produced can be removed by oxidation
to pyruvate for use in the Krebs cycle in the mitochondrion matrix, or by conversion
to glucose via gluconeogenesis in the liver before being released back into the
circulation, otherwise known as the Cori cycle (Nelson & Cox, 2005). It is known
that the blood lactate concentration is increased in patients with obesity,
hypertension, and type 2 diabetes mellitus (non-insulin-dependent) (Digirolamo et al.,
1992). The lactate level is also elevated locally in tissues suffering injury, infection,
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inflammation or ischemia. This is probably due to increased tumour necrosis factor
secretion and transcription during lactic acidosis (Jensen et al., 1990). Although
tissue hypoxia plays a role in the elevation of lactate concentration, the high activity
of anaerobic glycolysis in activated macrophages and adipose tissue can also lead to
high lactate production (Digirolamo et al., 1992, Beckert et al., 2006). Lactate has
been shown to be not only an important intermediary in metabolic processes, but also
an active player in inflammation (Iscra et al., 2002, Hunt et al., 1978, Mustafa &
Leverve, 2002). Lactate enhances lipopolysaccharide (LPS)-stimulated cytokine
expression by macrophages, indicating that lactate promotes the innate immune
activation (Nareika et al., 2005). It is known that bacterial infection and LPS lead to
increased lactate production (Jensen et al., 1990, Tsai et al., 2005). Elevated plasma
lactate is also a marker for cellular stress (Miller et al., 2007). Lactate increased ROS
production and upregulated 673 genes in L6 myogenic cells; many known to be
responsive to ROS (Hashimoto et al., 2007). Lactate and ROS boosted LPS
signalling-mediated inflammatory gene expression. Lactate and LPS promotes TLR4-
mediated inflammation and contributes to a number of diseases, including type 2
diabetes and cardiovascular disease (Samuvel et al., 2009). Extracellular lactate in
wounds stimulates macrophages to secrete vascular endothelial growth factor and
TGF-β, both known to be immunosuppressive factors (Trabold et al., 2003). Pre-
incubation of myeloid U937 and HMDM cells with lactate increases the expression of
inflammatory cytokines, IL-6 and IL-8 (Samuvel et al., 2009). It was also shown that
low pH environment and high concentration of lactate in peritoneal dialysis fluids
inhibits macrophage/monocyte IL-1 β and TNF-α (Douvdevani et al., 1993). Lactate
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can have opposing effects on the activation of different types of immune cells.
Tumour environment have low pH (Gatenby & Gillies, 2004) due to accumulation of
lactate as a result of accelerated glycolysis. Lactate upregulates transcription and
secretion of IL-23, a tumour-promoting cytokine, in human monocytes (Shime et al.,
2008). Tumour-derived lactate strongly inhibits both the differentiation of monocytes
to DCs (Dietl et al., 2010, Gottfried et al., 2006) and the activation of T cells (Fischer
et al., 2007). TNF-α secretion of monocytes depends on both glycolysis and export of
its end product lactate. Monocytes take up extracellular lactate, which results in a
decreased glycolytic flux and an inhibition of TNF-α release. Tumour-derived lactate
and concomitant acidification could modulate and disturb monocyte cytokine
production by blocking lactate export and glycolytic flux. Impairment of glycolysis
may contribute to the immunosuppressive effects of lactate in wounds and tumours
(Dietl et al., 2010).
1.4.2 Lactate dehydrogenase enzyme
Lactate dehydrogenase (LDH) catalyses the reaction that transforms pyruvic acid into
lactate (under anaerobic conditions) in many cells, and vice versa, transforming
lactate into pyruvic acid under aerobic conditions. The essential coenzyme for this
reaction is NAD+ which is converted to NADH. LDH is found in many human
tissues, and is found in the greatest concentration in kidneys, myocardial, skeletal
muscles and liver. Within cells it is located in the cytoplasm. Its concentration in
serum and other tissue fluids is lower than in body tissues. There are at least five
different LDH isoenzymes (LDH1-LDH5) (Bansal & Kaw, 1981, Jovanovic et al.,
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2010, Barrett et al., 1988) separable by electrophoresis. LDH1 founded in the heart
and red blood cells, LDH2 in the reticuloendothelial system LDH3 in the lungs, LDH4
in the kidneys, placenta, and pancreas, LDH5 in the liver and striated muscle (Nelson
& Cox, 2005). LDH1 is called α-hydroxybutyrate dehydrogenase (HBDH) (Barrett et
al., 1988). The extracellular activity of this intracellular enzyme increases under the
conditions of oxidative stress, due to the loss of integrity of the cell membrane in the
course of lipid peroxidation by the influence of free radicals. This leads to an increase
in lactate concentration (Jovanovic et al., 2010). Accumulation of lactate in
myocardial cells has been proposed as a primary trigger of ischemic damage in the
heart (Geisbuhler & Rovetto, 1990). Damage to heart tissues results in the release of
LDH into the blood and the differences in the isoenzyme content of tissues can be
used to assess the timing and extent of heart damage.
The release of LDH is also used as a marker of cell lysis and therefore loss of cell
viability (Legrand, 1992). Measurement of lactate production in cells where cell
death is occurring need to take into accounts this possible loss of LDH activity from
the cells. Unlike the glycolytic enzyme GAPDH to be discussed below, LDH has not
been reported to be sensitive to inactivation by general intracellular oxidative stress
mediated by O2●-, H2O2 or ROO● though it is likely that HOCl will inactivate the
enzyme.
1.4.3 Glyceraldehydes-3-phosphate dehydrogenase enzyme
Glyceraldehydes-3-phosphate dehydrogenase (GAPDH) is an enzyme that catalyses
the sixth step of glycolysis. In the cytosol, GAPDH catalyes the oxidation of
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glyceraldehyde-3-phosphate (GAP) to 1, 3-diphospho-glycerate (1, 3-PGA) with the
conversion of NAD+ to NADH. NADH must be re-oxidised to keep the glycolytic
pathway supplied with NAD+. Usually this oxidation happens within the
mitochondria to produce adenosine triphosphate (ATP) (Nelson & Cox, 2005).
GAPDH, therefore, maintains glycolysis and provides substrates for the Krebs cycle
and electron transport chain (ETC) during the metabolism of sugars (Nelson & Cox,
2005, Yamaguchi et al., 2003).
The molecular mass of the GAPDH enzyme is 36 kDa (Torchinsky, 1981) and is
made up of two domains; one of the domains binds NAD+ and the second domain
binds GAP (Yamaguchi et al., 2003). The loss of GAPDH activity in the cell can be
partly attributed to the loss of NAD+, a cofactor required for the activity of GAPDH
(Schraufstatter et al., 1990). The types of GAPDH can be differentiated by their
cysteine residue active site and GAPDH reversibility and irreversibility.
The GAPDH molecule has four cysteine residues (Cys149, Cys153, Cys244 and Cys281)
(Nakajima et al., 2007) that contain sulfhydryl (-SH) groups. Cys149 and Cys153 are
essential for GAPDH catalytic activity and sensitive to thiol modification and
oxidation (Schuppe-Koistinen et al., 1994). In rat GAPDH the -SH group of Cys150 is
essential for its catalytic activity (Hara et al., 2006). The cysteine thiol group is
sensitive to oxidants as detected by fluorescence labelling (Baty et al., 2002) and can
be oxidised to sulfenic (-SOH), sulfinic (-SO2H) and sulfonic (-SO3H) acids, S-
nitrosothiols (-SNO) and disulfides (R-S-S-R) (Cuddihy et al., 2009b, Sukhanov et
al., 2006, Pullar et al., 2000, Albina et al., 1999).
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Reversible GAPDH enzyme inhibition is mediated by S-nitrosylation of its active site
Cys149 (Mohr et al., 1996). S-Nitrosylation modification protects thiol-containing
enzymes such as GAPDH from oxidative inactivation in settings of cytokine
overproduction and regulates glycolysis, seen in cellular systems activated with
inflammatory cytokines (Horton et al., 1994). In contrast, irreversible enzyme
inhibition in some cellular systems (Molina Y Vedia et al., 1992) is likely to be
explained by covalent attachment of NADH. This modification is more likely to be a
pathophysiological event associated with inhibition of gluconeogenesis.
In nitric oxide-producing rat peritoneal macrophages, NO inhibits GAPDH activity
and decreases ATP content, synthesis and turnover by uncoupling of glycolytic flux
from substrate level phosphorylation by the acyl phosphatase activity of NO-modified
GAPDH (Albina et al., 1999). In HUVECs, GAPDH can be inhibited by S-thiolation
after H2O2 treatment, which is reversed upon removal of the oxidative stimulus
(Schuppe-Koistinen et al., 1994). The post-translational modification of GAPDH by
reversible thiol redox reactions with GSH may represent a physiologically relevant
mechanism for the control of the enzyme in HUVECs (Schuppe-Koistinen et al.,
1994). NO has been shown to react with the four thiols of each of the GAPDH
tetramer. This reaction of NO causes a decrease in GAPDH activity as the modified
thiol group in the active site of GAPDH is converted to sulfenic acid. This inhibition
cannot be reversed by dithiothreitol (DTT). GAPDH activity is inhibited also by NO
donors such as sodium nitroprusside (SNP), and S-nitroso-N-acetyl-DL-penicillamine
(SNAP). SNAP but not SNP modifies the active site thiol via process called S-
nitrosylation which can be reversed by treating with DTT after the SNAP treatment.
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The DTT prevents the thiol from oxidising to sulfenic acid (Ishii et al., 1999). NADH
and DTT are required for the S-nitrosylation of GAPDH caused by the NO-
generating compound sodium nitroprusside. S-Nitrosylation of GAPDH may be a key
covalent modification of multiple regulatory consequences in chronic liver
inflammation (Molina Y Vedia et al., 1992). In macrophage cells, NO gas has been
shown to inhibit of lactate production due to NO-modified GAPDH and also
inactivate the Krebs cycle enzyme aconitase (Messmer et al., 1996). In the colon,
epithelial cells of patients with inflammatory bowel disease, NO and ROS-mediated
oxidation of GAPDH thiol has been reported resulting in GAPDH inactivation
(Mckenzie et al., 1996).
OxLDL has been shown to cause increased ROS formation, including rapid elevation
of H2O2. OxLDL has been shown to induce the down-regulation of GAPDH via a
H2O2-dependent mechanism resulting in inhibition of glycolysis and marked
depletion of cellular ATP levels in HASMCs (Sukhanov et al., 2006) and in U937
cells (Colussi et al., 2000). OxLDL down-regulated-GAPDH appears to play an
important role in the mechanisms of atherogenesis (Sukhanov et al., 2006). In U937
cells, GAPDH is also inhibited by HNE and 4-hydroxy-2-hexenal (HHE), which are
produced during the oxidative modification of LDL (Tsuchiya et al., 2005).
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1.5 Research programme
1.5.1 Aim
The major aim of this PhD research is to determine the effect of oxidised low-density
lipoproteins (oxLDL) on macrophage cell metabolic functions using U937 cells and
human monocyte-derived macrophage (HMDM) cells.
1.5.2 Hypothesis experimental approach
The central hypothesis to this research was that oxLDL induced cell death in
macrophages was due to the oxidative loss of glycolysis activity as a result of the
oxidative inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
In chapter 3, initial characterisation of oxLDL and its effect on both U937 and human
monocyte derived macrophage (HMDM) on both cell morphology and viability was
characterised and standardised for further experimentation on GAPDH and the
relationship to cell death. The protective effect of the antioxidant 7,8-
dihydroneopterin was also characterised to establish appropriate concentrations and
incubation times for further analysis. Much of this analysis was aimed at extending
and confirming the studies of previous researchers within the laboratory.
Chapter 4 will examine the effect of oxLDL on U937 cell metabolism by measuring
lactate production and the activity of lactate dehydrogenase (LDH) and GAPDH. The
loss of these enzyme activities will be related in time and oxLDL concentration to the
changes in cell glutathione (GSH) level and adenosine triphosphate (ATP) formation.
The oxidative inhibition of GAPDH will be confirmed by sodium dodecyl sulfate
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polyacrylamide gel electrophoresis (SDS-PAGE) analysis of changes in thiol
oxidation states of GAPDH. The effectiveness of intracellular reactive oxygen
species (ROS) scavenging by 7,8-dihydroneopterin (7,8-NP) will be further
quantified by measuring the protection of cell metabolism from oxLDL inhibition.
Changes in metabolic function will be further characterised by measuring changes in
the rate of oxygen consumption (VO2) following the addition of oxLDL and the
protection of metabolism by 7,8-dihydroneopterin.
Chapter 5 will examine the same glycolytic metabolic markers as the study with the
U937 cells using the clinically more relevant HMDM cells. This will provide some
validation to the effects observed in U937 cells. However, VO2 will not be studied
due to the difficultly of culturing the strongly adherent HMDM cells in the oxygen
sensing ringers of the chamber of the respirometers. The effect of 7,8-
dihydroneopterin in protecting HMDM cell metabolism will be quantified and
compared to that observed in U937 cells. The uptake of oxLDL by HMDM cells and
the effect of 7,8-dihydroneopterin on this uptake is examined to observe whether
oxLDL uptake is critical to the loss in cell viability.
This study will provide strong evidence that oxLDL triggers a rapid cell death
mechanism resulting in necrosis, by causing oxidative inactivation of glycolysis and
specifically, GAPDH activity. The resulting loss of ATP generation is proposed to
lead to a systematic failure of cellular function leading to cell necrosis. The study also
shows clearly how the protection of the cellular GSH levels by 7,8-dihydroneopterin
prevents the loss of GAPDH activity. This work provides an alternative mechanism
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to that proposed by others where specific oxysterols causes activation of apoptopic
mechanism causing cell death within the atherosclerotic plaque.
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2 Materials and methods
2.1 Materials
2.1.1 Reagents and media
All reagents and media used were of analytical grade or better (Table 2.1 and Table 2.2).
All solutions were prepared using ion-exchanged ultra filtered water, obtained using a
nanopure ultrapure water system from Barnstead/Thermolyne (IA/USA).
Table 2.1 Names of chemicals and suppliers.
Chemical
Name/Abbreviations/Formula/MW in g/mol
Company/ Supplier
-Mercaptoethanol (C2H6OS) (MW 78.13) Sigma Chemical Co., St. Louis, USA/
NZ Sigma
1,1'-Dioctadecyl-3,3,3',3'-tetramethylindo
carbocyanine perchlorate (DiI) (MW 5341)
Sigma-Aldrich Chemical Co., Wisconsin,
USA/ NZ Sigma-Aldrich
1,1,3,3-Tetramethoxypropane (TMP)
(CH3O)2CHCH2CH(OCH3)2 (MW 164.2)
Sigma Chemical Co., Missouri, USA/
NZ Sigma
2-Thiobarbituric acid (TBA) (C4H4N2O2S)
(MW 144.15)
Merck, Darmstadt, Germany/ NZ Merck
3-[(3Cholamidopropyl) dimethylammonio]-
1-propanesulfonate (CHAPS)
(C32H58N2O7S) (MW 614.9)
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
4-Morpholine-propanesulfonic acid
(MOPS) (C7H15NO4S) (MW 209.3)
Sigma Chemical Co., Missouri, USA/
NZ Sigma
5-(Iodoacetamido) flurescein (5-IAF)
(C22H14INO6) (MW 515.26)
Molecular Probes, Eugene, Oregon, USA/
NZ Global
7,8-Dihydroneopterin (7,8-NP)
(MW 255.2)
Schircks Laboratory, Switzerland/
NZ Schircks laboratory
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Chemical
Name/Abbreviations/Formula/MW in g/mol
Company/ Supplier
Acetic acid (CH3COOH) (MW 60.05) Merck Ltd, Poole, England/ NZ Merck
Acetone (CH3COCH3) (MW 58.08) Merck Ltd, Poole, England/ NZ Merck
Acetonitrile (Acn) (CH3CN) (MW 41.05) Merck, Darmstadt, Germany/ NZ Merck
Adenosine diphosphate (ADP) (MW 427.2) Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Adenosine monophosphate (AMP)
(MW 347.2)
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Adenosine triphosphate (ATP)
(MW 551.14)
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Argon gas BOC Gasses; Auckland, NZ
Bicinchoninic acid (BCA) protein kit Pierce, Illinois, USA/ NZ Global
Butylated hydroxytoluene (BHT)
(C15H24O) (MW 220.4)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Bovine serum albumin (BSA) Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Bromophenol blue (MW 670.02) Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Chelex 100 resin Bio-Rad Laboratories, California, USA/
NZ Global
Cholesterol reagent Roche Diagnostics GmbH, Mannheim,
Germany/ NZ Global
Copper chloride (Cu2Cl) (MW 170.48) AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
Coumassie blue Bio-Rad Laboratories, California, USA/
NZ Global
Dialysis tubing Biolab Scientific, Auckland, NZ
Dimethyl sulphoxide (DMSO)
(CH3)2SO (MW 78.18)
AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
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Chemical
Name/Abbreviations/Formula/MW in g/mol
Company/ Supplier
Ethanol (C2H5OH) (MW 46.07) Merck, Darmstadt, Germany/ NZ Merck
Ethylene diamine tetraacetic acid (EDTA)
(C10H16N2O8) (MW 292.24)
AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
Ethlylene glycol-bis(2-aminoethylether)
N,N,N’,N’-tetracetic acid (EGTA) (-
CH2OCH2CH2N(CH2CO2H)2)2 (MW 380.4)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Glyceraldehyde-3-phosphate (GAP)
(MW 170.6)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Glyceraldehyde-3-phosphatedehydrogenase
(GAPDH), marker from rabbit muscle
(36 kDa)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Glycerol (C3H8O3) (MW 92.10) Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Glycine (C2H5NO2) (MW 75.07) Bio-Rad Laboratories, California, USA/
NZ Global
Glutathione (reduced form) (GSH)
(MW 307.3)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Hexane 85% (CH3(CH2)4CH3) (MW 86.18) Merck, Darmstadt, Germany/ NZ Merck
Hydroxy ethyl prazine ethane sulphonic
acid (HEPES) (C8H18N2O4S) (MW 238.3)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Hydrochloric acid (HCl) (MW 36.46) Merck, Darmstadt, Germany/ NZ Merck
Isopropanol (CH3CHOHCH3) (MW 60.1) J.T. Baker, New Jersey, USA/ NZ Merck
Lactic acid kit Roche, Darmstadt, Germany/ NZ Global
Malondialdehyde (MDA) (CH3H4O2)
(MW 72.06)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Methanol (CH3OH) (MW 32.04) Merck, Darmstadt, Germany/ NZ Merck
Molecular Weight Proteins Marker Fermentas International Inc, Ontario,
Canada/ NZ Global
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Chemical
Name/Abbreviations/Formula/MW in g/mol
Company/ Supplier
Monobromobimane (MBB)
(C10H11BrN2O2) (MW 271.1)
Sigma-Aldrich, Steinheim, Switzerland/
NZ Sigma-Aldrich
Nicotinamide adenine dinucleotide (NAD+)
(MW 663.43)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Nicotinamide adenine dinucleotide
(Reduced form) (NADH) (MW 709.4)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Nicotinamide adenine dinucleotide
phosphate (NADP+) (MW 743.4)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Nitrogen gas BOC Gasses, Auckland, NZ
NuPAGE 4-12 % Bis-Tris Gel, 1.0 mm x
10 well
Invitrogen, California, USA/ NZ
Invitrogen
Perchloric acid (PCA) (HClO4)
(MW 100.46)
AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
Phosphoric acid 85% (H3PO4) (MW
97.994) (1L=1.71kg)
Merck, Darmstadt, Germany/ NZ Merck
Potassium bromide (KBr) (119.01) Merck, Darmstadt, Germany/ NZ Merck
Potassium carbonate (K2CO3) (MW 138.21) Merck, Darmstadt, Germany/ NZ Merck
Protease inhibitors Roche, Mannheim, Germany/ NZ Global
Pyruvate (C3H4O3) (MW 88.06) Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Sodium arsenate (Na2H2AsO4.7H2O)
(MW 312.01)
AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
Sodium chloride (NaCl) (MW 58.44) Merck, Darmstadt, Germany/ NZ Merck
Sodium dihydrogen orthophosphate
(NaH2PO4H2O) (MW 137.99)
Merck, Darmstadt, Germany/ NZ Merck
Sodium dodecyl sulfate
(lauryl sulfate) (SDS) (MW 288.38)
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
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Chemical
Name/Abbreviations/Formula/MW in g/mol
Company/ Supplier
Sodium hydrogen carbonate (NaHCO3)
(MW 84.01)
Sigma Chemical Co., Missouri, USA/ NZ
Sigma
Sodium hydroxide (NaOH) (MW 39.9971) Merck, Darmstadt, Germany/ NZ Merck
Tetrabutylammonium bisulfate
(C16H37NO4S) (MW 339.54)
Merck, Darmstadt, Germany/ NZ Merck
Thiazolyl blue tetrazolium bromide (MTT)
(C18H16N5SBr) (MW 414.33)
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Trichloroacetic acid (TCA) (CCl3COOH)
(MW 163.39)
Merck, Darmstadt, Germany/ NZ Merck
Tris(hydroxymethyl)aminomethane (Tris)
(C4H11NO3) (MW 121.1)
Roche Diagnostics GmbH, Mannheim,
Germany/ NZ Global
Triton X-100 AnalaR®, B.D.H. Laboratory Chemicals
Division Poole, England/ NZ Biolab
Trypan blue solution (0.4 %) Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Table 2.2 Chemicals and suppliers of cell culture media.
Chemical Company/ Supplier
Granulocyte macrophage colony
stimulating factor (GM-CSF)
Bayer Health Care Pharmaceuticals, LLC.
Seattle, WA/ Shipping to NZ
Heat-inactivated foetal calf serum Invitrogen, California, USA/ NZ Invitrogen
Penicillin/streptomycin (containing
5000 units of penicillin and 5000 μg of
streptomycin/ml)
Invitrogen, California, USA/ NZ Invitrogen
Roswell Park Memorial Institute-1640
(RPMI-1640) media, with phenol red
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
Roswell Park Memorial Institute-1640
(RPMI-1640) media, without phenol red
Sigma-Aldrich Chemical Co., Missouri,
USA/ NZ Sigma-Aldrich
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2.1.2 General buffers, media and solutions
2.1.2.1 Phosphate buffered saline
Phosphate buffered saline (PBS) was prepared by adding 150 mM sodium chloride
(NaCl, MW 58.44) to 10 mM sodium dihydrogen orthophosphate (NaH2PO4H2O, MW
137.99), pH 7.4. It was stirred with 1 g of washed Chelex 100 resin for at least 4 hours to
remove metal ions. Subsequently, it was vacuum-filtered through a 0.45 µm Phenex filter
membrane (Phenomenex). PBS used for cell culture work was autoclaved for 15 minutes,
at 121°C and 15 psi.
2.1.2.2 Roswell park memorial institute media-1640
The Roswell park memorial institute-1640 (RPMI-1640) media was prepared as per the
manufacturer’s instructions. Powdered RPMI-1640 (with or without phenol red) was
dissolved in nanopure water, then sodium hydrogen carbonate (NaHCO3) was added and
the solution adjusted to pH 7.4 with 1 M sodium hydroxide (NaOH). The media was put
into sterile bottles in a Class II biological safety cabinet (Clyde-Apex BH 200) and was
sterilised using a peristaltic pump (CP-600, Life Technologies, Maryland, USA) and a 0.2
µm Millex®-GP50 filter (Sartorius AG, Goettingen, Germany). The media was stored at
4°C.
2.1.2.3 7, 8-Dihydroneopterin solution
7,8-Dihydroneopterin (7,8-NP, MW 255.2) was prepared fresh prior to each experiment.
The stock concentration was 2 mM, which was dissolved in a degassed ice cold RPMI-
1640 medium followed by 5 minute sonication. The 7,8-dihydroneopterin stock solution
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was sterilised by filtering through a 0.22 μm membrane filter with 25 mm diameter
(Sartorius AG, Goettingen, Germany) in a Class II biological safety cabinet (Clyde-Apex
BH 200).
2.1.2.4 Determination of protein concentration
Protein concentration was determined using the bicinchoninic acid (BCA) protein
determination kit from Pierce (supplied by Global Scientific).  The working reagent was
freshly prepared by mixing Reagent A (sodium carbonate (Na2CO3), NaHCO3, BCA and
sodium tartrate (Na2C4H4O6) in 0.1 M NaOH) and Reagent B (4% copper sulfate
pentahydrate, CuSO4.5H2O) in a 50:1 ratio. The assay was carried out by mixing 50 µl of
cell suspension with 1 ml of working reagent and incubated at 60°C for 30 minutes while
being gently shaken in a heated shaking block.  The reaction was subsequently stopped
by placing samples on ice before reading the absorbance at 562 nm against the water
blank.  Protein concentration was determined from a standard curve prepared by the
incubation of known concentrations of BCA (0-250 µg/ml) in 1 ml of working reagent.
2.2 Methods
Experiments were carried out on the U937 monocyte-like cell line and human monocyte-
derived macrophage (HMDM) cells. The cells were incubated with and without oxidised
low density lipoprotein (oxLDL) to determine its effect on cells’ metabolic function
along with 7,8-dihydroneopterin (7,8-NP) production.
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2.2.1 Cell culture
Cells were manipulated for experiments under aseptic conditions in a Class II biological
safety cabinet (Clyde-Apex BH 200). Sterile plasticware was supplied by Becton
Dickinson & Co., Falcon, Nunc, Terumo, Unomedical, and Greiner Bio-one. Media and
solutions were sterilised either by autoclaving or by filtration through a sterile membrane
filter, or both. All equipment for cell culture experiments was sprayed with 70% (v/v)
ethanol before being transferred into the Class II biological safety cabinet.
Experiments were conducted on both the U937 and HMDM cells. The cells were
incubated at 37°C in a humidified incubator, with an atmosphere calibrated to 5% carbon
dioxide: 95% air (Nuaire™ IR Autoflow).
2.2.1.1 Cell culture media
RPMI-1640 medium (with phenol red) (see section 2.1.2.2) containing 100 U/ml
penicillin-G and 100 μg/ml streptomycin (pen/strep) was supplemented with either 5%
(v/v) heat-inactivated foetal calf serum (HI-FCS) or 10% (v/v) heat-inactivated human
serum (HIHS) for culturing U937 cells or HMDM cells, respectively. The cell culture
medium was warmed to 37°C before use in maintaining the cells. In this thesis, the above
described cell culture media for U937 cells is referred to as U937 culture medium and for
HMDM cells as HMDM culture medium.
2.2.1.2 Preparation of heat-inactivated human serum
Unlinked (anonymised) blood from consenting haemochromatosis patients was collected
in 600 ml dry bags by the NZ Blood Bank (Riccarton Road, Christchurch). The blood bag
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was incubated in a vertical position at room temperature for 2 hours and then at 4°C
overnight. This treatment allowed the blood to coagulate and the serum to separate from
the blood clot. In a Class II biological safety cabinet (Clyde-Apex BH 200) the serum
was subsequently collected into 50 ml centrifuge tubes and centrifuged at 4,100 g for 15
minutes to pellet any remaining blood cells. The resulting serum was transferred into new
50 ml centrifuge tubes, heat inactivated in a water bath at 56°C for 30 minutes and then
stored at –80ºC (Freshney, 2000).
2.2.1.3 Culture of U937 human monocyte-like cell line
The human monocyte-like cell line U937 cells were a gift from the Haematology
Research laboratory at the Christchurch School of Medicine, University of Otago.
Originally, the U937 cell line was obtained from a human haematopoietic cell line
derived from histiocytic lymphoma. It was derived from a 37 year old man with a
generalized lymphoma (Sundstrom & Nilsson, 1976).
Two vials of U937 cells at 20 ×106 cells/ml, at 1 ml per vial, were removed from liquid
nitrogen storage and defrosted in a 37°C water bath until only a small piece of frozen
liquid remained in the vials. In a Class II biological safety cabinet (Clyde-Apex BH 200)
the liquid in both vials was then poured into 30 ml of U937 culture medium in a 50 ml
centrifuge tube, followed by centrifugation at 500 g for 5 minutes to remove the dimethyl
sulfoxide (DMSO) freezing medium.
The resulting cell pellet was re-suspended in 10 ml of U937 culture medium in a 25 cm2
tissue culture flask. Cell concentration was maintained at 0.5-1 ×106 cells/ml by changing
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media and transferring cells to 75 cm2 tissue culture flasks every 3 days after counting
cells under a microscope using a haemocytometer and trypan blue dye to distinguish
between intact and damaged cells. The cells were counted by adding 100 µl of cells
suspension to 100 µl trypan blue and mounting onto a haemocytometer.
2.2.1.4 Preparation and culture of human monocyte-derived
macrophage cells
Human monocyte-derived macrophage (HMDM) cells were prepared from whole blood
donated by clinically healthy haemochromatosis patients at the New Zealand Blood
Services (Christchurch) under ethics approval CTY/98/07/069 granted by the New
Zealand Upper South B Ethics Committee. The monocytes were purified by
centrifugation of leukocytes to within a rich buffy coat layer using Lymphoprep™ and
differentiated into adherent macrophages in adherent 12-well plates (Firth et al., 2007a).
This method was developed in the laboratory over a number of years from that originally
used by Professor Wendy Jessup (University of New South Wales, Sydney).
All the media and solutions were warmed up to room temperature prior to use, except for
the HMDM culture medium, which was warmed up to 37°C in a water bath.
Unlinked blood was collected by the NZ Blood Bank (Riccarton Road, Christchurch)
from consenting haemochromatosis patients into 600 ml autologous bags containing the
anticoagulant citrate-phosphate-dextrose-adenine-1 (CPDA-1).
At the Free Radical Biochemistry Laboratory, the blood bag was gently inverted five
times to ensure even distribution of blood cells. Then the bag was placed in a Class II
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biological safety cabinet (Clyde-Apex BH 200) and blood poured gently into 50 ml
centrifuge tubes. The blood was then centrifuged (Multifuge 1 S-R, Heraeus) for 20
minutes at 3000 g, with slow deceleration.
The resulting buffy coat layer was collected using a mixing cannula attached to a 10 ml
syringe after removing a plasma layer above this buffy coat layer. The buffy coat layer
was then transferred into new centrifuge tubes at 15 ml per tube, and mixed well with
PBS at 20 ml per tube. The mixture was then under laid with 15 ml of Lymphoprep, and
centrifuged at 1000 g for 20 minutes with slow acceleration and deceleration.
After centrifugation, a white layer of monocytes/lymphocytes appearing about half-way
down each the centrifuge tube was transferred to new centrifuge tubes, with 15 ml per
tube. Each tube was topped up to 45 ml with sterile PBS and centrifuged at 500 g for 15
minutes. The resulting cell pellet was washed three times in 45 ml of PBS at 500 g for 10
minutes.
The cell pellet was subsequently re-suspended in 30 ml serum-free HMDM culture
medium (RPMI-1640 medium containing pen/strep). Cells were then counted by adding
20 µl of cell suspension to 180 µl trypan blue and transferring 20 µl of the mixture to a
haemocytometer for counting. The cell concentration was adjusted to 5 x106 cells/ml in
serum-free HMDM culture medium and 6-8 ml of this suspension placed into each well
of a 6-well suspension culture plates (Greiner Bio-one). The plates were then incubated at
37ºC/5% CO2 for 40 hours to allow T cell death and platelet adhesion to the plates, while
monocytes remained viable in suspension.
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After 40 hours incubation, the cell suspension was transferred from each well into 50 ml
centrifuge tubes and the viable monocytes were pelleted by centrifugation at 500 g for 15
minutes at room temperature. The cells were then re-suspended in 30 ml serum-free
HMDM culture medium. The cells were counted as described above and the
concentration was adjusted to 5.0 x106 cells/ml in RPMI-1640 with pen/strep and
supplemented with 10% (final concentration in total media volume) HIHS. To each well
1 μl of 25 µg/ml granulocyte macrophage colony stimulating factor (GM-CSF) was
added (Leukine® GM-CSF prepared in filtered (0.22 μm filter) sterilised nanopure water)
per 1 ml of cell suspension. The cells were then plated at 5.0 ×106 cells/well in 12-well
adherent plates (Nunclon- Surface Nunc) and then incubated at 37°C.
The HMDM culture medium was replaced every 3-4 days. Experiments were not
conducted until more than 70% of monocytes had matured to macrophages, which
usually took up to 14 days after plating.
2.2.2 Preparation of low density lipoprotein
Low density lipoprotein (LDL) was isolated from human plasma using a Beckman Near
Vertical Rotor (NVTi-65) and involved the preparation of a single step gradient. LDL
prepared via this simple method generated highly toxic oxLDL after oxidation with
CuCl2. Previously, LDL was prepared using a Beckman Swing out Bucket Rotor (SW41-
Ti) which required a much more complex preparation procedure. Both methods are
described in detail in sections 2.2.2.3 and 2.2.2.7.
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2.2.2.1 Blood collection for isolation of plasma
A written consent was first obtained from the healthy blood donors who were required to
fast overnight. Blood was collected from donors by venipuncture using a 21G x ¾ inch or
19G needle attached to a 30 ml syringe. The blood was transferred into 50 ml centrifuge
tubes containing 0.5 ml of 10% (w/v) ethylene diamine tetraacetic acid (EDTA, MW
292.24) (pH 7.4). The blood containing tubes were centrifuged (Multifuge 1 S-R,
Heraeus) for 20 minutes at 4°C in a swing-out rotor at 4,100 g with a soft start.
The resulting yellow plasma at the top of the tube was transferred to 50 ml round bottom
centrifuge tubes and spun for 30 minutes at 11,000 g in a fixed angle rotor to remove any
remaining traces of cells. Plasma from all donors (between 5 and 7 donors) was pooled
and the total volume was recorded. The pooling of plasma minimised inter-individual
variation. The plasma was stored in 20 ml or 32 ml aliquots at –80°C for a maximum of 6
months (Gieseg & Esterbauer, 1994).
2.2.2.2 Preparation of dialysis tubing
The dry dialysis membrane tubing (Medical International Ltd, London, England) with a
14.4 mm flat width and molecular weight cut-off of 14,000 Daltons was pre-treated
before use. The dialysis tubing was first cut into 22 cm lengths.
The tubes were boiled in a glass beaker containing a solution of 5% w/v NaHCO3 (MW
84.01) and 1 mM EDTA (MW 292.24). After 20 minutes boiling, the tubes were washed
with reverse osmosis-water (RO-H2O) and boiled again in a glass beaker containing RO-
H2O.  After 20 minutes the tubes were washed thoroughly with RO-H2O and stored in a
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solution of RO-H2O: ethanol (50:50 v/v) at 4C. The tubes were washed thoroughly with
RO-H2O before being used for dialysis.
2.2.2.3 Preparation of LDL using Beckman Near Vertical (NVTi-65)
rotor method
This method of LDL isolation utilises a Beckman Near Vertical (NVTi-65) rotor  and
employs the method of (Chung et al., 1986), with modifications described by (Gieseg &
Esterbauer, 1994). The protocol requires a single gradient that redistributes during
ultracentrifugation to form a density gradient, which separates lipoproteins.
A 32 ml tube of frozen human plasma was defrosted under cold running water and
centrifuged at 4700 rpm for 10 minutes at 4ºC to pellet precipitated fibrinogen. The
supernatant was decanted into a beaker and placed immediately on ice. Potassium
bromide (KBr) was gradually dissolved in plasma, to a final concentration of 382 mg
KBr/ml plasma, altering the plasma density to 1.24 g/ml. Plasma was stirred gently to
prevent foam formation, which is an indication of LDL denaturation. Plasma was
maintained on ice and under argon gas until ultracentrifugation.
Eight millilitres of 1 mg/ml EDTA (pH 7.4) was added to each of eight OptiSeal™
polyallomer centrifuge tubes (Beckman Coulter, USA) before under-layering with 4 ml
or less of KBr-plasma, using a needle attached to a 5 ml syringe. Ultracentrifuge tubes
were transferred to the NVTi-65 rotor and centrifuged at 60,000 rpm for 2 hours at 10ºC
with slow acceleration/deceleration using an Optima™ L-90K Preparative
Ultracentrifuge (Beckman Coulter, Inc., Fullerton, California). Following centrifugation,
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a yellow/orange coloured band of LDL in the density range of 1.019 – 1.063 g/ml was
collected using a 20 ml syringe attached to a 90º bend needle (Figure 2.1).
2.2.2.4 Measurement of LDL concentration
LDL concentration was determined by enzymatic cholesterol assay using a CHOL kit
(Roche Diagnostic). Ten microlitres of LDL was incubated with 1 ml of cholesterol
reagent at room temperature for 10 minutes. The absorbance was read at 500 nm against a
blank containing only cholesterol reagent.
LDL concentration as total mass was then calculated from the absorbance, based on the
estimate that cholesterol accounts for 31.69% of the entire LDL particle, by weight, and
that LDL has a molecular weight of 2.5 x103 kDa and the cholesterol molecular weight
was 386.64 (g/mol) (Gieseg & Esterbauer, 1994). The extinction coefficient for the assay
was 14.9 at 500 nm.
LDL total mass (mg/ml) = Absorbance x 14.9 x (1/1000) x 386.64 x (100/31.69)
2.2.2.5 LDL washing and concentration
The LDL was adjusted to a final concentration of 10 mg/ml (total mass) before any
subsequent manipulations or use in experiments. LDL was concentrated using Amicon®
Ultra-15 ultrafiltration tubes (Millipore, USA). LDL was transferred to two filter tubes.
Each was made up to 15 ml with chelex-treated PBS and centrifuged at 3000 g for 30
minutes at 10ºC. This step was then repeated twice. The duration of the third
centrifugation was adjusted according to the desired final volume/concentration of LDL,
as determined by cholesterol assay (see section 2.2.2.4).
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Figure 2.1 Location of different density lipoproteins bands after ultracentrifugation
using NVTi-65 rotor.
The top yellow layer is very low density lipoprotein (vLDL). The second yellow/orange
layer is low density lipoprotein (LDL). The third yellow layer is high density lipoprotein
(HDL). The bottom yellow layer is plasma proteins.
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If no further manipulations were to be made to the LDL, it was filter-sterilised through a
0.22 μm membrane filter with 25 mm diameter (Sartorius AG, Goettingen, Germany) and
stored at 4ºC in the dark, under argon gas.
2.2.2.6 LDL oxidation
LDL at 10 mg/ml (total mass) was transferred to 12-14 kDa dialysis tubing (Medicell
International, UK) secured at one end with a double knot and a weighted closure at the
other. Fifty millimolar copper chloride (CuCl2) solution was combined with the LDL
inside the dialysis tubing to give a final concentration of 0.5 mM CuCl2. The LDL-
containing dialysis tubing was placed in a large bottle containing 1 L PBS/50 mg LDL,
plus CuCl2 at a final concentration of 0.5 mM CuCl2. LDL was dialysed against 0.5 mM
CuCl2 in PBS for 24 hours at 37ºC in a heated shaker.
The dialysis bag containing oxLDL was then transferred to a fresh bottle containing 1L of
PBS and stirred with 1 g of washed chelex-100 at 4ºC for 2 hours. This was repeated
twice, with the final incubation taking place overnight. OxLDL was filter-sterilised using
a 0.22 μm membrane filter with 25 mm diameter (Sartorius AG, Goettingen, Germany)
and stored at 4ºC (Gerry et al., 2007).
2.2.2.7 Preparation of LDL using Beckman Swing out Bucket (SW41-
Ti) rotor method
During few of the U937 cell studies, LDL was prepared using a (SW41-Ti) rotor method.
Previous studies have shown there is no difference in the LDL prepared by Beckman
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Near Vertical NVTi-65 rotor and Beckman Swing out Bucket (SW41-Ti) rotor (Gieseg &
Esterbauer, 1994).
Density gradient solutions for ultracentrifugation were prepared by dissolving the
required amount of NaCl (MW 58.44) in nanopure water. Firstly, a 10 mg/ml EDTA
solution was prepared by dissolving EDTA (MW 292.24) in nanopure water and
adjusting the pH to 7.4 with 10 M NaOH. Solution A of density 1.08 g/ml was made up
by adding 8 g NaCl to 10 ml of 10 mg/ml EDTA solution and made up to 100 ml with
nanopure water.  Solution B of density 1.05 g/ml was made up by adding 5 g NaCl to 10
ml of 10 mg/ml EDTA solution and made up to 100 ml with nanopure water.  Finally,
solution C of density 1.0 g/ml was made up by adding 10 ml of 10 mg/ml EDTA solution
to 90 ml of nanopure water.
A 20 ml tube of plasma was thawed under cold running water (at approximately 6°C) and
centrifuged at 4,700 rpm for 10 minutes at 4°C to remove any precipitated fibrinogen.
The supernatant was decanted into a beaker placed on ice. Potassium bromide (KBr)
(MW 119.01, 410 mg/ml) was gradually added to the plasma with continuous stirring
using a magnetic flea to produce a plasma density of 1.41 g/ml. The plasma was pipetted
evenly between six Beckman ultracentrifuge tubes. Three millilitres of solution A was
gently layered onto the plasma using a syringe attached to a 180-bend needle followed
by 3 ml of solution B and finally solution C.
The centrifuge tubes were then transferred to a Beckman SW41-Ti rotor and centrifuged
at 40,000 rpm for 22 hours at 10°C using an OptimaTM L-90K Preparative Ultracentrifuge
(Beckman Coulter, Inc., Fullerton, California).  The top very low density lipoprotein
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(vLDL) layer was first discarded. A yellow/orange band of LDL in the density range of
1.019 g/ml to 1.063 g/ml was collected using a 20 ml syringe attached to a 90°-bend
needle (Figure 2.2). The high density lipoprotein (HDL) band which was the second
yellow band from the bottom of the tube was discarded.
The LDL was transferred to a treated dialysis tube, layered with argon gas and dialysed
for 24 hours at 4°C against four changes of degassed PBS containing Chelex 100 resin in
order to remove all traces of EDTA.
Freshly dialysed LDL was stored under argon and filter-sterilised through a 0.22 μm
membrane filter with 25 mm diameter (Sartorius AG, Goettingen, Germany) and stored at
4C until the oxidation was carried out.
For LDL oxidation CuCl2 (MW 170.48) from a sterile 50 mM stock was added to filter-
sterilised 3 mg/ml LDL in a 25 ml cell culture flask at a final concentration of 300 to 400
M. The mixture was incubated overnight at 37C. Complete oxidation of LDL occurred
after 24 hours when the LDL became colourless.
The copper ions were removed by mixing the oxLDL with 1 g Chelex 100 resin and
placing the tube on a rotating turntable which inverts the tube 8 times per minute.  This
was done at 4C for 2 hours. The Chelex 100 resin was allowed to settle down by
centrifugation at 500 g for 2 minutes before collecting the oxLDL from above it.
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Figure 2.2 Location of different density lipoproteins bands after ultracentrifugation
using SW41-Ti rotor.
The top yellow layer is very low density lipoprotein (vLDL). The next yellow/orange
layer is low density lipoprotein (LDL). The following yellow layer is high density
lipoprotein (HDL). The bottom yellow layer is plasma proteins.
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OxLDL was concentrated using an Amicon® Ultra-15 filter tubes (Millipore, USA) to
the concentration (usually between 10 to 12 mg/ml) necessary to allow a small volume of
oxLDL to be added to the medium during subsequent use in experiments.  OxLDL was
filter-sterilised through a 0.22 μm membrane filter with 25 mm diameter (Sartorius AG,
Goettingen, Germany) and stored at 4C.
2.2.3 Lipoprotein gel electrophoresis of LDL and oxLDL
Relative electrophoretic mobility (REM) on native gels was determined using a SEBIA
HYDRAGEL LIPO K20 kit and apparatus according to the manufacturer’s instructions.
Two 10 µl applications of native LDL (nLDL) or oxLDL (from 10 mg/ml stock) were
applied per lane, allowing 7 minutes for absorption between each application. The gel
was electrophoresed for 90 minutes at 50 volts. The gel was dried at 90°C for 45 minutes
before staining for 15 minutes in Sudan black stain. The gel was then destained, washed
in distilled water and dried as before.
2.2.4 OxLDL labelling and uptake measurement using DiI
1,1'-Dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI, MW 5341) is a
highly lipophilic molecule and it is extensively used in studies of receptor–mediated
metabolism of LDL. The lipoproteins were labelled with the fluorescent probe DiI as
described by (Stephan & Yurachek, 1993) and (Devaraj et al., 2001). Sterilised oxLDL of
known lipoprotein concentration (1-2 mg protein/ml) was incubated with 25 l of 3
mg/ml DiI in DMSO for each milligram of lipoprotein in a 25 cm2 tissue culture flask.
The flask was covered with aluminium foil to prevent exposure to light. The mixture was
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then incubated overnight for between 15 to 18 hours at 37°C. DiI-oxLDL was kept at 4°C
in the dark and used immediately due to the instability of DiI.
Measurement of DiI-oxLDL uptake was conducted according to the method of (Stephan
& Yurachek, 1993). HMDM cells at 5.0 x106 cells/ml were incubated at 37°C to measure
cell-associated DiI-oxLDL. At the end of the incubation period, the medium was
removed and cells were washed three times with warm PBS. Then 1ml isopropanol was
added to each well and plates were gently shaken on an orbital shaker (Bioline, Edwards
Instrument Company, Australia) for 15 min. The cells were harvested and the cell lysates
were transferred into 1.7 ml microtubes and centrifuged at 3000 rpm for 15 min.
The supernatant was taken out for determination of fluorescence intensity using a
fluorescence spectrophotometer (Cary Eclipse). The excitation and emission wavelengths
were set at 520 and 580 nm, respectively. The cell pellets were dissolved in 2 M NaOH
for protein determination. Results were expressed as mean fluorescence intensity (MFI)
of cell associated (37°C) DiI-oxLDL per mg of cell protein.
2.2.5 Measurement of cell viability using MTT reduction assay
The thiazolyl blue tetrazolium bromide (MTT, MW 414.33) assay provides an indirect
measure of cell viability. Metabolically active cells can endocytose and metabolise the
yellow MTT compound, via the action of cellular nicotinamide adenine dinucleotide
phosphate dehydrogenases (NAD(P)H-dehydrogenases), into a purple insoluble MTT-
formazan product that, when dissolved in detergent, that can be quantified
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spectrophotometrically at 570 nm (Mosmann, 1983a). The colour intensity provides an
indication of the concentration of cells and their metabolic activity.
MTT was dissolved in RPMI-1640 medium (without phenol red), at a concentration of 5
mg/ml. The mixture was then sterilised through a 0.22 μm membrane filter (Sartorius
AG, Germany) and stored at –20°C in the dark. Ten percent (w/v) sodium dodecyl sulfate
(SDS, MW 288.38) in 0.01 M hydrochloric acid (HCl) was stored at room temperature.
After experimental treatments, U937 cells at 0.5 x106 cells/ml were transferred to a 1.7 ml
microtube for washing with PBS (see section 2.1.2.1) then re-suspended in suspension
culture plates (Greiner Bio-one). With HMDM cells, (at 5.0 x106 cells/ml) they were
washed with PBS (see section 2.1.2.1) in the adherent plates (Nunclon- Surface, Nunc).
Cells in each well were incubated at 37°C with 1 ml of RPMI-1640 without phenol red
containing 0.5 mg/ml MTT for 2 hours (U937 cells) or 10 minutes (HMDM cells). The
insoluble purple crystals that developed in each well were then dissolved by mixing with
1 ml of 10% (w/v) SDS. The absorbance was read at 570 nm, against a blank lacking
cells but containing all other reagents.
2.2.6 Measurement of lactate production
Lactate within cell culture media was measured using a lactate kit (Roche
Pharmaceuticals and supplied through Global Science NZ Ltd) as per the manufacturer’s
instructions. The kit measured lactate via its enzymatic oxidation to pyruvate by lactate
dehydrogenase (LDH) which is coupled to the reduction of NAD+ to NADH, and is
measured by its absorption at 340 nm. The reaction equilibrium becomes shifted towards
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pyruvate by the presence of glutamate-pyruvate transaminase which converts the
pyruvate to 2-oxoglutarate. The lactate concentration was calculated using the molar
extinction coefficient of NADH (6220 M-1cm-1).
For experiments measuring lactate production U937 cells at 0.5 x106 cells/ml or HMDM
cells at 5.0 x106 cells/ml were incubated in RPMI-1640 (no phenol red). For HMDM cells
pen/strep and 10% HIHS were added. Samples of media were centrifugated at 21,000 g to
remove any particulates before placing on ice before analysis. The analysis was carried
out using the kit’s reagents in a semi-micro cuvette which containing 500 µl
glycylglycine buffer, 100 µl NAD+, 10 µl glutamate-pyruvate transaminase suspension,
50 µl sample and 450 µl water (H2O), for blank 500 µl H2O, in this order, followed by
mixing. The absorbance was recorded after 5 minutes at 340 nm. The absorbance was
then recorded at 340 nm, 30 minutes after the reaction was started by adding 10 µl lactate
dehydrogenase solution.
The lactate concentration was calculated from the difference between the absorbance
using as the molar extinction coefficient of NADH (6220 M-1cm-1) and the lactate
molecular weight (90.1 g/mol).
2.2.7 Measurement of LDH activity
Lactate dehydrogenase (LDH) is an enzyme found in all cell types. It is rapidly released
into the cell culture medium upon damage to the plasma membrane. LDH catalyses the
reduction of pyruvate to lactate and is coupled to the oxidation of NADH to NAD+.
NADH has an absorbance peak at 340 nm, so LDH activity can be measured by
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monitoring the loss of absorbance using excess pyruvate and NADH. Extracts are taken
from both the cell culture media and the lysed cells, which gives a calculation of released
LDH and cellular  LDH (Decker & Lohmann-Matthes, 1988).
U937 cells and HMDM cells were incubated in RPMI-1640 (no phenol red) at 0.5 x106
cells/ml and 5.0 x106 cells/ml, respectively. For the HMDM cells pen/strep and 10%
HIHS were added. LDH activity was measured in the cell culture medium which was
removed and stored on ice before analysis. The intracellular LDH activity was also
measured following the resuspension of cell pellets with 480 µl PBS and 20 µl Triton X-
100 (5% solution in PBS) before incubation for 30 minutes at 37°C. A small amount of
resuspended pellets, 10 µl, was used for protein assay (see section 2.1.2.4). The LDH
assay was carried out in a semi-micro cuvette which contained 870 µl of PBS, 90 µl cell
extract (supernatant or pellets), 60 µl of 3 mg/ml NADH (made up fresh, wrapped with
foil and kept on ice during use) and 30 µl of 0.8 mg/ml pyruvate, added in this order and
followed by mixing.
The absorbance at 340 nm was recorded at 0.1-minute intervals over 5 minutes at 340
nm. The molar extinction coefficient of NADH (6220 M-1cm-1) was used to calculate the
rate of NADH release in µmol per minute.
2.2.8 Measurement of GAPDH activity
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme that
catalyses the oxidative phosphorylation of glyceraldehyde-3-phosphate (GAP) to 1,3-
diphospho-glycerate (1,3-PGA). In the process, the NAD+ cofactor is reduced to NADH,
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which has a strong absorbance at 340 nm. The activity of GAPDH can hence be
monitored spectrophotometrically by measuring the rate of NADH formation using an
assay modified from (Steck & Kant, 1974).
The solutions, 30 mM NaH2PO4H2O, pH adjusted to 8 with 10 M NaOH in nanopure
water, 0.2 M sodium arsenate (Na2H2AsO4.7H2O, MW 312.01) in nanopure water, and
0.2% (v/v) Triton X-100 in 30 mM NaH2PO4H2O (pH 8.0) were stored at room
temperature. A 294 mM GAP (MW 170.6) solution in nanopure water was stored at -
80°C, which was diluted to 15 mM working concentration in nanopure water. The 20 mM
NAD+ (MW 663.43) was made up fresh on the day of analysis in cold nanopure water.
Both substrates were stored on ice during use.
U937 cells at 0.5 x106 cells/ml were transferred to 1.7 ml microtubes and the cells were
pelleted by centrifugation. After washing the cell pellet in PBS (see section 2.1.2.1), the
cell mixture was placed on ice. For HMDM cells, (at 5.0 x106 cells/ml) the cells were
scraped off using cell scrapers (Greiner bio-one, Germany) into 1 ml of cold PBS (see
section 2.1.2.1). The resulting cell mixture was transferred to 1.7 ml microtubes and
stored on ice.
In a semi-micro cuvette 100 μl of cell mixture and 100 μl of 0.2% (v/v) Triton X-100
were mixed, which was then incubated for 1 minute in the spectrophotometer at 37°C. To
this was added 600 μl of 30 mM NaH2PO4H2O (pH 8.0) that had already been
equilibrated to 37°C, 50 μl of 0.2 M sodium arsenate, 50 μl of 20 mM NAD+, and 100 μl
of 15 mM GAP in this order and followed by mixing.
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The absorbance at 340 nm was recorded at 0.1-minute intervals over 3 minutes at 340
nm. The molar extinction coefficient of NADH (6220 M-1 cm-1) was used to calculate the
rate of NADH release in µmol per minute.
2.2.9 Measurement of the sensitivity of free thiol in GAPDH enzyme
The sensitivity of the thiol groups in GAPDH to oxidation was measured by fluorescent
labelling of reduced thiol in combination with sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) to detect changes in the redox state of cultured cells and to
show the loss of reactive thiol in the GAPDH enzyme. Reduced thiol were labelled with
the fluorescent compound 5-iodoacetamidofluorescein (5-IAF). Gel electrophoresis was
conducted using a simpler modification of a technique developed by Dr. Mark Hampton
(Cuddihy et al., 2009a).
2.2.9.1 Solutions for thiol analysis
The extraction buffer consisted of (40 mM hydroxy ethyl prazine ethane sulfonic acid
(HEPES, MW 238.31), 50 mM NaCl (MW 58.44), 1 mM EDTA (MW 292.24), 1 mM
ethlylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetracetic acid (EGTA, MW 380.4),
protease inhibitors solution and 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS, MW 614.9) w/v (prepared fresh) in nanopure water, with the
pH adjusted to 7.4 using 10 M NaOH and was stored on ice until use.
Complete mini protease inhibitor stock (25×) was added to the extraction buffer, with 40
µl added per 1 ml of buffer. The 25× stock protease inhibitor solution was prepared as per
the manufacturer’s instructions. One complete mini protease inhibitor cocktail tablet
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(Roche, Germany) was dissolved in 1.5 ml of nanopure water to give a 25× stock
solution. Tablets were stored in 4ºC fridge and stocks in a -20ºC freezer.
The cracker buffer was prepared by dissolving SDS (MW 288.38), glycerol (MW 92.10),
and bromophenol blue (MW 670.02) in 0.5 M Tris-HCl in nanopure water (pH adjusted
to 6.8 using 11.4 M HCl) and s making up to a final volume of 50 ml. Prior to use 1 ml of
the above solution was mixed with 20 μl of β-mercaptoethanol and 2 µl of 100 mg/ml
EDTA. The complete cracker buffer consisted of 0.125 M Tris-HCl (pH 6.8), 1% (w/v)
SDS, 20% (w/v) glycerol, 0.1% (w/v) bromophenol blue, 2% (v/v) β-mercaptoethanol,
and 0.5 mM EDTA.
4-Morpholine-propanesulfonic acid (MOPS) buffer consisted of 50 mM MOPS (MW
209.3), 50 mM Tris(hydroxymethyl)aminomethane (Tris, MW 121.1), 0.1% (w/v) SDS
(MW 288.38), and 1 mM EDTA (MW 292.24) in nanopure water, with the pH adjusted
to 7.7 by adding concentrated HCl.
2.2.9.2 IAF labelling of reduced thiol
U937 cells at 5.0 x106 cells/ml were washed with PBS (see section 2.1.2.1) after the
culture medium was removed by centrifugation. The pellets were suspended in 100 µl of
extraction buffer (see section 2.2.9.1), and incubated at room temperature for 15 min. Ten
microlitres of 10% CHAPS was added to the final concentration of 1% w/v for cells,
before the extract was mixed and incubated for another 15 min. One millilitre of -20°C
acetone was added, mixed and placed on ice, before being centrifuged at 15,000 rpm for
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5 min, at 4°C to precipitate proteins and insoluble material. The supernatant was gently
removed by aspiration.
Cell pellets were suspended in 100 µl of extraction buffer and then centrifuged at 15,000
rpm for 5 min at 4°C to separate the insoluble material and remove cell debris. Eighty
microlitres of supernatant was transferred to clean 1.7 ml microtubes. Sixteen microlitres
of 1 mM IAF (prepared in DMSO) was added to the extract to a final concentration of
200 µM. The extract was incubated in the dark at room temperature for 10 min. One
millilitre of -20°C acetone was added before the mixture was centrifuged at 15,000 rpm
for 5 min, at 4°C to remove excess IAF. The supernatant was gently removed by
aspiration.
The resulting pellets were dissolved in 20 µl of 100 mM Tris (to stop the reaction). Then
5 μl was taken for protein assay (see section 2.1.2.4). After protein analysis, the protein
concentration in the remaining 15 μl of each sample was adjusted with excess Tris to give
the same protein concentration in all samples. Then the same amount of each sample was
then transferred to new 1.7 ml microtubes.
The cracker buffer (see section 2.2.9.1) was added (to dissolve the precipitated protein)
with an amount equivalent to the cells lysate to give a final protein concentration of 1.25
μg/μl (at this time the samples may be stored at -20°C until used). The samples were then
heated in a heating block at 95ºC for 3 minutes and centrifuged for 5 minutes at 15,000
rpm at 4°C (to remove any cell debris) before SDS-PAGE analysis (see section 2.2.9.3).
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2.2.9.3 SDS-PAGE analysis
A 4-12% gradient polyacrylamide gel (Bis-Tris Gel, Invitrogen, Carslband, CA, USA),
was placed in the XCell SureLock™ Mini-Cell system (Invitrogen, US) and the MOPS
running buffer (see section 2.2.9.1) was added to the buffer reservoir. Five microlitres of
Fermentas pre-stained molecular weight marker mix (Fermentas International Inc,
Canada), 5.0 µl of GAPDH marker for identification of thiol sensitivity and 20 μl of
samples (containing 25 μg proteins) were loaded into the wells of the gel, before
electrophoresis in the dark at 200 V for approximately 1 hour until the buffer loading dye
reached the bottom of the gel.
The gel was kept wet in a running buffer in a dark box until it was scanned using a Bio-
Rad Molecular Imager FX (Bio-Rad Laboratories, Hercules, CA, USA) with an
excitation wavelength of 488 nm and an emission/detection wavelength of 530 nm. Then
the gel was stained with coomassie blue to show the position of the authentic GAPDH
marker (supplied by Sigma), which has a molecular size of 36 kDa.
2.2.10 Measurement the rate of oxygen consumption
The rate of oxygen consumption (VO2) was determined by measuring the change in the
partial pressure of oxygen (PO2) (Forgan & Forster, 2009). U937 cells at 2.0 x106
cells/ml were placed into 1 ml of appropriately stirred air-saturated ringer solution of the
chamber in a temperature controlled 37°C Strathkelvin Instruments model RC 300
respirometers (Strathkelvin, Glasgow, Scotland). These were fitted with model IL1302 O2
electrodes and model 781 metres. The signal was fed via a Powerlab 4/25 into a notebook
computer running Chart 5 software (both AD Instruments, Castle Hill, Waverley, NSW,
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Australia) recording at 1 Hz. The air supply was disconnected and the cells were allowed
to deplete the oxygen contained within the respirometers. The experiment was terminated
when the PO2 fell from air saturation (PO2 155 mmHg) to zero. The VO2was determined
from the equation 2.1.
= ∆ ×∝ ×× 2.1
Where VO2 is the rate of oxygen consumption (µl O2. 106cells-1 .hr-1), ΔPO2 is the change
in the PO2 during the treatment period (mmHg.time-1 (sec)), αO2 is the oxygen solubility
of the ringer based on the osmolarity (0.0021 mmol O2.L-1.mmHg-1), V is the volume in
the respirometers (ml), t is the time (hour) between the PO2 measurements and M is the
number of the cells in the respirometers. The instantaneous VO2 was calculated in two
different ways, both using linear regression. For the first method, the VO2 is calculated
during every 10 minutes period over the time course of the experiment (7 hours) and for
the second method, the VO2 is calculated at 0, 3, 5, 7 hours where the cells were placed in
the cell chambers at each time point, after being held at 37°C in a humidified incubator,
with an atmosphere calibrated to 5% CO2: 95% air (Nuaire™ IR Autoflow), in the
absence of HI-FCS and pen/strep.
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2.2.11 HPLC instrumentation
The High Performance Liquid Chromatography (HPLC) system used in this research was
supplied by Shimadzu Corporation, Japan and consisted of a 2LC-20ADvp pumps with
prepump solvent mixing, inline vacuum degasser (DGU-20A5), an autosampler (SIL-
20AD vp), a column oven (CTO-20A(C)vp), a fluorescence detector (RF-20AXL), a UV-
Vis diodearray (SPD-20A(V)vp), and a communication bus module (CBM-20A)
connected to a PC. Peak areas were quantified using the Shimadzu LC solution software
package.
All aqueous mobile phases used were filtered through a 0.45 µm Phenex filter membrane
(Phenomenex) and sonicated (Alphatech Systems Ltd & Co., Auckland) for 10 minutes.
Analytes in samples were standardised against particular standards of known
concentrations.
2.2.12 TBARS-HPLC lipid analysis
The thiobarbituric acid reactive substances (TBARS) assay provides a means of
quantifying general lipid peroxidation. It relies on the ability of 2-thiobarbituric acid
(TBA) to readily react with the malondialdehyde (MDA) lipid hydroperoxide break-down
product, forming the pink TBA-MDA adduct which is fluorometrically detectable via the
HPLC system. The method used here is slightly modified from the 1993 Drapper method
which uses butylated hydroxytoluene (BHT) in the incubation media to prevent further
lipid oxidation and fluorescent detection of the TBA-MDA (Draper et al., 1993).
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Lipoproteins samples (200 l; 50 l of sample from 10 mg/ml stock and 150 l of PBS)
were mixed with 100 µl of 150 mM phosphoric acid (H3PO4, MW 97.994) and any
further oxidation was inhibited by the addition of 20 µl of 20 mg/ml BHT (MW 220.4).
After addition of 100 µl of fresh 42 mM TBA (MW 144.15) reagent the tubes were
mixed by inversion and placed in a heating block at 95°C for 30 minutes with very gentle
shaking. Samples were then cooled on ice and centrifuged at 4°C for 10 minutes at 15000
rpm.
The resulting supernatant (100 µl) was transferred to auto sampler vial and 20 µl was
injected onto the HPLC. The HPLC was equipped with a phenosphere reverse phase C-
18, 4.6 x150 mm, 5 µm column (Phenomenex; Auckland, NZ), heated to 30°C.  TBARS
were fluorometrically detected using excitation and emission wavelengths of 525 nm and
550 nm, respectively. The mobile phase consisted of 50 mM NaH2PO4H2O with pH
adjusted to 6.8 with 10 M NaOH and filtered through 0.45 m filter. This was mixed with
HPLC grade methanol in a ratio of 65:35 before degassing by sonication. The mobile
phase was pumped through the system at a flow rate of 1 ml/min.
TBARS concentrations in all samples were quantified by comparison with the peak areas
of 1 µM MDA (MW 72.06) standards. A fresh MDA standard was prepared before each
assay by hydrolysis of 6.07 M of 1,1,3,3-tetramethoxypropane (TMP, MW 164.2) in 2:3
(v/v) ethanol:water, with subsequent dilution in water to the appropriate concentration.
H3PO4 and BHT were then added, as per the experimental samples.
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2.2.13 Free 7-ketocholesterol analysis
Free 7-ketocholesterol (7-KC) was analysed by HPLC analysis (Kritharides et al., 1993).
Lipid extraction of 100 µl of lipoprotein (20 µl of samples from 10 mg/ml stock and 80
µl water) was carried out by the addition of 10 µl of 20 mg/ml BHT, 20 µl of 100 mg/ml
EDTA, 500 µl ethanol and 2 ml of hexane, before vortexing for 60 seconds. Samples
were then centrifuged at 200 g for 10 minutes at 4ºC to obtain complete phase separation.
Then 1400 µl of the top hexane layer was removed, transferred to a tapered glass test tube
and dried completely under nitrogen gas. The dried residue was re-solubilised in 100 µl
of solvent mix (ACN/isopropanol, 4:5).
Then 80 µl of the resulting supernatant was transferred to a glass auto sampler vial insert
and 20 µl was injected onto a phenosphere reverse phase C-18, 250 ×4.6 mm, 5 μm
column (Phenomenex, Auckland, NZ), heated to 35°C. Mobile phase was
acetonitrile:isopropanol:H2O in a ratio of 44:54:2. Detection of free 7-ketocholesterol was
via monitoring 234 nm absorbance. Quantification of the oxysterol was by comparison of
peaks from known concentrations of the standard.
2.2.14 Intracellular GSH analysis
Monobromobimane (MBB) is a cell-permeable fluorescent dye that binds thiol groups,
specifically those of glutathione (GSH). The GSH-MBB adducts can then be detected by
the HPLC after protein precipitation (Cotgreave & Moldeus, 1986). The procedures were
carried out under minimum exposure to light as MBB is light sensitive. MBB (MW
271.1) was dissolved in acetonitrile to give a 40 mM stock, which was stored in darkness
at 4°C for up to two weeks. Reduced GSH (MW 307.3 g/mol), at 5 and 10 μM
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concentrations, was prepared in cold PBS immediately before HPLC analysis to serve as
a standard. For analysis, U937 cells at 0.5 x106 cells/ml were washed with PBS (see
section 2.1.2.1). Then 400 μl of PBS, 9 μl of 0.1 M NaOH (to bring up the pH to 8), and
10 μl of 40 mM MBB were added to each sample of U937 cells. After 20 minutes of
incubation in the dark at room temperature, 20 μl of 100% (w/v) trichloroacetic acid
(TCA, MW 163.39) was added to lyse the cells and precipitate cellular proteins. The cell
lysate was collected and centrifuged in 1.7 ml microtubes at 15,000 rpm for 5 minutes at
4°C. Ten microlitres of the resulting supernatant was injected onto the phenosphere
reverse phase C-18, 150 ×4.6 mm, 5 μm column (Phenomenex, Auckland, NZ), heated to
35°C. GSH-MBB adducts were detected by the fluorescence detector with excitation and
emission wavelengths set at 394 nm and 480 nm, respectively. Mobile phase A
(consisting of 0.25% acetic acid in nanopure water) and mobile phase B (consisting of
100% acetonitrile) were pumped through the column at a flow rate of 1.5 ml/minute with
gradient program as described in Table 2.3.
Table 2.3 HPLC gradient for GSH measurement.
Time
(minutes)
Mobile phase A
(0.25% acetic acid)
Mobile phase B
(100% acetonitrile)
0 90% 10%
10 90% 10%
11 0% 100%
15 0% 100%
16 90% 10%
20 90% 10%
CHAPTER 2 82
___________________________________________________________
2.2.15 Measurement of intracellular purine nucleotides ATP, ADP,
AMP, NAD+ and NADP+
The effect of oxLDL on purine nucleotides which are adenosine triphosphate (ATP),
adenosine diphosphate (ADP), adenosine monophosphate (AMP), nicotinamide adenine
dinucleotide (NAD+) and nicotinamide adenine dinucleotide phosphate (NADP+) in U937
cells and HMDM cells was examined by measuring intracellular purine nucleotides levels
upon oxLDL exposure via HPLC analysis.
Purine nucleotides (ATP, ADP, AMP, NAD+ and NADP+) were quantified by reverse
phase ion pair-HPLC with UV detection at 254 nm (Tuckey et al., 2010, Pelzmann et al.,
2003, Furst & Hallstrom, 1992). A purine nucleotides stock of 1 mM concentration was
prepared in 50 mM NaH2PO4H2O, pH 7.2 and stored at -20°C. The stock was diluted to
25 μM in cold nanopure water immediately before use to serve as a standard for
quantifying the elution time and peak size of purine nucleotides.
For a sufficient signal to be detected by the HPLC system, U937 cells were used at 5.0
x106 cells/ml. Cells were transferred to 1.7 ml microtubes and centrifuged at 1500 rpm for
5 min at 4ºC before washing with PBS. Then 100 μl of cold 0.07 M perchloric acid (PCA,
MW 100.46) in nanopure water was added. In the case of HMDM cells, for a sufficient
signal to be detected by the HPLC, a combination of three wells containing 5.0 ×106
HMDM cells was required. HMDMs were collected by scraping, using a total of 125 μl
cold 0.07 M PCA in nanopure water after washing with cold PBS.
The cell lysate was then sonicated for 1 minute, left on ice for 30 minutes and centrifuged
at 15,000 g for 5 minutes at 4°C to remove proteins. The supernatant was neutralised with
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10 or 12.5 μl of 2 M potassium carbonate (K2CO3, MW 138.21) in nanopure water (the
ratio between 0.07 M PCA and 2 M K2CO3 was 10:1) for U937 cells or HMDM cells,
respectively, and then centrifuged as above.
The supernatant (40 μl) was injected onto a reverse phase 5 μm ODS (C18), 250 x 4.6
mm, 5 μm column (Phenomenex). This column was developed with gradient of mobile
phases A and B. Mobile phase A consisted of 6.9 g/L of NaH2PO4H2O and 2 g/L of
tetrabutylammonium bisulfate (C16H37NO4S, MW 339.54) in nanopure water, pH
adjusted to 5.5 using 10 M NaOH.  Mobile phase B consisted of mobile phase A and
acetonitrile at a ratio of 75:25. Both were pumped at a flow rate of 1 ml/minute with
gradient program as described in Table 2.4.
Table 2.4 HPLC gradient for purine nucleotides measurement.
Time
(minutes) Mobile phase A Mobile phase B
0 100% 0%
5 100% 0%
25 30% 70%
28 30% 70%
30 100% 0%
50 100% 0%
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2.3 Statistical analysis
Data was graphed and statistically analysed using the Prism software (version 4.0;
GraphPad Software, USA). The significance was confirmed by a one-way analysis of
variance (ANOVA), followed by Tukey’s multiple comparison test to provide a more
quantitative indication of significance between treatments and/or time points. Where
appropriate, linear regression and correlation analyses were also applied with r2 values
calculated assuming a Gaussian distribution. Significance levels are indicated in the
following manner: * p < 0.05; ** p < 0.01; *** p< 0.001.
Results displayed in this thesis are taken from one experiment, which is representative of
at least three separate experiments. The means and standard errors of the mean (SEM)
shown within each experiment were calculated from triplicate samples.
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3 Characterisation of oxLDL, the effect of oxLDL and the effect of
7,8-dihydroneopterin on cell viability and morphology
3.1 Introduction
The formation of oxidised low density lipoprotein (oxLDL) within the atherosclerotic
plaque is a significant event in the progression and development of atherosclerosis (Niu
et al., 1999, Salvayre et al., 2002). In contrast to low density lipoprotein (LDL), oxLDL
is taken up by macrophages in a rapid and uncontrolled manner leading to the formation
of cholesterol filled macrophages (foam cells). OxLDL at high concentrations is
cytotoxic in tissue culture and most likely within atherosclerotic plaques. OxLDL causes
death of a variety of cell types including macrophages by both necrosis and apoptosis.
Therefore, the change from fatty streak to complex plaque may be driven in part by the
oxLDL-induced death of macrophages within the plaque (Hardwick et al., 1996, Hegyi et
al., 1996).
This laboratory had shown that oxLDL was cytotoxic to two different human monocyte-
like cell lines, THP-1 and U937 cells (Baird et al., 2004) and human blood monocyte-
derived macrophage (HMDM) cells (Gieseg et al., 2010). However, only in the U937 and
HMDM cells oxLDL induced death shows high levels of oxidative stress which can be
inhibited by the addition of the antioxidant 7,8-dihydroneopterin. Previous studies have
highlighted a significant variation in the potency and type of cell death caused by
different preparation of oxLDL, especially between different laboratories (Darley-Usmar
et al., 1991, Draper et al., 1993, Kritharides et al., 1993) and surprisingly we have seen
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small changes in potency within our laboratory between individuals oxLDL preparation
over the years (Baird, 2003, Amit, 2008).
Primary goal of the research reported in this chapter was to characterise the potency of
the oxLDL prepared against U937 and HMDM cells prepared from human blood.
Previous studies have shown that oxLDL at cytotoxic concentrations causes both U937
cells and HMDM cells to undergo necrosis after the loss of cellular glutathione (GSH).
U937 cells normally appear more sensitive to the oxLDL than the HMDM cells. A
number of published studies have shown HMDM cells to undergo caspase independent
“apoptosis” but these studies have been conducted in the absence of serum or with only a
trace amount of serum suggesting the cells were already in a highly stressed, apoptosis
primed state which is then activated by the oxLDL (Baird et al., 2004, Asmis & Begley,
2003). The HMDM cells studies were therefore conducted in the same heat-inactivated
human serum (HIHS) containing media that they were cultured in.
This first results chapter begins by reporting measurements key biochemical
characteristics of native low density lipoprotein (nLDL) and heavily oxidised low density
lipoprotein (oxLDL). Previous studies in this laboratory have prepared the oxLDL by
incubating the LDL in a concentrated solution of copper ions. To gain a more
reproducible oxidation this study used the method of Dr. David Leake (Gerry et al.,
2007) which oxidises the LDL in a dialysis bag placed in a large volume of copper ions
so maintaining the overall copper ion concentration even though the LDL binds
significant amounts of these ions. The prepared oxLDL is analysed for an increase in
relative electrophoretic mobility (REM), unesterified 7-ketocholesterol (7-KC) formation,
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and lipid oxidation, measured as thiobarbituric acid reactive substances (TBARS). The
second part of the chapter characterises the cytotoxicity of the oxLDL prepared in this
laboratory in U937 and HMDM cell viability and morphology.
Previous studies in the laboratory have usually measured cell death after a standard 24
hours incubation (Baird, 2003, Amit, 2008). In order to obtain a more detailed
understanding of the nature of both oxLDL-induced cytotoxicity and any; present form
makes an unjustified assumption corresponding protective effect of 7,8-dihydroneopterin
on U937 and HMDM cells, this chapter presents the oxLDL induced changes in U937
and HMDM cell morphology over time and with different levels of 7,8-dihydroneopterin
protection. These morphological changes will be compared to the loss of cell viability
measured by the thiazolyl blue tetrazolium bromide (MTT) reduction assay and will
establish the concentration of oxLDL that will be used for further study in chapters 4 and
5. Finally, time course studies of the mechanism of 7,8-dihydroneopterin protection on
U937 and HMDM cells against oxLDL-induced cytotoxicity were conducted.
3.2 Results
3.2.1 Characterisation of native LDL and heavily oxidised LDL
Heavily oxidised low density lipoprotein (oxLDL) was prepared by added 50 mM copper
chloride (CuCl2) solution to 10 mg/ml native low density lipoprotein (nLDL) (total mass)
in 12-14 kDa dialysis tubing and in to the baaathing fluid to give a final concentration of
0.5 mM CuCl2 for 24 hours at 37ºC (Gerry et al., 2007). This procedure keeps the copper
ion level at a stable concentration which was not affected by the level of copper binding
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by the relatively low amount of LDL. This oxLDL was used for the majority of the
experiments.
The properties of nLDL and oxLDL are most commonly assessed by measurement of
relative electrophoretic mobility (REM), unesterified 7-ketocholesterol (7-KC) content
and thiobarbituric acid reactive substances (TBARS) levels (Darley-Usmar et al., 1991,
Draper et al., 1993, Kritharides et al., 1993, Ehrenwald & Fox, 1996). In gel mobility
analysis, LDL oxidation leads to the loss of positive charge on LDL and hence the shift in
REM. OxLDL mobility was 3-fold greater than that of nLDL showing a significant level
of LDL oxidation had been achieved. Native LDL contained very low levels of 7-
ketocholesterol, which was significantly increased after oxidation by approximately 53–
fold in the oxLDL. Native LDL also contained very low levels of TBARS, which was
significantly increased after oxidation, by approximately 130–fold in the oxLDL (Table
3.1 and Figure 3.1). These data are consistent with previous characterisations of heavily
oxidised LDL in our laboratory (Gieseg et al., 2009a).
Table 3.1 Characterisation of native LDL (nLDL) and heavily oxidised LDL
(oxLDL).
nLDL oxLDL
REM 8 mm 24 mm
Free 7-KC 6.5 µM ± 0.5 347.2 µM ± 18.6
TBARS 0.0025 mol/mol LDL±0.004 0.324 mol/mol LDL± 0.015
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Figure 3.1 Lipoprotein gel of native LDL (nLDL) and heavily oxidised LDL
(oxLDL).
Electrophoresis was performed on 1% agarose gel and Sudan black stain was used. Lanes
1 and 4 represent the REM position of nLDL; lanes 2 and 5 represent the REM position
of oxLDL.
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3.2.2 Effect of oxLDL on U937 and HMDM cells’ morphologies
The effect of oxLDL on the U937 and HMDM cells was monitored by observing changes
in morphology under a Leica light microscope at 40x magnification (Figure 3.2 and
Figure 3.3).
U937 cells were incubated in serum free RPMI-1640 media with or without 0.5 mg/ml
oxLDL over 24 hours. The control cells showed a round shape and classic U937 cell
morphology which did not change over the course of the incubation in the serum free
media (Figure 3.2). With the addition of oxLDL, the U937 cells started to have a swollen
appearance after 3 hours which became more noticeable with time (Figure 3.2). By 12
hours many cells had distorted cellular membranes with some blebbing structures. At 24
hours, a large amount of damage to the cells was apparent which included the loss of
cellular contents, disruption of cellular membranes and the presence of cellular debris
from lysed cell (Figure 3.2). These cellular morphologies appear to be consistent with the
necrotic cell death process.
HMDM control cells incubated in RPMI-1640 media containing 10% HIHS showed a
poached egg-like appearance, which is the classic morphology of macrophage cells
(Figure 3.3). HMDM cells treated with 2.0 mg/ml oxLDL did not show significant
morphological changes after 3 hours of incubation but by 6 hours of incubation, the cells
appeared swollen and enlarged compared to the control cells (Figure 3.3). After 9, 12 and
24 hours of incubation with oxLDL, the cellular membranes looked distorted and
disrupted, and cell debris was observed. A number of cells were also found detached and
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(a) Control 0 hr, U937 cells (b) 3 hr
(c) 6 hr (d) 9 hr
(e) 12 hr (f) 24 hr
Figure 3.2 Changes in U937 cell morphology during incubation with oxLDL.
U937 cells at 0.5 x106 cells/ml were incubated with or without 0.5 mg/ml oxLDL over a
24 hour period. (a) Control U937 cells (b) U937 cells with oxLDL after 3 hr; (c) 6 hr; (d)
9 hr; (e) 12 hr; (f) 24 hr.
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(a) Control 0 hr, HMDM cells (b) 3 hr
(c) 6 hr (d) 9 hr
(e) 12 hr (f) 24 hr
Figure 3.3 Changes in HMDM cell morphology during incubation with oxLDL.
HMDM cells seed at 5.0 x106 cells/ml were incubated with and without 2.0 mg/ml
oxLDL over a 24 hour period. (a) Control HMDM cells without oxLDL added (b)
HMDM cells with oxLDL after 3 hr; (c) 6 hr; (d) 9 hr; (e) 12 hr; (f) 24 hr.
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floating in the medium. Like the U937 cells, the morphological changes induced by the
oxLDL appear to be characteristic of necrotic cell death (Figure 3.3). The results clearly
showed that the cytotoxic effect of oxLDL on U937 cell morphology appeared from the
initial 3 hours of incubation. In contrast, the oxLDL only appear to affect HMDM cell
morphology after 6 hours of incubation.
3.2.3 Effect of oxLDL concentration on U937 cell viability
U937 cells were incubated in serum free RPMI-1640 media for 24 and 48 hours with a
range of oxLDL concentrations. This study also aimed to determine a suitable
concentration of oxLDL that can cause approximately 50% loss in U937 cell viability.
Loss of cell viability was determined by MTT reduction assay and the results are
displayed as a percentage of the viability of control cells (no treatment).
OxLDL caused a concentration dependent loss in U937 cell viability after 48 hours
incubation with high oxLDL concentrations (Figure 3.4). A drastic 94% loss in cell
viability was observed with 0.5 mg/ml oxLDL and near total loss of cell viability
occurred with 1.5 and 3.0 mg/ml oxLDL, suggesting that these concentrations were very
cytotoxic (Figure 3.4). The study also showed that by 48 hours of incubation the cell
death process was complete with the majority of cells losing viability.
The cell death was therefore re-examined using lower oxLDL concentrations. The
oxLDL caused a concentration dependent loss in U937 cell viability after 24 and 48 hours
(Figure 3.5).  Incubation of U937 cells for 24 hours with 0.2 mg/ml oxLDL caused a loss
of viability of 61%, 0.5 mg/ml oxLDL caused a 66% loss in cell viability and only 24%
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Figure 3.4 Effect of high concentrations of oxLDL on U937 cell viability after 48
hours.
U937 cells at 0.5 x106 cells/ml were incubated with increasing oxLDL concentrations for
48 hours before viability analysis by measuring MTT reduction. Significance is indicated
as *** P < 0.001 vs 0.0 mg/ml oxLDL control. Results shown are the mean ± SEM of
triplicate samples.
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Figure 3.5 Effect of low concentrations of oxLDL on U937 cell viability.
U937 cells at 0.5 x106 cells/ml were incubated with increasing oxLDL concentrations for
24 and 48 hours before viability analysis by measuring MTT reduction. Significance is
indicated as *** P < 0.001 vs respective 0.0 mg/ml oxLDL control. Results shown are the
mean ± SEM of triplicate samples.
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were still viable after incubation with 1.0 mg/ml oxLDL (Figure 3.5). However, 48 hours
appeared to be a relatively long time to expose the cells to a toxic agent and showed
similar result as above. From this data it was decided to only incubate U937 cells for 24
hours with 0.5 mg/ml oxLDL.
3.2.4 Rate of U937 cell viability loss induced by oxLDL
A time course study of oxLDL-mediated cellular damage was conducted by incubating
U937 cells in serum free RPMI-1640 media with 0.5 mg/ml oxLDL for 24 hours (Figure
3.6). The cell viability dropped drastically over the first 3 hours by 44% compared to the
control. The U937 cell viability continued to decline reaching a level 59% lower than the
control after 6 hours. After 10 hours of incubation only 20% of cells were still viable and
no further change was measured after 24 hours. Therefore, oxLDL exerts its toxic effect
on U937 cells within the initial 3 hours. This result is consistent with the finding in
section 3.2.2 where U937 cells morphology changed after 3 hours of incubation with
oxLDL (Figure 3.2).
3.2.5 Effect of serum on U937 cell viability loss induced by oxLDL
Heat-inactivated foetal calf serum (HI-FCS) is a commonly used supplement in cell
culture as it provides growth factors and cytokines necessary for cell growth and stability
of phenotype. However the albumin in the serum is a well documented radical scavenger
so may mask the cytotoxicity of the oxLDL in vitro. It is possible that atherosclerotic
plaques may have lower levels of albumin than plasma due to filtration.
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Figure 3.6 Time course showing the effect of oxLDL on U937 cell viability.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL over a 24 hour
period. The cell viability was measured by MTT reduction at various time points.
Significance is indicated as *** P < 0.001 vs 0 h control. Results shown are the mean ±
SEM of triplicate samples.
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The effect of HI-FCS on U937-treated oxLDL cell viability loss was studied by
incubating U937 cells in RPMI-1640 media containing 10% HI-FCS and 0.5 mg/ml
oxLDL for up to 24 hours. The cell viability was determined at the indicated times by
MTT reduction assay (Figure 3.7). Results showed that 0.5 mg/ml oxLDL did not cause
U937 cell viability loss when 10% HI-FCS was added to the RPMI-1640 media. There
was a slight increase in the cell viability but this was not significant. This result clearly
shows, HI-FCS has a protective effect on U937 cells when exposed to oxLDL. This will
discussed further in the discussion section 3.3.
3.2.6 Effect of oxLDL concentration on HMDM cell viability
HMDM cells were incubated in RPMI-1640 media containing 10% HIHS for 24 hours
with oxLDL at a range of concentrations. This study determined a suitable concentration
of oxLDL that can cause approximately 50% loss in HMDM cell viability. Serum was
included in the incubations as the HMDM cells become unstable in serum free RPMI-
1640 media over extended incubation periods. OxLDL caused a concentration dependent
loss in HMDM cell viability after 24 hours as measured by MTT reduction assay (Figure
3.8a).The HMDM cells appeared to be more resistant to the cytotoxic effect for the
oxLDL than the U937 cells requiring more oxLDL to cause significant viability loss. As
2.0 mg/ml oxLDL caused approximately 50% viability loss, this was the oxLDL
concentration chosen in the subsequent experiments involving HMDM cells.
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Figure 3.7 Time course showing the effect of oxLDL on U937 cell viability in the
presence of HI-FCS.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL and 10 % HI-FCS
over a 24 hour period. The cell viability was measured by MTT reduction at various time
points. Results compared to 0 h control and are the mean ± SEM of triplicate samples.
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Figure 3.8 Effect of different oxLDL concentration on HMDM cells viability.
HMDM cells at 5.0 x106 cells/ml were incubated with different oxLDL concentrations (0,
0.5, 1.0, 1.5 and 2.0 mg/ml) for 24 hours before viability analysis by measuring MTT
reduction. (a) Shows effect of oxLDL#4 of plasma pool 30; (b) Shows comparison
between the effects of oxLDL from different plasma pools. Significance is indicated as
*** P < 0.001 vs 0.0 mg/ml oxLDL control. Results shown are the mean ± SEM of
triplicate samples.
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Previous study in this laboratory used 1.0 mg/ml oxLDL to cause approximately 50%
loss in the cell viability (Amit, 2008). The reason for this change is not fully understood
and will be discussed further in the discussion section 3.3.
It was observed over the course of the research that there was no significant difference
oxLDL cytotoxicity to HMDM cells between different oxLDL preparations prepared
from different plasma pools (Figure 3.8b).
3.2.7 Time course study the effect of oxLDL on HMDM cell viability
A time course study of oxLDL-mediated damage was conducted by incubating HMDM
cells in RPMI-1640 media containing 10% HIHS with 2.0 mg/ml oxLDL for 24 hours
(Figure 3.9). The cell viability did not show any significant change compared with the
control until 6 hours of incubation. Between 6 and 9 hours, the cell viability dropped
drastically, by 41% compared to the control. After 12 hours of incubation the cell
viability continued to decline to 47% of the control value. After 24 hours of incubation,
only 38% of cells were still viable (Figure 3.9). This shows that the toxic effect of oxLDL
on cell viability only becomes apparent in HMDM cells after 6 hours of incubation. This
corresponds with the timing of the major morphological changes that were observed in
HMDM cells as discussed in section 3.2.2 and showed in Figure 3.3.
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Figure 3.9 Time course showing the effect of oxLDL on HMDM cells viability.
HMDM cells at 5.0 x106 cells/ml in RPMI-164 with 10% HIHS were incubated with 2.0
mg/ml oxLDL over a 24 hour period. The cell viability was measured by MTT reduction
at various time points. Significance is indicated as *** P < 0.001 vs 0 h control. Results
shown are the mean ± SEM of triplicate samples.
CHAPTER 3 102
___________________________________________________________
3.2.8 Effect of 7,8-dihydroneopterin concentration on oxLDL-
treated U937 cells
The antioxidant effect of 7,8-dihydroneopterin on cell viability loss was characterised by
pre-incubated U937 cells for 10 minutes with various concentrations of 7,8-
dihydroneopterin (0, 20, 50, 100 and 200 M) in serum free RPMI-1640 media with and
without 0.5 mg/ml oxLDL for 24 hours (Figure 3.10). Previous studies have shown the
pre-incubation period is required for consistent results (Gieseg et al., 1995). The presence
of up to 200 μM 7,8-dihydroneopterin alone did not affect U937 cell viability, while the
presence of 0.5 mg/ml oxLDL alone caused 70% loss of cell viability comparing to the
cell control (Figure 3.10).
The presence of 7,8-dihydroneopterin caused a significant concentration dependent
protection against oxLDL-induced loss of cell viability but only at 7,8-dihydroneopterin
concentrations of 50 M and above. At 100 M 7,8-dihydroneopterin, the cell viability
was increased by approximately 68% compared to the oxLDL treated U937. An oxLDL
cytotoxicity was completely inhibited with 200 M 7,8-dihydroneopterin therefore, 200
M 7,8-dihydroneopterin was used in subsequent experiments for testing the protective
effect of 7,8-dihydroneopterin against oxLDL-induced damage in U937 cells.
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Figure 3.10 Effect of 7,8-NP concentration on cell viability of oxLDL-treated U937
cells.
U937 cells at 0.5 x106 cells/ml were incubated with different concentrations of 7,8-NP (0,
20, 50, 100 and 200 µM) before incubation with or without 0.5 mg/ml oxLDL for 24
hours before viability analysis by measuring MTT reduction. Significance is indicated as
** P < 0.01, *** P < 0.001 vs oxLDL only control. Results shown are the mean ± SEM
of triplicate samples.
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3.2.9 Effect of 7,8-dihydroneopterin concentration on oxLDL-
treated HMDM cells
The antioxidant effect of 7,8-dihydroneopterin on cell viability loss was characterised by
pre-incubated HMDM cells for 10 minutes with various concentrations of 7,8-
dihydroneopterin (0, 50, 100, 150 and 200 M) in RPMI-1640 media containing 10%
HIHS with and without 2.0 mg/ml oxLDL for 24 hours (Figure 3.11). The presence of
7,8-dihydroneopterin alone, up to a concentration of 200 M did not affect HMDM cell
viability, while the presence of 2.0 mg/ml oxLDL alone caused 52% loss of cell viability
comparing to the only cells control (Figure 3.11).
The presence of 7,8-dihydroneopterin caused a significant concentration-dependent
protection against oxLDL-induced loss of HMDM cell viability but only at 7,8-
dihydroneopterin concentrations of 100 M and higher. At 100 and 150 M 7,8-
dihydroneopterin the cell viability increased by approximately 40% and 47% compared
to the oxLDL only control, respectively, while 50 μM had no protective effect. Complete
protection against oxLDL was observed with 200 M 7,8-dihydroneopterin. Therefore,
200 M 7,8-dihydroneopterin was used in subsequent experiments for testing the
protective effect of 7,8-dihydroneopterin against oxLDL-induced damage in HMDM
cells.
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Figure 3.11 Effect of 7,8-NP concentration on cell viability of oxLDL-treated
HMDM cells.
HMDM cells at 0.5 x106 cells/ml were incubated with different concentrations of 7,8-NP
(0, 50, 100, 150 and 200 µM) before incubation with or without 2.0 mg/ml oxLDL for 24
hours before viability analysis by measuring MTT reduction. Significance is indicated as
*** P < 0.001 vs oxLDL only control. Results shown are the mean ± SEM of triplicate
samples.
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3.2.10 Effect of 7,8-dihydroneopterin on oxLDL treated-U937 and
HMDM cells morphologies
The effect of 7,8-dihydroneopterin on the U937 and HMDM cells was monitored by
observing U937 and HMDM cell morphology under a Leica light microscope at 40x
magnification. The change in U937 cell morphology was studied by pre-incubated U937
cells for 10 minutes with various concentrations of 7,8-dihydroneopterin (0, 20, 50, 100
and 200 M) with and without 0.5 mg/ml oxLDL in serum free RPMI-1640 media for 24
hours (Figure 3.12) and via time course study of cells incubated with 0.5 mg/ml oxLDL
(0, 3, 6, 9, 12 and 24 hours) with and without 200 M 7,8-dihydroneopterin in serum free
RPMI-1640 media for 24 hours (Figure 3.13).
In Figure 3.12 the presence of 7,8-dihydroneopterin alone, up to a concentration of 200
M (b ,c, d and e) did not result in any change in U937 cell morphology compared to
control cells (a), which showed a typical, round shape. In the presence of 0.5 mg/ml
oxLDL alone, the U937 cells showed morphological changes consistent with necrosis as
previously described. In the presence of 20 and 50 M 7,8-dihydroneopterin with 0.5
mg/ml oxLDL (f and g) the U937 cells also showed levels of cellular damage compared
to their respective controls (a and b). There was no change in U937 cell morphology
compared to the respective controls (c, d and e) in the presence of 100 and 200 M 7,8-
dihydroneopterin with 0.5 mg/ml oxLDL (h, i and j). 7,8-Dihydroneopterin, at a
concentration between 100 and 200 M, protects U937 cells from the cytotoxic effect of
oxLDL characterised by changes in cell morphology.
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Figure 3.12 Changes in U937 cell morphology during incubation with different
concentrations of 7,8-dihydroneopterin.
U937 cells at 0.5 x106 cells/ml were incubated with 200 M 7,8-NP and without 0.5
mg/ml oxLDL (I) or with 0.5 mg/ml oxLDL (II) for 24 hours. (a), (f) 0 M 7,8-NP; (b),
(g) 20 M 7,8-NP; (c), (h) 50 M 7,8-NP; (d), (i) 100 M 7,8-NP; (e), (j) 200 M 7,8-
NP.
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Figure 3.13 Time course of changes in U937 cell morphology during incubation with
7,8-NP.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL and without 200
M 7,8-NP (I) or with 200 M 7,8-NP (II) over a 24 hour period. (a), (g) 0 hr; (b), (h) 3
hr; (c), (i) 6 hr; (d), (j) 9 hr; (e), (k) 12 hr; (f), (l) 24 hr.
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The time course study of U937 cell morphology showed cell damage in cells incubated
for 3 to 24 hours with 0.5 mg/ml oxLDL alone (b, c, d, e and f) compared to control cells
(a). There was no difference in cell morphology between control cells (g) and cells
incubated with 200 M 7,8-dihydroneopterin with 0.5 mg/ml oxLDL for any time point
(h, i, j, k and l) (Figure 3.13). Therefore, 200 M 7,8-dihydroneopterin protected the
U937 cells from the changes in cell morphology caused by the oxLDL during the initial 3
hours of incubation.
With HMDM cells, the change in morphology was studied by pre-incubated HMDM
cells for 10 minutes with various concentrations of 7,8-dihydroneopterin (0, 50, 100, 150
and 200 M) in RPMI-1640 containing 10% HIHS with and without 2.0 mg/ml oxLDL
for 24 hours (Figure 3.14). The timing of the changes in morphology were studied in a
time course experiment where the HMDM cells were incubated with 2.0 mg/ml oxLDL
for up to 24 hours with and without 200 M 7,8-dihydroneopterin in RPMI-1640
containing 10% HIHS (Figure 3.15).
The presence of 7,8-dihydroneopterin alone (b, c, d and e), up to a concentration of 200
M did not cause any change in HMDM cell morphology compared to control cells (a).
The control cells were the typical, round shaped poached egg like morphology of HMDM
cells. However, in the presence of 2.0 mg/ml oxLDL alone (f), the HMDM cells showed
morphological changes characteristic of severe cellular damage characterised by swollen
cells, appearance of large vacuoles, distorted cellular membranes and cell debris. Also,
some cells were detached and floating in the medium.
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Figure 3.14 Changes in HMDM cell morphology during incubation with different
concentrations of 7,8-NP.
HMDM cells at 5.0 x106 cells/ml were incubated with 200 M 7,8-NP and without 2.0
mg/ml oxLDL (I) or with 2.0 mg/ml oxLDL (II) for 24 hours. (a), (f) 0 M 7,8-NP; (b),
(g) 50 M 7,8-NP; (c), (h) 100 M 7,8-NP ; (d), (i) 150 M 7,8-NP; (e), (j) 200 M 7,8-
NP.
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Figure 3.15 Time course of changes in HMDM cell morphology during incubation
with 7,8-NP.
HMDM cells at 5.0 x106 cells/ml were incubated with 2.0 mg/ml oxLDL and without 200
M 7,8NP (I) or with 200 M 7,8NP (II) over a 24 hour period. (a), (g) 0 hr; (b), (h) 3 hr;
(c), (i) 6 hr; (d), (j) 9 hr; (e), (k) 12 hr; (f), (l) 24 hr.
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With 50 M 7,8-dihydroneopterin (g) there was no observable reduction in the observed
cellular damage compered to their respective control (b), but at a concentration of 100
μM (h) or greater (i and j) the cells morphology was the same as the control cell not
treated with oxLDL (c, d and e) (Figure 3.14).
The time course study of the morphology of HMDM cells treated with 2.0 mg/ml oxLDL
only showed cells with normal morphology after 3 hours (b) but damaged cells at 6 hours
on wards (c) compered to control cells (a). There was no difference in cell morphology
between control cells (g) and cells incubated with 200 M 7,8-dihydroneopterin in the
presence of 2.0 mg/ml oxLDL for any time point (h, i, j, k and l) (Figure 3.15). The data
shows 100 M 7,8-dihydroneopterin protects the HMDM cells from the effect of oxLDL
on cell morphology after 6 hours.
3.3 Discussion
3.3.1 Characterisation of native LDL and oxidised LDL
There are significant differences in the characteristics of oxLDL prepared by different
laboratories. A few factors can contribute to these differences and they include the
concentration of LDL when oxidised, the types of oxidants used and their concentrations,
the length of the oxidation, temperature of oxidation and transition metal or metal
chelator concentration (Lougheed & Steinbrecher, 1996, Ziouzenkova et al., 1998).
The REM of oxLDL used in this study was 3-fold greater than that of nLDL. The REM
values of nLDL and oxLDL prepared in this study were similar to those reported in the
literature (Darley-Usmar et al., 1991, Asmis & Jelk, 2000a, Baird, 2003, Amit, 2008).
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OxLDL used in the present study contained very high levels of 7-ketocholesterol,
approximately 53–fold more than that of the nLDL. Analysis of highly oxidised LDL
revealed that, in terms of oxysterol content, it contained almost exclusively unesterified
7-ketocholesterol (Harris et al., 2006). In some studies, 7-ketocholesterol, when delivered
directly to cell cultures, has been shown to be a potent inducer of apoptosis in various cell
types (Berthier et al., 2004, Leonarduzzi et al., 2006, Lizard et al., 1998). OxLDL
prepared in this study also had a very high TBARS level, i.e. 130-fold greater than the
nLDL. In contrast, oxLDL prepared by this laboratory using alternative methods
contained between 9-fold (Baird, 2003) and 52-fold (Amit, 2008) greater TBARS than
the corresponding nLDL. The present study used 500 M CuCl2 to oxidise 10 mg/ml
LDL whereas Amit, (2008) used 300-350 M CuCl2 to oxidise 3 mg/ml LDL and Baird,
(2003) used 50 M CuCl2 to oxidise 0.5 mg/ml oxLDL. The most likely explanation for
the disparity in the TBARS values is that nLDL is very heterogeneous also, differences in
conditions used would have large bearing. It contains different ratios of components such
as polyunsaturated fatty acids (PUFAs) and antioxidants from each group of donors,
which will then affect the properties of the resulting oxLDL (Esterbauer et al., 1990). The
high value of TBARS gives an indication that the resulting oxLDL is highly toxic. All
three characteristics mentioned above (REM, 7-KC, TBARS) suggest that the oxLDL
prepared in this study was heavily oxidised.
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3.3.2 Cytotoxicity of oxLDL
3.3.2.1 Cell Viability
Following the characterisation of the heavily oxidised LDL, the MTT reduction assay
was used to assess the degree of toxicity of the oxLDL to U937 cells and HMDM cells.
The MTT assay measures the cells’ ability to reduce MTT to formazan by NADPH
oxidase enzymes (Mosmann, 1983b). This makes the assay very sensitive to changes in
the cells’ metabolic state. Other studies have used the trypan blue assay to measure the
failure of the cell membrane and therefore, tends to be less sensitive to changes in cell
metabolic activity (Duggan et al., 2001). However, the MTT assay has previously been
shown to correlate strongly with cell viability results obtained by trypan blue exclusion
assay and phosphatidylserine exposure/propidium iodide staining in human monocyte-
like U937 and THP-1 cells (Baird et al., 2004). The loss of cell viability measured using
the MTT assay was dependent on the oxLDL concentration and the duration of
incubation. In this study, oxLDL concentrations between 0.2 mg/ml and 0.5 mg/ml
oxLDL were toxic to U937 cells in terms of cell viability loss with 0.5 mg/ml oxLDL
causing approximately 50% loss in cell viability after 24 hours incubation. With HMDM
cells, oxLDL concentrations greater than 0.5 mg/ml and up to 2.0 mg/ml were toxic in
terms of cell viability loss with 2.0 mg/ml oxLDL causing approximately 50% loss in cell
viability after 24 hours incubation. The concentrations of oxLDL used in the present
experiments are within the range of LDL concentrations in vivo, as serum concentrations
of LDL in normolipidemic persons are maintained at approximately 3.0 mg/ml total mass
(Esterbauer et al., 1992). Previous results indicate that the equivalent median lethal dose
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was between 1.5 and 2.0 mg/ml oxLDL in U937 cells (Baird, 2003) and between 1.0 and
2.0 mg/ml oxLDL in HMDM cells (Amit, 2008) depending upon the individual oxLDL
preparation. A likely explanation for this difference in cytotoxicity is that different
methods of copper ion-mediated LDL oxidation were used. The recently adapted method
for LDL oxidation employed in this study eliminates the possibility of decreased yield
during processing, and instead involves contained dialysis against copper ions at 37ºC
(Gerry et al., 2007).
The exact mechanism of oxLDL cytotoxicity is difficult to ascertain since oxLDL is not a
single set of molecules but a large collection of different oxidation products. The
structural and physical properties of the oxLDL vary according to method and degree of
oxidation. The nature of oxLDL prepared by different laboratories is different due to
variations in the conditions of oxidation and the source of the LDL (Gieseg et al., 2009a).
Slight variations in the conditions of oxidation might also result in a different degree of
toxicity of oxLDL. Surprisingly, few authors characterise the oxLDL used in their studies
except for stating that it is oxidised. This appears to have given rise to discrepancies in
the reported biological effects or mechanisms implicated in oxLDL-induced death. The
effect of oxLDL on various types of cells has been discussed in great detail in chapter 1
(section 1.2.6). The differences in oxLDL-induced cell death between U937 and HMDM
cells may be due to the differences in cell type, cell size, varying mechanisms of uptake
of oxLDL, cell metabolism, incubation conditions and the presence or absence of serum
would also surly play a part. In previous studies, oxLDL showed a high degree of toxicity
to U937 cells and HMDM cells (Firth et al., 2008a, Gieseg et al., 2001a, Gebicki et al.,
2000, Vicca et al., 2003, Baird et al., 2005). In U937 cells the time course studies
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indicated that the loss of cell viability caused by oxLDL in the absence of serum occurred
rapidly within 3 hours. With HMDM cells, the time course studies indicated a loss of cell
viability in the following 6 hours of incubation with oxLDL in the presence of 10%
HIHS. The presence of the serum in HMDM cells may affect the toxicity of the oxLDL
in the first 3 hours and delay the drop in cell viability after 6 hours of incubation. In
contrast, incubation of U937 cells with 10% HI-FCS in the presence of oxLDL did not
result in a loss of cell viability. Therefore, HI-FCS in the cell culture media of U937 cells
has a protective effect when cells are exposed to oxLDL. It is unknown whether this
effect of serum protecting the U937 cell line is the results of serum antioxidants or a
general cell stabilisation effect through various cytokines and/or nutrients. After
ascorbate and urate, albumin by its concentration is the next most significant scavenger of
ROS in the plasma (Kouoh et al., 1999, Roche et al., 2008). Albumin readily forms
carbonyls and has a free thiol, Cys34, which may play a further antioxidant role through
thiol oxidation. Oxidised albumin is effectively cleared  from the systemic circulation by
the liver (Anraku et al., 2004). However, in inflammation, the antioxidant properties of
albumin have been considered biologically insignificant to protect cells but significant
amounts of oxidised albumin has been found in the plasma in certain pathological
conditions such as atherosclerosis, anemia, kidney and liver diseases (Anraku et al.,
2004, Quinlan et al., 2005). Other studies in this laboratory have failed to demonstrate
albumin damage during oxLDL incubation either. Other studies within this laboratory
have clearly shown that the oxLDL induced stress is intracellular as dihydroethidium
(DHE) staining and GSH loss are intracellular (Gieseg et al., 2010). The significant
amount of albumin could not enter the cell to provide the needed antioxidant protection
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suggesting that the serum albumin protection is not via an antioxidant effect. The
ascorbate within the serum would be taken up by the cell but with a serum concentration
of only 10% it is unlikely that enough would be absorbed to have an effect. The
combination of ascorbate and urate may be sufficient however. More revealing is that the
same concentration of albumin is not protecting the HMDM cells suggesting that the
serum protection effect is more cell stabilisation.
3.3.2.2 Morphology
Many published studies extensively use a single cell viability assay with little or no
comment on what was actually happening to the cells physically. In this research we
linked the MTT assay with an examination of U937 and HMDM cell morphology during
incubation with a toxic concentration of oxLDL. This study clearly showed that oxLDL
caused U937 cells and HMDM cells to show the classic morphology of necrotic cell
death. Cell swelling and lysis was observed in both U973 and HMDM cells treated with
oxLDL. Previous studies by this laboratory have shown that oxLDL caused necrotic
death in HMDM cells in the presence of serum with a rapid loss of intracellular GSH
without caspase-3 activation (Gieseg et al., 2009b). Other studies found that the presence
of toxic concentrations of oxLDL caused HMDM cells to undergo death processes of
both apoptotic mechanism (in the absences of serum) due to cell membrane
phosphatidylserine exposure and intracellular caspase-3 activation (Nhan et al., 2003,
Asmis & Begley, 2003). In U937 cells, oxLDL caused necrotic death with a rapid loss of
intracellular glutathione, resulting in caspase-3 inactivation due to oxidation of the
essential free thiol groups in the active site, with no phosphatidylserine exposure on the
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plasma membrane (Baird et al., 2004). In contrast, in THP-1 cells, oxLDL caused
apoptotic death with a small reduction in cellular thiol, caspase-3 activation and plasma
membrane phosphatidylserine exposure (Baird et al., 2004). The difference in cellular
response to oxLDL could be related to the varying mechanisms of uptake of oxLDL.
There is growing evidence that CD36 has an important physiological function in the
uptake of oxLDL by macrophages (Acton et al., 1994) and by U937 cells (Nguyen-Khoa
et al., 1999). Macrophage scavenger receptors have been implicated as key players in the
pathogenesis of atherosclerosis (Febbraio et al., 2000). OxLDL scavenger receptor A
(SR-A) and CD36 are involved in foam cell formation and oxLDL mediated cell death
(Plüddemanna et al., 2007). During oxidative stress, an initial burst of oxLDL uptake
may be the result of U937 cells expressing four-fold higher levels of CD36 scavenger
receptor than seen in THP-1 cells (Nguyen-Khoa et al., 1999). THP-1 cells have been
shown to express the transcriptional regulator peroxisome proliferator-activated receptor-
γ (PPAR-γ) in response to oxLDL. However, it has been found that this is not the case
with U937 cells (Inoue et al., 2001).
3.3.3 7,8-Dihydroneopterin protection to cell viability
7,8-Dihydroneopterin is a redox active compound capable of acting as either a pro-
oxidant or antioxidant depending on the chemical environment. This laboratory has
previously shown that at low micromolar concentrations, 7,8-dihydroneopterin is a very
potent antioxidant (Gieseg et al., 2009b, Gieseg et al., 2008). It protects erythrocytes
from lysis induced by peroxyl radicals (ROO●), hydrogen peroxide (H2O2) and
hypochlorite (HOCl) (Gebicki et al., 2000, Duggan et al., 2001). In separate studies, 7,8-
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dihydroneopterin has been demonstrated to protect free proteins, cellular proteins and
protein thiol from oxidant damage (Duggan et al., 2001, Duggan et al., 2002). 7,8-
dihydroneopterin has also been shown to dramatically increase, in a dose dependent
manner, the lag time of LDL oxidation mediated by copper and ROO● (Gieseg et al.,
1995). The present study found that 100-200 μM 7,8-dihydroneopterin provided
significant protection for U937 and HMDM cells against toxic concentrations of heavily
oxLDL that caused approximately 50% loss in cell viability in the absence of 7,8-
dihydroneopterin. An examination of cell morphology during incubation with a toxic
concentration of oxLDL with or without 7,8-dihydroneopterin showed that oxLDL-
induced changes in cell morphology did not occur in the presence of 100 µM 7,8-
dihydroneopterin.
These results are consistent with the findings from previous studies by this laboratory
which showed that 7,8-dihydroneopterin provides protection for U937 cells (Baird et al.,
2005) and for HMDM cells (Amit, 2008, Gieseg et al., 2010) against the toxic effect of
oxLDL. The protective effect of 7,8-dihydroneopterin appears to depend on the nature of
the cell and of the oxidant. For example, the addition of 7,8-dihydroneopterin to THP-1
cells failed to inhibit oxLDL-dependent loss of cell viability or restore the THP-1 cellular
thiol content. Surprisingly, 7,8-dihydroneopterin was very effective at protecting U937
cells from oxLDL-induced cell viability and intracellular GSH loss (Baird et al., 2005).
The peroxyl radical scavengers, Trolox and α-tocopherol, have been shown to inhibit
oxLDL- and 7β-hydroperoxycholesterol-induced apoptosis in blood derived macrophages
and U937 cells, respectively (Asmis & Begley, 2003, Coffey et al., 1995). It is possible
that a similar mechanism is established in the U937 cells since 7,8-dihydroneopterin is a
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potent peroxyl radical scavenger (Kappler et al., 2007, Gieseg et al., 1995). This suggests
that 7,8-dihydroneopterin may protect cells from intracellular oxidative stress by
scavenging oxidants generated within the cells due to the binding of oxLDL. This
possible mechanism is further explored in the following chapters.
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4 Effect of oxLDL and 7,8-dihydroneopterin on the metabolic function
of U937 cells
4.1 Introduction
In chapter 3 the cytotoxic activity of laboratory prepared copper oxidised low density
lipoprotein (oxLDL) was examined in both human derived monocyte-like (U937) cell
line and human monocyte-derived macrophage (HMDM) cells by measuring the loss of
cell viability. The main method for measuring the cell viability loss was the thiazolyl blue
tetrazolium bromide (MTT) reduction assay which measures the ability of cells to
generate reducing potential as nicotinamide adenine dinucleotide phosphate/nicotinamide
adenine dinucleotide (NADPH/NADH). We therefore hypothesised that much of the
cytotoxic process induced by oxLDL is through the loss of cellular metabolic function
and 7,8-dihydroneopterin (7,8-NP) acts to prevent this loss of cellular function. Cellular
activity is a complex network of enzymatic functions. To measure this activity, a number
of key indicators are available to measure a cells metabolic activity which are lactate
production, the activity of lactate dehydrogenase (LDH) and the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and adenosine triphosphate (ATP) formation.
Lactate is the end product of anaerobic glycolysis, which is one of the major metabolic
pathways in macrophage cells. Lactate, which plays a role in cell metabolic functions, is
produced by anaerobic respiration (fermentation) during normal metabolism. The
enzymatic reduction of pyruvate to lactate by the LDH enzyme is coupled to the
oxidation of NADH to NAD+. Regeneration of NAD+ is important for the continuity of
glycolysis, when oxygen levels are restricted such that NAD+ is being released from the
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mitochondria. During inflammation macrophages produce a high lactate concentration
(Loike et al., 1993). Cancer cells such as U937 cells (a human histocytic lymphoma cell
line) (Sundstrom & Nilsson, 1976), produce excessive lactate because of their
dysfunctional mitochondria, which prevents their use of the citric acid or Krebs cycle.
Consequently, pyruvic acid, the end product of glycolysis, which normally would enter
the mitochondria for its total combustion into energy, is instead converted to lactate
(John, 2001). Lactate has been shown to be not only an important intermediary in
metabolic processes, but also an active player in inflammation (Leverve & Mustafa,
2002). Lactate enhanced lipopolysaccharide (LPS) stimulated inflammatory gene
expression by U937 cells and monocyte derived macrophages indicating that lactate
promotes the innate immune activation (Samuvel et al., 2009, Nareika et al., 2005).
Therefore, the LDH enzyme is one of the key enzymes in glycolysis (Nelson & Cox,
2005). LDH is an enzyme found in all cell types. LDH is rapidly released into the cell
culture medium upon damage to the plasma membrane but appears to be relatively
resistant to oxidative damage. This makes measurement of intracellular and extracellular
LDH activity a useful marker of cell integrity and when coupled with lactate generation,
overall glycolysis activity.
In contrast, the GAPDH is a key glycolytic enzyme in the cytosol which is known to be
sensitive to oxidative stress (Sukhanov et al., 2006). GAPDH enzyme has active site
cysteine residue (Cys149) that is relatively easily oxidised to a sulfenic acid, disulfides or
other high oxidation product(s) (Torchinsky, 1981). The cysteine thiol group has been
shown to be sensitive to oxidants by fluorescence labelling (Baty et al., 2002). Loss of
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the free thiol group within the enzymes catalytic site causes the loss of enzyme activity
(Sukhanov et al., 2006). Treatment of NOC18-HeLa cells, a human carcinoma cell line
with NOR3 a nitric oxide donor induces oxidative stress that causes dimerisation,
oligomerisation and aggregation of GAPDH through formation of intermolecular
disulfide bonds and lead to cell death (Nakajima et al., 2007). Combined with lactate
measurement GAPDH activity measurement provides a sensitive measure of cellular
glycolytic potential. Other studies have found that nitric oxide (NO) also denatures
GAPDH (Mcdonald & Moss, 1993, Minetti et al., 1996).
The role of catabolic metabolism is the production of adenosine triphosphate (ATP).
Adenine and pyrimidine nucleotides are involved in the energetic charge and redox state
of cells and participate as cofactors in enzymic reactions. It is, therefore, of interest to
determine levels of both the high-energy phosphates, which are directly related to the cell
energy level, and of the purine metabolites, which serve as substrates for the generation
of oxygen-free radicals (Nelson & Cox, 2005). The high energy phosphate compound
ATP, which is a coenzyme used as the main energy storage and transfer molecule in the
cells of all known organisms, is further metabolised to adenosine diphosphate (ADP) then
to adenosine monophosphate (AMP) and finally to hypoxanthine before conversion to
xanthine and ending with uric acid (Furst & Hallstrom, 1992).
NADH plays a central role in the energy homeostasis of a cell. NADH carries electrons
derived from catabolic reaction to their entry into the respiratory chain leading to the
synthesis of ATP. This electron transfer results in the formation of NAD+. Almost all of
the cardiac ATP is regenerated by respiratory chain-linked phosphorylation, whereby the
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reduction potential for the respiratory chain is mainly supplied as the reduced coenzyme
NADH, which is oxidised by complex I of the respiratory chain. The cellular NADH
content can be influenced by extracellular supply of metabolic substrates (Pelzmann et
al., 2003). The simultaneous measurement of these nucleotides provides a measure of
overall cellular metabolic activity.
Cells usually need a constant supply of oxygen and nutrients to produce energy in the
form of ATP. An insufficient supply of oxygen and nutrients results in ATP depletion,
which leads to impaired cell function and cell death (Leppänen et al., 2006).
Compromised energy supply during hypoxia can be mitigated by ATP which is rapidly
regenerated from ADP by creatine phosphate, via the creatine kinase pathway, and/or by
anaerobic glycolysis (Hochachka & Guppy, 1987). ATP-demanding pathways are down-
regulated, which often involves an inhibition of glycolysis, which generally results in a
decrease in the rate of oxygen consumption (VO2) (Hochachka et al., 1996).
Macrophages however function within sites in the body of low oxygen levels such as
within an atherosclerotic plaque. The cells therefore should be able to reduce oxygen
consumption and therefore generate more lactate.  Bone marrow macrophages and human
peripheral blood monocytes have increased survival under hypoxia in the presence of
colony stimulating factor-1 (CSF-1), which is the primary growth factor for macrophages
(Roiniotis et al., 2009). Hypoxia actual stimulates the cells to generate their own CSF-1
which enhances the survival. Hypoxia caused these cells to have increased glycolytic
activity, measured as increased glucose uptake, LDH enzyme activity and lactate
production. Hypoxia also made the macrophages less adherent and show reduced
spreading on tissue culture surface (Roiniotis et al., 2009).
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Studies on aortas removed from male albino New Zealand White rabbits, showed the
tissue oxygen consumption decreased as the degree of atherosclerosis increased. In the
advanced lesions, the ratio of foam cells increased, which lead to a thickening of the
arterial wall and the rate of oxygen consumption decreased. Overall the cell viability
decreased and the metabolic activity reduced (Bjornheden & Bondjers, 1987). Increased
oxygen consumption is also a consequence of inflammation and activation of phagocytic
cells. Zymasan activation of the murine macrophages-like cell line J774 causes increased
oxygen consumption via activation of the membrane-bond NADPH-oxidase (NOX)
which generates superoxide (O2●-) and hydrogen peroxide (H2O2) (James et al., 1998).
OxLDL may also activate NOX activity so increasing macrophage oxygen consumption
(Shatrov et al., 2003).
Glutathione (GSH) is a key component of the cellular defense mechanism against
oxidative and nitrosative stresses and plays important roles in the detoxification of free
radicals (Ballatori et al., 2009). Previous studies in our laboratory found that intracellular
GSH is the main protective antioxidant against hypochlorite (HOCl) in HMDM cells.
Interestingly, GSH is out competed for HOCl by 7,8-dihydroneopterin when added
extracellularly to the cells (Yang, 2009). Removal of GSH from human monocyte-like
cell line THP-1 cells with buthionine sulfoximine (BSO) demonstrated that GSH is the
major antioxidant protecting cells from peroxyl radicals (Kappler et al., 2007). Once
GSH is lost from the cells, peroxyl radicals cause protein oxidation and cell death.
As discussed in the previous chapters, γ–interferon released from T-cells stimulates
macrophages to synthesise 7,8-dihydroneopterin (Gieseg et al., 2008). In vitro studies
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have shown, 7,8-dihydroneopterin is a potent antioxidant that can protect a range of
biomolecules and cells from various oxidants, including hydroxyl and peroxyl radicals
(Gieseg et al., 2008). It appears that the cells during oxidative stress need more protection
than that provided by GSH suggesting the role of 7,8-dihydroneopterin is to give the cells
added protection. Whether 7,8-dihydroneopterin addition can protect cellular metabolism
from oxLDL will be examined in U937 cells as part of the research described in this
chapter.
4.2 Results
4.2.1 Effect of oxLDL on lactate concentration released to U937 cell
culture medium
The effect of oxLDL on the metabolic energy of U937 cells was studied by examining
the lactate concentration released into the cell culture medium over 24 hours. A time-
course study was carried out by incubating U937 cells in serum-free RPMI-1640 media
without phenol red, with and without 0.5 mg/ml oxLDL over 24 hours. Untreated control
cells were counted at each time point for comparison. There were no changes in the cell
concentration with time (Table 4.1), but there was continuous production of lactate into
the cell culture medium by the cells (Figure 4.1). During the initial 3 hours, there was a
significant lactate production in oxLDL-treated cells, measured as lactate-release into the
media, but after 3 hours lactate release completely stopped, with no significant increase
in lactate levels at 6, 10 and 24 hours compared to the 0 hour control. In comparison to
the respective controls of each time point, oxLDL-treated cells showed a rapid decrease
in rate of lactate release into the cell culture medium (Figure 4.1).
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Table 4.1 Time course of lactate production experiment showing control U937 cells
concentration and treated cells.
Control cells were counted at various time points and treated cells with 0.5 mg/ml oxLDL
were counted at 0 hours in the determination of lactate production experiment. U937 cells
at 0.5 x106 cells/ml were incubated in media over a 24 hour period.
Time (hours) 0 3 6 10 24
Control cell conc.
(x106 cells/ml) 0.5 0.5 0.49 0.48 0.49
Treated cell conc.
(x106 cells/ml) 0.5
0 3 6 10 24
0
1
2
3
4
5
Control (no oxLDL)
With 0.5 mg/ml oxLDL
***
*******
Time (hours)
[L
act
ate
](µ
M)
Figure 4.1 Time course showing the effect of oxLDL effect on lactate production in
U937 cells.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL over a 24 hour
period. The lactate released to the culture media was measured at various time points.
Mean protein content was 50 mg/106 cells. Significance is indicated as *P < 0.05, ***P <
0.001 vs respective control of each time point containing cells alone. Results shown are
the mean ± SEM of triplicate samples.
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After 3, 6, 10 and 24 hours, lactate production was 32%, 50%, 60% and 64% lower than
the respective controls at each time point (Figure 4.1). Therefore, oxLDL causes a
dramatic decrease in the lactate production and release to the cell culture media from the
initial 3 hours in U937 cells.
4.2.2 Effect of oxLDL on LDH activity in U937 cells
The effect of oxLDL on metabolic energy in U937 cells was studied by treating the cells
with oxLDL and measuring the LDH activity both intracellularly and in cell culture
media over 24 hours. U937 cells were incubated in serum-free RPMI-1640 media with
0.5 mg/ml oxLDL for 24 hours and the LDH activity measured at set time points. There
was a loss of LDH activity inside the cells and an increase in LDH activity in the cell
culture medium, after the initial 3 hour period (Figure 4.2a). The loss of LDH activity, as
measured in cell pellets, was likely caused by the release of LDH through holes in plasma
membrane. The observed release of LDH and corresponding cell lysis are caused by
prolonged exposure to oxLDL. However, the total LDH activity remained stable over the
course of the study (Figure 4.2b). This does not explain why within U937 cells, the
oxLDL caused a drop in lactate production following the initial 3 hours, while the LDH
enzyme release to the cell culture media did not occur after 3 hours. That indicating
metabolism slowed before cell lysis took place and LDH was lost from the cells.
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Figure 4.2 Time course showing the effect of oxLDL on the LDH activity in U937
cells.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL over a 24 hour
period. (a) The LDH activity was measured in the cell culture media and in the cell
pellets at various time points. (b) The total LDH activity was measured at various time
points. Mean protein content was 50 mg/106 cells. Significance is indicated as * P < 0.05,
** P < 0.01, *** P < 0.001 vs respective 0 hr control. Results shown are the mean ± SEM
of triplicate samples.
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4.2.3 GAPDH activity in U937 cells
The loss of GAPDH activity was examined to explain the difference in timing between
loss of LDH activity and lactate production in U937 cells treated with oxLDL. Initial
studies examined the most suitable cell and oxLDL concentrations for the measurement
of changes in GAPDH activity.
The GAPDH activity was measured in U937 cells using a range of different cell
concentrations (0.3, 0.6, 1.2, 2.4 and 4.8 x106 cells/ml) to determine the best
concentration to measure GAPDH activity changes. There was a concentration-dependent
increase in GAPDH activity with increasing cell concentration (Figure 4.3). All cell
concentrations between 0.3 and 4.8 x106 cells/ml gave sufficient signal to detect the
GAPDH activity changes, even with low activity changes. In subsequent experiments,
U937 cells were used at 0.5 x106 cells/ml to measure the GAPDH activity changes.
U937 cells were incubated in serum-free RPMI-1640 media for 48 and 24 hours with a
range of oxLDL concentrations to determine a suitable concentration of oxLDL to
examine changes in GAPDH activity. OxLDL caused a dramatic loss in GAPDH activity
after 48 hours incubation with all oxLDL concentrations (Figure 4.4a). Incubation of
U937 cells with 0.5 mg/ml oxLDL for 48 hours caused a 92% loss in GAPDH activity,
1.5 mg/ml oxLDL caused a 94% loss in GAPDH activity and 95% loss of GAPDH
activity occurred with 3.0 mg/ml oxLDL. However, 48 hours appeared to be a relatively
long time to expose the cells to such a toxic agent.
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Figure 4.3 Effect of cell concentration of U937 cell GAPDH activity.
GAPDH activity (µmol/min) was measured in different concentrations of U937 cells
(x106 cells/ml). Results shown are the mean ± SEM of triplicate samples.
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Figure 4.4 Effect of oxLDL concentration on GAPDH activity in U937 cells.
U937 cells at 0.5 x106 cells/ml were incubated with different oxLDL concentrations
before GAPDH activity was measured: (a) (0, 0.5, 1.5 and 3.0 mg/ml) at 48 hours. (b) (0,
0.2, 0.5 and 1.0 mg/ml) at 24 hours. Mean protein content was 50 mg/106 cells.
Significance is indicated as *** P < 0.001 vs 0.0 mg/ml oxLDL control. Results shown
are the mean ± SEM of triplicate samples.
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Using lower oxLDL concentrations and only incubating for 24 hours, oxLDL was shown
to cause a concentration-dependent loss in U937 GAPDH activity after 24 hours (Figure
4.4b). Incubation of U937 cells for 24 hours with 0.2 mg/ml oxLDL caused a loss in
GAPDH activity of 66%, with 0.5 mg/ml oxLDL a 91% loss in GAPDH activity was
observed and a 96% loss in GAPDH activity with 1.0 mg/ml oxLDL. Therefore, in the
time course experiments, U937 cells were incubated with 0.5 mg/ml oxLDL for no longer
than 24 hours to determine the rate of GAPDH activity loss.
4.2.3.1 Rate of GAPDH loss by oxLDL in U937 cells
A time course study of the effect of oxLDL on GAPDH activity was conducted by
incubating U937 cells in serum-free RPMI-1640 media with 0.5 mg/ml oxLDL for 24
hours. The GAPDH activity dropped dramatically, reaching a level 64% less than the
control after 3 hours. The GAPDH activity  decreased by 75% after 6 hours, followed by
90% loss after 10 and 24 hours (Figure 4.5). Therefore, GAPDH activity in U937 cells is
very sensitive to the effect of oxLDL, which showed a rapid decrease between 0 and 3
hours of incubation. The rate of GAPDH loss appears to follow that observed with the
timing of oxLDL-induced loss in lactate production.
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Figure 4.5 Time course showing the effect of oxLDL on GAPDH activity in U937
cells.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL over a 24 hour
period. The GAPDH activity was measured at various time points. Mean protein content
was 50 mg/106 cells. Significance is indicated as *** P < 0.001 vs 0 hr control. Results
shown are the mean ± SEM of triplicate samples.
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4.2.3.2 Effect of foetal calf serum on oxLDL induced loss of GAPDH
activity in U937 cell.
The rate of GAPDH activity in the presence of heat-inactivated foetal calf serum (HI-
FCS) was studied by incubating U937 cells in RPMI-1640 with 10% HI-FCS and 0.5
mg/ml oxLDL for 24 hours (Figure 4.6). There was no significant change in GAPDH
activity in the presence of 10% HI-FCS and 0.5 mg/ml oxLDL during 24 hours
incubation (Figure 4.6). Therefore, HI-FCS had a protective effect against the toxic
effects of oxLDL on GAPDH enzyme activity in U937 cells.
4.2.4 Effect of oxLDL on GAPDH protein thiol in U937 cells
The most likely cause of the loss of GAPDH activity is the oxidation of the free thiol in
the active site. This was measured by fluorescence labeling of the reduced thiol using 5-
iodacetamidoflurescein (5-IAF) and separation of the cellular proteins by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). This method has been used to
previously show that GAPDH is one of the main cellular proteins whose thiol are
oxidised during oxidative stress (Sukhanov et al., 2006). Using this technique the effect
of oxLDL on GAPDH free thiol levels was examined. Lysates were prepared by
incubating U937 cells in serum-free RPMI-1640 media with 0.5 mg/ml oxLDL for 12
hours and reduced protein thiol were labeled with 5-IAF (Figure 4.7). Following 5-IAF
staining, a series of intense bands were observed (Figure 4.7a). Lane 1 corresponds to
control cells (without oxLDL added) and is indicative of the large number of reduced
thiol proteins present in the cells.  Lanes 2, 3 and 4 represent the incubation of U937 cells
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Figure 4.6 Time course showing the effect of oxLDL on GAPDH activity in U937
cells in the presence of HI-FCS.
U937 cells at 0.5 x106 cells/ml were incubated with 0.5 mg/ml oxLDL and 10 % HI-FCS
over a 24 hour period. The GAPDH activity was measured at various time points. Mean
protein content was 50 mg/106 cells. Results are compared to the 0 hr control and are the
mean ± SEM of triplicate samples.
CHAPTER 4 137
_____________________________________________________
Figure 4.7 The effect of oxLDL on the reduction of thiol groups in GAPDH in U937
cells using SDS-PAGE.
U937 cells at 5.0 x106 were incubated with 0.5 mg/ml oxLDL over a 12 hour period. (a)
Reduced thiol following IAF stain. Lane 1: Control U937 cells without oxLDL added;
Lane 2: 3 hr; Lane 3: 6 hr; Lane 4: 12 hr. (b) Reduced thiol following coomassie blue
stain. Lane 1: protein marker; Lane 2: GAPDH marker; Lane 3: Control U937 cells
without oxLDL added; Lane 4: 3 hr; Lane 5: 6 hr; Lane 6: 12 hr. Protein content was 25
μg/20 μl of sample/gel well.
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with oxLDL for 3, 6 and 12 hours, respectively. Over the 12 hours of incubation there
was many changes in the thiol pattern with some proteins become more reduced (36 kDa
band at 6 hours) while all others before 6 hours were less. Authentic pure GAPDH runs
as a single 36 kDa band (line 2, Figure 4.7b) which aligns to a strongly fluorescing 5-IAF
staining band in the zero time samples. This 36 kDa bands 5-IAF staining decreases with
increasing time showing there is less free thiol associated with this protein.
The coomassie staining showed that the protein associated with the 5-IAF thiol staining
was relatively stable but then was significantly lost at 12 hours suggesting the protein had
been degraded. The 12 hours coomassie staining still shows many other proteins with no
significant change in staining intensity which suggests the loss of this possible GAPDH
coomassie staining protein band was a lost due to selective degradation as has been
previously described in endothelial cells (Sukhanov et al., 2006).
To gain a better understanding of the staining of the hypothesised GAPDH band, the
staining intensity was digitised and plotted against coomassie staining and the GAPDH
activity. The loss in 5-IAF staining intensity is faster than the loss detected by coomassie
staining (Figure 4.8a). There was no significant loss in 5-IAF staining over the first 3
hours during which there was a major loss in enzyme activity (Figure 4.8b). However
after 3 hours there was a linear relation between the 5-IAF staining intensity of the 36
kDa band and the GAPDH activity (Figure 4.8b). The intensity of fluorescing 5-IAF
staining protein band decreased as the GAPDH activity decreased.
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Figure 4.8 Measurement of 36 kDa protein band 5-IAF staining intensity.
The staining intensity of 5-IAF and coomassie of the 36 kDa band in Figure 4.7 was
digitised using Image J software and the data was plotted for each time point to show (a)
difference in coomassie and 5-IAF staining and (b) 5-IAF staining against GAPDH
activity in U937 cells at 5.0 x106 were incubated with 0.5 mg/ml oxLDL over a 12 hour
period.
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This data shows that loss of reduced thiol in the 36 kDa proposed to be the GAPDH
protein band is associated with the loss in GAPDH enzyme activity. The data supports
the hypothesis that GAPDH activity loss is due to the oxidation of the free thiol in the
GADPH activity site.
4.2.5 Effect of oxLDL on GSH concentration in U937 cells
Cellular GSH is a potent antioxidant and can efficiently neutralise reactive oxygen
species (ROS) (Bilzer & Lauterburg, 1991). It is also one of the key redox agents
maintain the reducing environment, and therefore the stability of the thiol status of
proteins such as GAPDH. The potential effect of oxLDL on GSH has been previously
documented by this laboratory (Gieseg et al., 2009b) but the exact timing of the GSH loss
in relationship to the GAPDH loss had not been examined.
U937 cells were incubated in serum-free RPMI-1640 media with and without 0.5 mg/ml
oxLDL for 24 hours and the GSH levels determined at various time points. The number
of control (no oxLDL) cells did not change with the time (Table 4.2), but there was a
steady increase in the intracellular GSH concentration with increasing time (Figure 4.9).
In contrast, in the oxLDL-treated cells, the intracellular GSH concentration decreased
over time. Over the first 3 hours the GSH level did not change and was 36% less than that
of the corresponding control cells. This difference between the control and oxLDL
treated cell increased with time as the oxLDL treated GSH levels actual decreased.
OxLDL caused a loss in intracellular GSH in the U937 cells and prevented the increase in
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Table 4.2 Time course of GSH concentration experiment showing control U937 cells
concentration and treated cells.
Control cells were counted over time and treated cells with 0.5 mg/ml oxLDL were
counted at 0 hours in the determination of GSH concentration experiment. U937 cells at
0.5 x106 cells/ml were incubated in media over a 24 hour period.
Time (hours) 0 3 6 10 24
Control cell conc.
(x106 cells/ml) 0.5 0.49 0.48 0.48 0.5
Treated cell conc.
(x106 cells/ml) 0.5
0 3 6 10 24
0
5
10
15
20 Control (no oxLDL)
With 0.5mg/ml oxLDL
***
* *** ***
Time (hours)
[G
SH
](µ
M)
Figure 4.9 Time course showing the effect of oxLDL on GSH concentration in U937
cells.
U937 cells at 0.5 x106 cells/ml were incubated with or without 0.5 mg/ml oxLDL over a
24 hour period. The intracellular GSH concentration was determined by HPLC analysis.
Mean protein content was 50 mg/106 cells. Significance is indicated as * P < 0.05, *** P
< 0.001 vs respective control at each time point containing cells alone. Results shown are
the mean ± SEM of triplicate samples.
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GSH levels observed in the control cells. It is uncertain from this data whether oxLDL is
preventing GSH formation or driving the oxidation of the GSH present in the cell.
4.2.6 Effect of oxLDL on intracellular purine nucleotides ATP, ADP,
AMP, NAD+ and NADP+ levels in U937 cells
The importance of intracellular purine nucleotides, ATP, ADP and AMP, lie in the
continuance of cellular homeostasis, modification of energy loads and play a key role in
mitochondrial metabolic control (Hochachka & Mcclelland, 1997). The importance of
NAD+ is for the formation of NADH, which acts to transfer electrons between both the
citric acid cycle and glycolysis and electron transport chain (Alberts et al., 2002). The
ratio of NAD+ and NADH are markers of metabolic state and intracellular redox potential
(Lin & Guarente, 2003). Although the NAD+: NADH ratio may be a good indicator of
metabolic state, in practice it is very labile and measurement is difficult (Caruso et al.,
2004). The effect of oxLDL on total metabolic energy of U937 cells was studied by
treating cells with oxLDL and examining intracellular purine nucleotides, ATP, ADP,
AMP, NAD+ and NADP+ at various time points. Initial studies were focused on
developing the method for use with U937 cells using HPLC analysis. The retention times
and the areas under chromatogram peaks for the purine nucleotides standards are shown
in Table 4.3. The chromatograms of standards purine nucleotides and purine nucleotides
levels (ATP, ADP, AMP, NAD+ and NADP+) and their levels in U937 cells incubated
with 0.5 mg/ml oxLDL over the 12 hour time period are shown in Figure 4.10.
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NAD+ AMP NADP+ ADP ATP
(c) 3 hr
(a) Standard
(b) Control, 0 hr
AMPNAD+ ADP ATPNADP+
AMPNAD+ ADP ATPNADP+
Table 4.3 HPLC characterisation of purine nucleotides ATP, ADP, AMP, NAD+ and
NADP+ standards.
The HPLC analysis shows the retention times and the areas under chromatogram peaks of
the purine nucleotides standards with 25 μM concentration.
Standard (25 µM)
Purine nucleotides NAD+ AMP NADP+ ADP ATP
Retention Time 14.666 17.605 21.904 25.090 33.216
Area 1080447 840132 904460 580779 559045
5.0 10.0 15.0 20.0 25.0 30.0 35.0 min
0
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100mVUV/Vis Ch1:254nm
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mV
UV/Vis Ch1:254nm
5.0 10.0 15.0 20.0 25.0 30.0 35.0 min
0
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mV
UV/Vis Ch1:254nm
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Figure 4.10 Chromatograms showing the effect of oxLDL on purine nucleotides
ATP, ADP, AMP, NAD+ and NADP+ levels in U937 cells over time.
5.0 x106 of U937 cells were incubated with 0.5 mg/ml oxLDL over a 12 hour period. (a)
purine nucleotides standards; (b) Control U937 cells without oxLDL added; (c) U937
cells with oxLDL after 3 hr; and at scale 0-15 mV (d) U937 cells with oxLDL after 3 hr;
(e) 6 hr; (f) 9 hr; (g) 12 hr.
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A time course study was conducted to investigate the effect of oxLDL on purine
nucleotides levels by incubating U937 cells in serum-free RPMI-1640 media with 0.5
mg/ml oxLDL over a 12 hour period (Figure 4.11 and Figure 4.12).
There was an increase in the ATP level of control cells during the first 3 hours, after
which time the ATP level then remained stable until 12 hours (Figure 4.11a). In oxLDL-
treated cells, the ATP level dropped dramatically after 3 hours to 70% of the respective
control values at 3 hours. The ATP level continued to decline, reaching a 75, 87 and 83%
decrease compared to the corresponding control data, after 6, 9 and 12 hours, respectively
(Figure 4.11a).
There was a slight increase in the ADP level of control cells during the initial 3 hours,
and then the ADP level remained stable for the duration of the incubation (Figure 4.11b).
In oxLDL-treated cells, the ADP level decreased by 49% during the first 3 hours. The
ADP level continued to decline, reaching a level that was 65%, 79% and 85 % less than
that of the corresponding control data, after 6, 9 and 12 hours, respectively (Figure
4.11b).
In comparison, there was no change in AMP level in control cells and in treated cells
over the incubation period (Figure 4.11c).
The combined data for AMP, ADP and ATP levels over the 12 hours incubation are
shown together in Figure 4.11d to clearly show the changes in concentration. OxLDL
caused a decrease in ATP and ADP levels from initial 3 hours.
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Figure 4.11 Time course showing the effect of oxLDL on ATP, ADP and AMP levels
in U937 cells.
5.0 x106 of U937 cells were incubated with 0.5 mg/ml oxLDL over a 12 hour period. (a)
ATP; (b) ADP; (c) AMP; (d) All ATP, ADP and AMP. All concentrations were
determined by HPLC analysis. Mean protein content was 50 mg/106 cells. Significance is
indicated as *** P < 0.001 vs respective control at each time point containing cells alone.
Results shown are the mean ± SEM of triplicate samples.
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This finding is in parallel to the loss in lactate, GSH levels and GAPDH activity that were
measured. Subsequently, the metabolic energy appears to slow down before cell lysis
occurs.
There was a decrease in the NAD+ level in control cells during the initial 3 hours, then
the NAD+ level remained stable over the following 9 hours (Figure 4.12a). In oxLDL-
treated cells the NAD+ level had dropped dramatically, by 54% after 3 hours. The NAD+
level continued to decline, reaching a level 68% lower than the corresponding control
after 6 hours, and 73% lower after 9 and 12 hours (Figure 4.12a).
There was a decrease in the NADP+ level in control cells during the initial 3 hours, before
the NADP+ level stabilised for the remaining length of the incubation (Figure 4.12b). In
comparison, in oxLDL-treated cells, the NADP+ level dropped by 46% during the initial 3
hours. The NADP+ level continued to decline and reached levels that were 60 and 70%
lower than their corresponding controls after 6 and 9 hours, respectively. There was no
further change in NADP+ levels after 9 hours incubation (Figure 4.12b).
Unfortunately NADH and NADPH were found to be too labile to measure using this
technique in U937 cells.
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Figure 4.12 Time course showing the effect of oxLDL on NAD+ and NADP+ levels in
U937 cells.
5.0 x106 of U937 cells were incubated with 0.5 mg/ml oxLDL over a 12 hour period. (a)
NAD+; (b) NADP+. All concentrations were determined by HPLC analysis. Mean protein
content was 50 mg/106 cells. Significance is indicated as *** P < 0.001 vs respective
control at each time point containing cells alone. Results shown are the mean ± SEM of
triplicate samples.
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4.2.7 Effect of 7,8-dihydroneopterin concentration on lactate
production in the cell culture media of oxLDL-treated U937
cells
All previous studies in U937 cells have shown 7,8-dihydroneopterin prevents the
destructive effects of oxLDL on cells. The antioxidant effect of 7,8-dihydroneopterin on
lactate production in cell culture media was studied by pre-incubated U937 cells for 10
minutes with various concentrations of 7,8-dihydroneopterin in serum-free RPMI-1640
(no phenol red) media before incubation with and without 0.5 mg/ml oxLDL for 12 hours
(Figure 4.13).
The presence of 7,8-dihydroneopterin alone, up to a concentration of 200 M did not
affect the lactate level in U937 cells (Figure 4.13), while the presence of 0.5 mg/ml
oxLDL alone caused a 50% decrease in the lactate concentration of the cell culture media
(Figure 4.13). The presence of 7,8-dihydroneopterin caused a significant concentration
dependent protection against oxLDL-induced loss of lactate production but only at 7,8-
dihydroneopterin concentrations above 50 M. In the presence of 100 and 150 M 7,8-
dihydroneopterin the lactate production increased by approximately 35% and 41%
compared to the oxLDL only control, respectively (Figure 4.13).
A maximum protective effect was established with 200 M 7,8-dihydroneopterin. The
results show that 7,8-dihydroneopterin has a protective effect against oxLDL-induced
damage to the overall glycolytic activity of the U937 cells as measured as lactate
production.
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Figure 4.13 Effect of 7,8-NP concentration on lactate production in the cell culture
media of oxLDL-treated U937 cells.
U937 cells at 0.5 x106 cells/ml were incubated with different concentrations of 7,8-NP (0,
50, 100, 150 and 200 µM) before incubation with or without 0.5 mg/ml oxLDL for 12
hours. The lactate released to the culture media was measured. Results shown are the
mean ± SEM of triplicate samples. Mean protein content was 50 mg/106 cells.
Significance of results was examined by comparing the lactate concentration with each
7,8-NP concentration with the positive control containing cells with oxLDL alone; * P <
0.05, ** P < 0.01, *** P < 0.001.
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4.2.8 Effect of 7,8-dihydroneopterin on GAPDH activity in oxLDL-
treated U937 cells
We had shown that GAPDH loss is a key event in oxLDL induced U937 cell death and
lactate production was maintained in the presence of oxLDL if 7,8-dihydroneopterin was
present. We therefore examined whether 7,8-dihydroneopterin was protecting the
GAPDH activity.
As previously described U937 cells were pre-incubated for 10 minutes with 200 M 7,8-
dihydroneopterin in serum-free RPMI-1640 media with and without 0.5 mg/ml oxLDL
for 12 hours. In the presence of 0.5 mg/ml oxLDL alone the GAPDH activity dropped
dramatically; by 65% during the initial 3 hours (Figure 4.14). The GAPDH activity
continued to decline, dropping to a level 76% less than the control after 6 hours. After 9
hours the GAPDH activity dropped by 88% and by 94% after 12 hours.
In the of presence of 200 M 7,8-dihydroneopterin and 0.5 mg/ml oxLDL, the GAPDH
activity remained the same over the incubation period compared to the corresponding
control of each time point that contained oxLDL alone. 7,8-Dihydroneopterin has a
protective effect against oxLDL-induced loss of GAPDH activity in U937 cells.
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Figure 4.14 Time course showing the effect of 7,8-NP on GAPDH activity in oxLDL-
treated U937 cells.
U937 cells at 0.5 x106 cells/ml were incubated with or without 200 µM 7,8-NP before
incubation with 0.5 mg/ml oxLDL over a 12 hour period. The GAPDH activity was
measured at various time points. Mean protein content was 50 mg/106 cells. Significance
is indicated as *** P < 0.001 vs respective control at each time point containing cells
with oxLDL alone. Results shown are the mean ± SEM of triplicate samples.
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4.2.9 The VO2 in U937 cells
Mitochondrial NADH metabolism is dependent on the VO2. NOX activity also requires
oxygen. The investigation has centred on glycolysis and shown that oxLDL has a major
effect on GAPDH and overall glycolytic function as measured by lactate generation.
OxLDL could be expected to either cause a large burst in the rate of VO2 through NOX or
the possible loss of mitochondrial function would appear as a decrease in the VO2. We
investigated these possibilities and examined the effect of oxygen tension on U937 cells
VO2.
4.2.9.1 Effect of 7,8-dihydroneopterin on the VO2 of U937 cells
The effect of 7,8-dihydroneopterin on the VO2 over time was examined by pre-incubated
U937 cells in a stirred temperature controlled (37ºC) respirometers for 10 minutes with or
without 200 M 7,8-dihydroneopterin in serum-free RPMI-1640 media (without oxLDL)
then sealing the ringer of the chamber and measuring the VO2 of cells every 10 minutes
over 7 hours as described in the methods chapter (section 2.2.10). There was no
difference between the VO2 of control cells (incubated with RPMI-1640 alone; without
7,8-dihydroneopterin and without oxLDL) and treated cells (incubated with RPMI-1640
and with 7,8-dihydroneopterin alone) over the incubation period (Figure 4.15a).
However, both treatments showed that there was a decrease in the VO2, by 20% during
the first 30 minutes before a steady state was reached. The control cells showed that the
VO2was dependent on the partial pressure of oxygen (PO2) (Figure 4.15b). There was no
difference between control cells and 7,8-dihydroneopterin treated cells in the VO2 with
CHAPTER 4 155
_____________________________________________________
(a)
0 20 40 60 80 100 120 140 160 180 200
0.0
0.2
0.4
0.6
0.8
1.0
1.2 Control (no 7,8-NP)
With 200 M 7,8-NP
Time (min)
VO
2(
lO
2.10
6ce
lls
-1.h
r-1
)
(b)
0 25 50 75 100 125 150 175
0.00
0.25
0.50
0.75
1.00
1.25  Control (no 7,8-NP)
With 200 M 7,8-NP
PO2 (mmHg)
VO
2(m
lO
2.10
6ce
lls
-1.h
r-1
)
Figure 4.15 Time course showing the effect of 7,8-NP on oxygen consumption in
U937 cells.
U937 cells at 2.0 x106 cells/ml were incubated with or without 200 µM 7,8-NP (without
oxLDL) over a 7 hour period. (a) VO2 vs time. (b) VO2 vs PO2. Mean protein content was
50 mg/106 cells. Results shown are the mean ± SEM of triplicate samples.
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respect to the change in the PO2 (Figure 4.15b). Therefore, 7,8-dihydroneopterin alone
has no effect on the VO2 of U937 cells.
4.2.9.2 Effect of oxLDL on the VO2 in U937 cells
The effect of 0.5 mg/ml oxLDL on the VO2 over time was performed by incubating U937
cells in serum-free RPMI-1640 media with or without 0.5 mg/ml oxLDL over 7 hours in
a closed respirometers at 37ºC (methods chapter, section 2.2.10). In control cells (without
oxLDL) there was decrease in the VO2 of 20% during the first 30 minutes before steady
state was reached as previously described (Figure 4.16a). The addition of oxLDL caused
the VO2 to decrease by 36% during the first 30 minutes before a slow phase of decreasing
the VO2 for the next 6.5 hours where a further decrease of 28% occurred. The total
decrease in the VO2 over the 7 hours was 64% with oxLDL. The PO2 in the control cells
remained stable over the course of the experiment, but in the oxLDL-treated cells there
was a constant decrease in the VO2 as the PO2 decreased (Figure 4.16b). OxLDL appear
to have removed the cells ability to regulate the rate of the VO2 and removed the ability to
maintain the VO2 in decreasing oxygen concentrations.
4.2.9.3 Effect of 7,8-dihydroneopterin on the VO2 of oxLDL-treated
U937 cells
The ability of 7,8-dihydroneopterin to protect the cells VO2 regulation in the presence of
oxLDL was examined by pre-incubated U937 cells for 10 minutes with or without 200
M 7,8-dihydroneopterin in serum-free RPMI-1640 media before incubation with 0.5
mg/ml oxLDL over 7 hours in a closed respirometers at 37ºC (methods chapter, section
2.2.10).
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Figure 4.16 Time course showing the effect of oxLDL on oxygen consumption in
U937 cells.
U937 cells at 2.0 x106 cells/ml were incubated with or without 0.5 mg/ml oxLDL over a
7 hour period. (a) VO2 vs time. (b) VO2 vs PO2. Mean protein content was 50 mg/106
cells. Significance is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001 vs respective
control at each time point containing cells alone. Results shown are the mean ± SEM of
triplicate samples.
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There was no difference in the VO2 between the cells incubated with oxLDL alone and
the cells incubated with 7,8-dihydroneopterin and oxLDL over the course of the
experiment (Figure 4.17). In both treatments, there was a decrease in the VO2, by 40%
during the first 30 minutes, before steady state was reached. This suggested that 7,8-
dihydroneopterin was unable to prevent the loss of the VO2 by oxLDL. This result was
different to the previously observed antioxidant effect of 7,8-dihydroneopterin. The most
likely explanation for this result was the 7,8-dihydroneopterin was being oxidised to
neopterin in the ringer of the chamber very quickly during the first 30 minutes of the
experiment. It is possible that this reaction was being enhanced at the oxygen electrode so
the 7,8-dihydroneopterin levels fell faster than normally observed in solution. This led to
modification of the method to measure the possible protective effect of 7,8-
dihydroneopterin on oxygen consumption. The experiments to date have measured the
VO2 in sealed respirometers chambers where the oxygen is consumed by the cells and the
PO2 (amount) decreases.
The experiment was changed so the U937 cells were incubated in the tissue flasks with
oxLDL or oxLDL plus 7,8-dihydroneopterin or without additives. At set time points the
cells were collected and placed in the respirometers and the initial VO2 recorded over 30
minutes. With control cells (incubated with RPMI-1640 alone, without 7,8-
dihydroneopterin and without oxLDL) there was a significant 3.8 fold increase in the
VO2 over the 7 hours of the experiment (Figure 4.18). The addition of 0.5 mg/ml oxLDL
cut the increase in U937 cells VO2 to only 1.7 fold after 7 hours. Relative to the control
cells, the oxLDL treated U937 cells VO2, had decreased by 25% at 3 hours, 42% at 5
hours and by 50% at 7 hours compared to the corresponding control cells at each time
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Figure 4.17 Time course showing the effect of 7,8-NP on oxygen consumption of
U937 cells.
U937 cells at 2.0 x106 cells/ml were incubated with or without 200 µM 7,8-NP before
incubation with 0.5 mg/ml oxLDL over a 7 hour period. Mean protein content was 50
mg/106 cells. Results shown are the mean ± SEM of triplicate samples.
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Figure 4.18 Time course showing the effect of 7,8-NP on oxygen consumption in
U937 cells.
U937 cells at 2.0 x106 cells/ml were incubated with or without 200 µM 7,8-NP before
incubation with 0.5 mg/ml oxLDL over a 7 hour period. Mean protein content was 50
mg/106 cells. Significance is indicated as * P < 0.05, *** P < 0.001 vs respective control
at each time point containing cells without 7,8-NP and without oxLDL. Results shown
are the mean ± SEM of triplicate samples.
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point. The addition of 7,8-dihydroneopterin prevented this loss in the VO2 caused by the
presence of the oxLDL. There was no significant difference in the VO2 between the
control cells and the 7,8-dihydroneopterin plus oxLDL treated cells. Therefore, 7,8-
dihydroneopterin is able to protect U937 cells VO2 in the presence of oxLDL. It appears
that using this approach of incubating the cells in flasks then measuring the initial VO2 at
normoxic levels allows the protective effect of 7,8-dihydroneopterin to be observed.
4.3 Discussion
4.3.1 Metabolic activity
In this chapter the cytotoxicity of oxLDL on U937 cell metabolism has been examined as
well as the protective effect of 7,8-dihydroneopterin on the cell metabolism. One of the
markers of the cytotoxic effect of oxLDL on metabolic functions in U937 cells was the
change in concentration of lact released into cell culture medium and the LDH activity.
Untreated U937 cells had a steady output of lactate into the media as part of their normal
metabolism in cell culture media. U937 cells being cancer cells derived from the
monocytes lineage were expected to be highly reliant on anaerobic glycolysis with high
lactate production. Inefficient mitochondrial function is thought to cause cancer cells to
produce excessive lactate (John, 2001). Other studies have demonstrated a large
production of lactate by macrophages in atherosclerotic lesions, which transform the
environment to an acidic one (Leppänen et al., 2006, Loike et al., 1993). This expected
reliance on anaerobic glycolytic activity by U937 cells, with its associated lactate
production, allowed the overall metabolism of the cells to be measured.
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The time course studies with oxLDL-treated U937 cells indicated that the decrease in
lactate concentration caused by incubation with oxLDL occurred rapidly; within 3 hours.
This rapid progression in the decrease of the lactate concentration was very closely
correlated with loss of cell viability, which was illustrated in the previous chapter.
In U937 cells, time course studies indicated that the loss of intracellular LDH activity and
the rise in LDH activity in the cell culture media both occur after the initial 3 hours
incubation with oxLDL and appears to be due to the lysis of the cells. There appeared to
no change in the total amount of LDH activity indicating that LDH was not inactivated
by the oxLDL-induced oxidative stress.
The loss of lactate and overall metabolism was therefore clearly due to changes in
enzyme activity before the loss of LDH enzyme. We and others have repeatedly shown
the oxLDL causes a string of oxidative stress in the cells. This was further shown here by
the loss of GSH (to be discussed later). GAPDH is an essential enzyme in glycolysis that
is one of several enzymes in the metabolic pathway converting glucose to pyruvate with a
net production of 2 ATP and 2 NADH molecules. It catalyses the conversion of
glyceraldehyde-3-phosphate to 1,3-bis-phosphoglycerate with the generation of 2 NADH
(Mathews & Van Holde, 1996). It is also highly susceptible to oxidative loss of activity
(Ralser et al., 2007). The incubation of U937 cells with oxLDL caused a concentration-
and time-dependent decrease in GAPDH activity (Figure 4.4b and Figure 4.5). This loss
occurred rapidly, within 3 hours of oxLDL addition and before the loss in U937 cell
viability.
CHAPTER 4 162
_____________________________________________________
GAPDH has two domains; one end binds NAD+ and the second one binds GAP
(Yamaguchi et al., 2003). The loss of GAPDH activity could be partly attributed to the
loss of NAD+, a cofactor required for the activity of GAPDH (Schraufstatter et al., 1990).
OxLDL can react with NAD+ within the cells. However, this was less likely to be the
major cause of GAPDH inactivation in U937 cells, because GAPDH activity was
measured in this research by supplementing the oxLDL-treated cell samples with
required substrates including NAD+, after which GAPDH activity was still not recovered.
A more likely explanation for GAPDH inactivation in oxLDL-treated U937 cells was that
oxLDL induced oxidation to the GAPDH active site. The GAPDH active site contains an
essential cysteine thiol group (Cys149) which can be oxidised by oxidants to a disulfide,
sulfenic acid, or other high oxidation product(s) (Albina et al., 1999, Pullar et al., 2000).
There is increasing evidence to suggest that GAPDH is a preferential target for oxidative
stress. The inactivation of GAPDH indicates oxidative stress (Ralser et al., 2007). NO
and ROS-mediated oxidation of GAPDH thiol and GAPDH inactivation was found in
inflamed mucosa in colon epithelial cells of patients with inflammatory bowel disease
(Mckenzie et al., 1996). OxLDL has been shown to cause increased ROS formation,
including rapid elevation of H2O2. OxLDL has been shown to induce the down-regulation
of GAPDH via a H2O2-dependent decrease in protein stability, resulting in inhibition of
glycolysis and marked depletion of cellular ATP levels in human aortic smooth muscle
cells (HASMCs) (Sukhanov et al., 2006). OxLDL down-regulated GAPDH appears to
play an important role in the mechanisms of atherogenesis (Sukhanov et al., 2006). The
inactivation of the GAPDH enzyme has been the subject of much research. Under
conditions where glucose uptake is inhibited, GAPDH is inactivated and ATP formation
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is halted (Schraufstatter et al., 1990). In addition, GAPDH inactivation by another
oxidant, acetylleucine chloromethyl ketone (ALCK), has also been reported in U937 cells
(Yamaguchi et al., 2003). NO has been reported to reduce GAPDH activity and ATP
content in macrophages (Albina et al., 1999). NO caused the thiol at the active site of
GAPDH enzyme to form sulfenic acid, resulting in activity loss (Ishii et al., 1999). The
reactive aldehydes, 4-hydroxy-2-nonenal (HNE) and 4-hydroxy-2-hexenal (HHE) both
primary products of LDL oxidation inhibit GAPDH (Tsuchiya et al., 2005) though this is
an unlikely mechanism in our experiments as these aldehydes are too reactive to be
present in the highly oxidised LDL. GAPDH inactivation by HOCl oxidation has been
demonstrated in colon epithelial cells (Mckenzie et al., 1999), human endothelial cells
(ECs) (Pullar et al., 1999) and human mononuclear leukocytes (Smit & Anderson, 1992).
These observations of GAPDH activity are supported by direct observation of the thiol
content of GAPDH by thiol staining of the U937 cell proteins on SDS-PAGE. This
method allowed the cells proteins to be rapidly separated and stained for thiol (Baty et
al., 2002). As expected GAPDH appeared to be extremely sensitive to thiol modification
most likely due to a cysteine residue (Cys149) located in the active site of the enzyme
(Schuppe-Koistinen et al., 1994). The human GAPDH molecular mass is 36 kDa
(Torchinsky, 1981). As commented in chapter 1, Cysteine is an ideal redox sensor due to
its sulfhydryl group (-SH) being easily oxidised. The presence of positively charged
residues in the local protein environment can stabilise the thiolate anion (-S-), providing a
mechanism for increasing the reactivity of selective cysteine residues. The -S- is a strong
nucleophile that can be oxidised to sulfenic (-SOH), sulfinic (-SO2H) and sulfonic (-
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SO3H) acids, S-nitrosothiols (-SNO) and disulfides (R-S-S-R) (Cuddihy et al., 2009a,
Sukhanov et al., 2006).
In this study, the detection of the GAPDH protein thiol reduction state was conducted
using the iodoacetyl group of 5-IAF that reacts specifically with reduced thiol and
provides a fluorescent label at the cysteine residue (Cys149) located in the active site of
the GAPDH enzyme with molecular size 36 kDa as well as with other thiol groups in the
cell. Reduced GAPDH protein thiol were labelled with 5-IAF while still within the cell,
so preventing the oxidation of the GAPDH during sample processing. This analysis
shows a large number of reduced thiol proteins in untreated U937 cells. SDS-PAGE
analysis of the 5-IAF stained cell lysates showed a number of proteins that lost thiol
staining. One of these bands had the same mobility as authentic GAPDH with a
molecular weight of 36 kDa suggesting that this band was GAPDH. This corresponded to
a coomaasie staining band also which showed increased levels of degradation after 12
hours of incubation. This suggests that there was increased degradation of the oxidised
GAPDH as was reported in smooth muscle cells (Sukhanov et al., 2006). Further analysis
of the data showed a relationship between decrease in 5-IAF staining 36 kDa band and
the loss of GAPDH activity upon exposure to oxLDL in U937 cells. This is consistent
with the hypothesis that the loss of GAPDH activity is primarily due to the oxidation of
the active site cysteine by oxLDL which cause proteolysis of the GAPDH at 12 hours.
These observations of GAPDH in U937 cells treated with oxLDL were similar to those
reported with HASMCs after exposure to oxLDL or H2O2. GAPDH-labelling efficiency
with the thiol-sensitive dye, fluorescein-5-maleimide, was dramatically decreased
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following treatment with oxLDL or H2O2 (Sukhanov et al., 2006). OxLDL and
exogenous H2O2 oxidised GAPDH thiol, decreasing GAPDH protein half-life and
increasing GAPDH sensitivity to proteasome-mediated protein degradation in vitro
(Sukhanov et al., 2006). Also, there was a decrease in the intensity of reduced GAPDH
protein thiol of Jurkat T-lymphoma cells which were labelled with 5-IAF after treatment
with H2O2 (Cuddihy et al., 2009a). Exposure of Jurkat T-lymphoma cells to diamide for
10 minutes led to a dramatic increase in thiol protein oxidation after labelling with 5-IAF
(Baty et al., 2002).
Surprisingly, the inhibition of GAPDH activity by oxLDL was prevented by the presence
of 10% HI-FCS in the U937 cell culture medium. It is possible that the HI-FCS prevented
the saturation of scavenger receptors with oxLDL, so that free oxLDL could not exert its
toxic effect, as measured in the absence of HI-FCS. This would prevent a decrease in
both GAPDH activity and cell viability from occurring. The major component of serum is
serum albumin which is considered to be a type of antioxidant as it can scavenge radicals
through reactions of the amino acid side changes (Stocker et al., 1987). Albumin binds
fatty acids protecting them from oxidation; binds copper and keeps it from participating
in oxidation reactions; binds cysteine and glutathione protecting them from oxidation and
binds bilirubin and pyridoxal-5’-phosphate preventing oxidation (Kouoh et al., 1999,
Roche et al., 2008).
4.3.2 Intracellular GSH concentration
OxLDL clearly causes an oxidative stress within the U937 cells resulting in the loss of
GAPDH. GSH is a key antioxidant within the cells and has previously been shown in this
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laboratory to be critical in the prevention of oxidative damage in the related THP-1 cell
line (Kappler et al., 2007). GSH loss also provides a direct measure of the cellular
antioxidant status and it has been established previously that cellular GSH loss results in
a further increased susceptibility to oxidative stress (Ballatori et al., 2009, Kappler et al.,
2007). Intracellular GSH levels must be maintained for cells to function properly. GSH
can act as an antioxidant by directly reacting with a range of oxidants such as hydroxyl
radical (HO●), HOCl, peroxynitrite (ONOO-), alkoxyl radical (RO●), nitric dioxide
(NO2●) and less efficiently with O2●- (Halliwell & Gutteridge, 2007). The GSH/GSSG
couple is a major contributor to the redox state of the cell, with most cells having this
couple at a ratio of 100:1 (Akerboom et al., 1982). Changes in this couple appear to
correlate with cell proliferation, differentiation, or apoptosis (Boggs et al., 1998, Ballatori
et al., 2009).
Time course studies with U937 cells showed that there was an increase in intracellular
GSH concentration in the control sample of cells. The increase in GSH concentration was
actually an increase in intracellular GSH concentration as there was no increase in cell
number. It appears that in the serum free condition of the experiment, the cells have taken
up cysteine to make more GSH suggesting that they are under some oxidative stress even
in the absence of oxLDL. The increase in cellular GSH appears to be the cells adapting
and reducing the oxidative stress. The lack of cell growth is most likely due to the known
effect of the serum free media inhibiting mitosis in cell lines (Freshney, 2000).
The time course studies conducted on oxLDL-treated U937 cells showed the decrease in
intracellular GSH concentration was very rapidly occurring within hours of the oxLDL
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addition. The loss of GSH appears to occur at the same time as the loss of the cell
viability. OxLDL clearly induces an oxidative stress in U937 cells, causing loss of
intracellular GSH concentration and cell death. The loss of GSH means the cells can no
longer protect and maintain the reduced state of the essential thiol in GAPDH leading to
the loss in glycolytic activity and therefore cell viability as measured by the cell ability to
reduce MTT. The leakage of LDH from the cells is the failure of the cell to maintain its
integrity. This study is consistent with previous studies of this laboratory showing oxLDL
caused a dramatic loss of cellular GSH and caspase-independent cell death in U937 cells
(Baird et al., 2004). This previous study did not explain what drove the death mechanism
in U937 cells as the loss of GSH alone does not necessary cause cell to die (Kappler et
al., 2007). The loss of metabolic function, particularly the loss of GAPDH appears to be a
key event causing the cells to die.
4.3.3 Intracellular purine nucleotides ATP, ADP, AMP, NAD+ and
NADP+ production
The relationship between intracellular ATP, ADP and AMP is particularly important for
maintenance of cellular homeostasis and adaptation to changing energy demands.
Although ATP represents the primary source of energy, ADP, AMP and inorganic
phosphate are substrates that are not only required for generation of ATP, but are thought
to play a key role in mitochondrial metabolic control (Hochachka & Mcclelland, 1997).
AMP in particular, acting through the cAMP-activated protein kinase cascade, has been
implicated in the control of a number of factors important to metabolic state in
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mammalian cardiac and skeletal muscle and allosterically activates the glycolytic enzyme
phosphofructokinase (Hardie, 2000, Lee et al., 2006).
NAD+ is the substrate for the formation of NADH, which serves to transfer electrons
between both the citric acid cycle and glycolysis and electron transport chain (Alberts et
al., 2002). NAD+ also functions as a coenzyme for hydride-transfer enzymes and as a
substrate for NAD+ consuming enzyme (Belenky et al., 2007).
The effect of oxLDL on metabolic energies was further investigated by examining the
ATP, ADP, AMP, NAD+ and NADP+ loss in oxLDL-treated U937 cells. Time course
studies showed that ATP and ADP levels increased in control cells during the initial 3
hours then remained stable, reaching equilibrium. OxLDL treatment induced ATP and
ADP depletion that occurred within 3 hours of the treatment and decreased further over
time. Interestingly, there was no change in the AMP level during incubation with oxLDL.
The time course studies of NAD+ and NADP+ showed a decrease in their levels in control
cells during the initial 3 hours, before stabilisation. In oxLDL-treated cells, NAD+ and
NADP+ dropped significantly within 3 hours of the treatment.
These results suggest that, relative to controls, oxLDL-treated U937 cells showed a rapid
decrease, in intracellular ATP, ADP, NAD+ and NADP+ levels 3 hours before cell lysis
(measured as LDH loss after 6 hours). This ATP loss is consistent with the loss in the
GAPDH activity, loss in lactate production and loss of the cells ability to protect itself
from oxidative stress with intracellular GSH. Loss of ATP is critical to the loss of cell
viability as measured by the MTT assay was observed to occur at the same time as ATP
loss.
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These results may model some of the process occurring in the plaque as low oxygen and
nutrients levels are thought to cause ATP depletion, and macrophage death in the
atherosclerotic lesions of rabbits leading to necrotic core formation (Leppänen et al.,
2006). The toxic effect of oxLDL on GAPDH would further enhance this failure of ATP
generation. Other oxidants have also been reported to inhibit ATP levels causing cell
death. In neuronal cells peroxynitrite and S-nitrosothiols inhibit GAPDH and glycolytic
ATP production, which causes necrosis via failure of the ATP-driven calcium and
sodium pumps resulting in osmotic rupture of the plasma membrane (Brown, 2010). In
contrast, peroxynitrite induced death in U937 and THP-1 cells is not dependent on the
loss of ATP and appears to be a regulated process (Cantoni et al., 2005). ATP loss also
features in the hydrogen peroxide mediated death of murine macrophages-like P388D1
cells where there was a 83% loss of ATP reported within minutes of H2O2 treatment
(Spragg et al., 1985). ATP loss has been cited as the switch between apoptosis and
necrosis where the loss of ATP triggers necrosis (Eguchi et al., 1997).
In this study, AMP levels in oxLDL-treated U937 cells did not significantly differ from
the controls. Previous studies have suggested that ATP may not always be degraded to
AMP. Supplementation of guinea-pig ventricular cardiomyocytes with NADH causes a
significant reduction of pinacidil-primed (IK(ATP)) and elevation in intracellular ATP
levels whereas no difference was detected in ADP and AMP levels (Pelzmann et al.,
2003). Using a bioluminescent enzymatic cycling assay for ATP and AMP, it was found
that ATP was not degraded to AMP in a number of food samples including milk
(Sakakibara et al., 1999). In addition, under hypoxic conditions AMP-activated protein
kinase (AMPK) activation is not associated with an increase in AMP/ATP ratio, but is
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dependent on the generation of mitochondrial reactive oxygen species (mtROS)
(Emerling et al., 2009).
As the cycling of NAD+ and NADH is a redox reaction, their relative ratios are indicators
of metabolic state and intracellular redox potential (Lin & Guarente, 2003). The
NAD+:NADH ratio can be increased by the addition of glutamate and other metabolic
substrates like pyruvate (Williams et al., 2001, White & Wittenberg, 2000). Although the
NAD+: NADH ratio may be a good indicator of metabolic state, in practice it is very
labile and measurement is difficult (Caruso et al., 2004). This finding is consistent with
our study, which found NADH and NADPH levels in U937 cells to be very labile to
measure by our HPLC method.
4.3.4 7,8-Dihydroneopterin protection to metabolic function
This study examined the protective effect of 7,8-dihydronepterin on U937 cells
metabolism. 7,8-Dihydroneopterin protected the U937 cells against oxLDL-induced
GAPDH activity loss in U937 and allowed the cells to maintain glycolytic metabolism as
measured as lactate production in cell culture media. The maximum protection of the
metabolic parameters measured was observed with 200 M 7,8-dihydronepterin.
Therefore, 7,8-dihydronepterin has a protective effect against oxLDL-induced damage by
maintaining U937 cellular metabolic activity. 7,8-dihydroneopterin appears to be able to
scavenge the ROS generated in response to the oxLDL. Previous studies have shown 7,8-
dihydroneopterin protects the intracellular GSH levels (Amit, 2008). Since 7,8-
dihydroneopterin was unable to reduce the oxidised protein thiol, it is unlikely that 7,8-
dihydroneopterin can regenerate or increase the intracellular GSH levels (Duggan et al.,
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2002). Therefore, it is very likely that with U937 cells, 7,8-dihydroneopterin protects the
intracellular thiol pool by scavenging ROS generated in the presence of oxLDL. With
THP-1 cells this does not occur and the reason still unknown (Baird et al., 2005). In
macrophages and U937 cells, the maintenance or protection of the cell GSH levels via
increasing the intracellular thiol pool (Kinscherf et al., 1998, Lizard et al., 2000) will
ensure the functioning of the GAPDH enzyme and overall metabolic function.
4.3.5 The VO2 and 7,8-dihydronepterin
A lack of oxygen leads to depletion of ATP which is generated by oxidative
phosphorylation and subsequently the ATP is supplied by an anaerobic pathway
(Hochachka et al., 1996). In vivo, there was a balance between oxygen supply by the
cardiovascular system for tissues respiration and oxygen demand. When the recovery
from exercise are included, the metabolic rate of working muscle are significantly
increased (Turner et al., 2006). Oxygen may play a regulatory role in aerobic
metabolism, particularly in skeletal muscle (Hochachka, 2003). Supplying oxygen in
excess of requirements could result in the formation of free radicals and facilitate damage
in the tissues (Tuckey et al., 2009, Gnaiger, 2003). Thus, balance must be maintained to
ensure that PO2 in the tissue is retained with the optimal range to prevent tissue damage
while ensuring oxygen demand is met under a range of conditions (Forgan & Forster,
2009).
The effect of oxLDL on metabolic energies and the antioxidant effect of 7,8-
dihydronepterin were studied by examining the effect of oxLDL on the VO2 of U937
cells using two methods. The first method involved, calculation of the VO2 for every 10
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minutes period over the course of the experiment for the same sample incubated in a
closed chamber while the other method involved calculating the VO2 every 10 minutes
period for 30 minutes for a new sample placed into the oxygen measuring chamber at
each time point during the course of the experiment. The first method examined the VO2
with decreasing oxygen levels while the latter method measured the VO2 at normoxic
levels. This showed that U937 cells could very effectively maintain their VO2 as the
oxygen levels decreased, which was abolished with the addition of oxLDL. This data also
showed that the VO2 is PO2-dependent. Diffusion down the partial pressure gradient is
unlikely to limit the VO2 in isolated cells. There are numerous cases where a similar
dependency of the VO2 on PO2 has been shown (Schumacker et al., 1993, Budinger et al.,
1996).
Surprisingly, 7,8-dihydroneopterin was found to be very labile in the chambers via the
first method suggesting it was being oxidised at the oxygen electrode. By separating the
7,8-dihydroneopterin plus oxLDL incubation from the oxygen measurement using the
second method it was shown that 7,8-dihydroneopterin did preserve the VO2 of the U937
cells. Surprisingly, the data did not show a significant burst on the VO2with the addition
of oxLDL suggesting the oxidant production in the cells is less than that reported for
classical respiratory burst (Fischer et al., 2002). It is possible that the oxidant production
causing the reported GSH loss and GAPDH inhibition observed in this research is very
localised and intracellular. So although the oxygen up take for the oxidant production is
small, it has a very destructive effect within the cell. As commented on above, the U937
cells showed remarkable alteration to their VO2with falling oxygen levels. The regulation
of ATP supply-demand pathways by the reduction of blood flow and therefore oxygen
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availability, could serve as an extremely important trait for species survival and
adaptation when oxygen supply is inadequate (Forgan & Forster, 2010).
In this experiment the U937 cells VO2 related to PO2 between 0 and 155 mmHg. Blood
vessel VO2 displayed varying degrees of independence in a PO2 range of 15-95 mmHg,
while VO2 by striated muscle tissue slices from all species related linearly to PO2 between
0 and 125 mmHg, despite VO2 rates varying greatly between species and muscle type
(Forgan & Forster, 2010). The reduction in the VO2with falling partial pressure results in
a decrease in ATP demand, suggesting that the hypoxic signal is sensed and cellular
changes effected (Forgan & Forster, 2010). Once oxygen delivery satisfies the metabolic
requirement of skeletal muscle, the VO2 is delivery independent. During increasing
aerobic muscle work and while recovering from anaerobic activity the oxygen
requirement of muscle increases. Furthermore, basal metabolic rate and aerobic scope of
muscle is related to the fibers that constitute it (Forgan & Forster, 2009). Patients with
chronic heart failure (CHF) have lower peak oxygen consumption (pVO2) than normal
subjects, and for a given quantity of work, have lower total VO2 than controls. This
apparent increase in biomechanical efficiency (BE) might be due to a higher proportion
of anaerobic metabolism which, although leading to lower VO2 during steady state
exercise, must be compensated for during recovery (Witte et al., 2007). Thus, lack of
oxygen and nutrients may cause ATP depletion in the core of atherosclerotic plaques.
ATP depletion, in turn, may promote cell death and the formation of a necrotic core
(Geiringer, 1951).
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Macrophages can efficiently adapt to hypoxic conditions via a compensatory increase in
anaerobic ATP production (Cramer et al., 2003). It is thus possible that macrophages
could maintain adequate ATP concentrations in the hypoxic plaque core. Anaerobic
glycolysis is inefficient, consuming 15 times more glucose per ATP molecule produced
than oxidative phosphorylation. This strains the glucose supply and may deplete available
glycogen stores. In addition, it causes lactate to accumulate in the tissue which may
decrease tissue pH (Leppänen et al., 2006). Indeed, lactate concentrations in plaque were
high, indicating that extensive anaerobic glycolysis consumes glucose, reducing its
availability to cells in the core. The combined lack of both oxygen and glucose may, in
turn, cause ATP depletion in macrophages which contributes to cell death and the
subsequent formation of a necrotic core (Leppänen et al., 2006).
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5 Effect of oxLDL and 7,8-dihydroneopterin on the metabolic function
of HMDM cells
5.1 Introduction
In this chapter the effect of oxidised low-density lipoprotein (oxLDL) on human
monocyte-derived macrophage (HMDM) cells is examined and compared to that
observed with U937 cells as described in chapter 4. In chapter 3, oxLDL was observed to
have the similar effect on cell viability as that observed with U937 cells but it was not
examined whether the mechanism also involved damage to the HMDM cells metabolic
systems. As with the U937 cells, here we examine the effect of oxLDL on lactate
dehydrogenase (LDH) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
activity, lactate production and purine nucleotide levels (ATP, ADP, AMP, NAD+ and
NADP+). If U937 cells are a good model of oxLDL induced HMDM cell death, we
expect that 7,8-dihydroneopterin (7,8-NP) will prevent the loss of HMDM cell metabolic
activity. These experiments also explore whether 7,8-dihydroneopterin may have an
effect on oxLDL uptake.
Macrophages derive a significant amount of their metabolic energy from glycolysis
which is why in tissue culture they generate a considerable amount of lactate.  During
inflammation, macrophage glucose levels decrease and the level of lactate production
increase, which in turn lowers the pH of the environment. Interestingly macrophages
possess stereospecific transporters for lactate that allows them to take up lactate
preferentially in an acidic environment which they can further metabolise. As a result,
macrophages can as a result accumulate extracellular lactate and utilise it as a source of
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energy if required (Loike et al., 1993). As seen in chapter 4 with U937 cells, cell
membrane rupture releases lactate dehydrogenase into the media increasing the
extracellular activity of the enzyme during oxidative stress (Jovanovic et al., 2010).
In human aortic smooth muscle cells (HASMCs), oxLDL was reported to down-regulate
GAPDH, causing a decrease in glycolytic activity and ATP levels (Sukhanov et al.,
2006). The death of macrophages in atherosclerotic lesions and the formation of a
necrotic core is associated with a reduction in ATP levels resulting from a lack of oxygen
and nutrition (Leppänen et al., 2006). As previously discussed, the loss of GAPDH
activity appears to be due to enzyme oxidative damage (Ralser et al., 2007). As seen with
the U937 cells, the antioxidant 7,8-dihydroneopterin should have a similar protective role
on HMDM cell metabolism, as demonstrated in this chapter. This study expects to see
7,8-dihydroneopterin addition preventing the loss of the various metabolic markers such
as lactate levels and GAPDH activity.
5.2 Results
5.2.1 Effect of oxLDL on HMDM cell lactate generation
The effect of oxLDL on the metabolic energy of HMDM cells was studied by examining
the lactate released into the cell culture medium during 12 hours incubation. The time
course study was performed by incubating HMDM cells in RPMI-1640 media without
phenol red containing 10% HIHS with and without 2.0 mg/ml oxLDL over 12 hours
(Figure 5.1). In control cells there was a continuous production of lactate which was
released into the cell culture medium over time (Figure 5.1). In oxLDL-treated cells,
lactate production was identical to the controls until 6 hours.
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Figure 5.1 Time course showing the effect of oxLDL on lactate production in
HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with 2.0 mg/ml oxLDL over a 12 hour
period. The lactate released to the culture media was measured at various time points.
Mean protein content was 0.5 mg/well. Significance is indicated as * P < 0.05, *** P <
0.001 vs respective control of each time point. Results shown are the mean ± SEM of
triplicate samples.
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Lactate release into the media completely stopped after this point with no significant
increase in lactate levels at 9 and 12 hours compared to 0 hour control. The lactate levels
in the oxLDL treated cells were reduced by 29% at 9 hours, and 38% at 12 hours
incubation, compared to the respective controls of each time point (Figure 5.1).
Therefore, with HMDM cells, oxLDL causes a large and dramatic decrease in the lactate
release after 6 hours.
5.2.2 Effect of oxLDL on LDH activity in HMDM cells
The LDH activity is a marker of the metabolic energy of cells. We measured both
intracellular and in cell culture media LDH activity to study the effect of oxLDL on the
metabolic energy of HMDM cells. The LDH activity of HMDM cells over time was
studied by incubating HMDM cells in RPMI-1640 media without phenol red containing
10% HIHS with 2.0 mg/ml oxLDL for 12 hours (Figure 5.2). There was a loss of LDH
activity inside the cells and an increase in LDH activity in the cell culture media,
although this was not significant until the 9 hour time point (Figure 5.2a). The loss of
intracellular LDH activity, as measured in cell pellets, was likely to be caused by the
release of LDH through plasma membrane lysis into the cell culture media. The observed
release of LDH and corresponding cell lysis are caused by prolonged exposure to oxLDL.
However, the total LDH activity remained stable over the course of the study showing
lactate dehydrogenase is not inhibited by the level of oxidative stress (Figure 5.2b).
Lactate production dropped after 6 hours. Significant LDH enzyme release into the cell
culture media did not occur until approximately 9 hours. It appears that oxLDL was
slowing the cells metabolism before cell lysis occurred in HMDM cells.
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Figure 5.2 Time course showing the effect of oxLDL on the LDH activity in HMDM
cells.
HMDM cells at 5.0 x106 cells/ml were incubated with 2.0 mg/ml oxLDL over a 12 hour
period. (a) The LDH activity was measured in the cell culture media and in the cell
pellets at various time points. (b) The total LDH activity was measured at various time
points. Mean protein content was 0.5 mg/well. Significance is indicated as * P < 0.05, **
P < 0.01, *** P < 0.001 vs respective 0 hr control. Results shown are the mean ± SEM of
triplicate samples.
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5.2.3 Effect of oxLDL on GAPDH activity in HMDM cells
A time course study of the effect of oxLDL on GAPDH activity was conducted by
incubating HMDM cells in RPMI-1640 media containing 10% HIHS with 2.0 mg/ml
oxLDL for 24 hours (Figure 5.3). The GAPDH activity dropped rapidly, reaching a level
39% less than the control after 3 hours and continued to decline to 53% after 6 hours.
Then it reached 69% after 10 hours and 91% after 24 hours incubation compared to the
control (Figure 5.3). Though not as dramatic as the loss of GAPDH activity with U937
cells (Figure 4.5) this loss of activity is very significant (Figure 5.3). Therefore, GAPDH
activity in HMDM cells is very sensitive to the oxidative stress induced by the oxLDL,
but was occurring 6 hours before cell lysis was observed as measured by LDH release.
The GAPDH loss though is occurring faster than the loss in lactate level.
5.2.4 Effect of oxLDL on intracellular purine nucleotides ATP, ADP,
AMP, NAD+ and NADP+ levels in HMDM cells
The effect of oxLDL on total metabolic energy of HMDM cells was studied by treating
cells with oxLDL and examining intracellular purine nucleotide levels at various time
points as described with U937 cells in Chapter 4. These purine nucleotides were
adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate
(AMP), nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine
dinucleotide phosphate (NADP+).
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Figure 5.3 Time course showing the effect of oxLDL on GAPDH activity of HMDM
cells.
HMDM cells at 5.0 x106 cells/ml were incubated with 2.0 mg/ml oxLDL over a 24 hour
period. The GAPDH activity was measured at various time points. Mean protein content
was 0.5 mg/well. Significance is indicated as *** P < 0.001 vs 0 hr control. Results
shown are the mean ± SEM of triplicate samples.
CHAPTER 5 182
___________________________________________________________
The chromatograms of standard purine nucleotides and purine nucleotide levels (ATP,
ADP, AMP, NAD+ and NADP+) in HMDM cells incubated with 2.0 mg/ml oxLDL over
the 12 hour time period are shown in Figure 5.4. The changes in the individual purine
levels identified over the 12 hours of incubation are shown graphically Figure 5.5 and
Figure 5.6.
In control cells, the ATP level remained stable for 12 hours (Figure 5.5a). In oxLDL-
treated cells, the ATP level dropped gradually, by 40%, 42% and 48% after 3, 6 and 9
hours, respectively, compared to the corresponding control data. The ATP level
continued to decline, until 61% decrease had occurred after 12 hours, compared to the
respective control (Figure 5.5a).
The ADP level remained stable in control cells for the entire duration of the incubation
(Figure 5.5b). While in oxLDL-treated cells, the ADP level dropped by 27% during the
first 3 hours. The ADP level continued to decline, reaching a level that was 33%, 45%
and 51% less than that of the corresponding control data, after 6, 9 and 12 hours,
respectively (Figure 5.5b).
In comparison, there was no change in the AMP level within control cells and in treated
cells during the incubation period (Figure 5.5c).
The data for AMP, ADP and ATP levels over the 12 hour incubation period are shown
together in Figure 5.5d.
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Figure 5.4 Chromatograms showing the effect of oxLDL on purine nucleotides ATP,
ADP, AMP, NAD+ and NADP+ levels in HMDM cells over time.
15.0 x106 of HMDM cells at were incubated with 2.0 mg/ml oxLDL over a 12 hour
period. (a) Standard; (b) Control HMDM cells without oxLDL added; (c) 3 hr; (d) 6 hr;
(e) 9 hr; (f) 12 hr.
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Figure 5.5 Time course showing the effect of oxLDL on ATP, ADP and AMP levels
in HMDM cells.
15.0 x106 HMDM cells were incubated with 2.0 mg/ml oxLDL over a 12 hour period. (a)
ATP; (b) ADP; (c) AMP; (d) All ATP, ADP and AMP. All concentrations were
determined by HPLC analysis. Mean protein content was 0.5 mg/well. Significance is
indicated as ** P < 0.01, *** P < 0.001 vs respective control of each time point. Results
shown are the mean ± SEM of triplicate samples.
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In HMDM cells, oxLDL caused a decrease in ATP and ADP levels, which began during
the initial 3 hours. This loss of ADP and ATP levels is faster than the previously
measured loss in lactate but is similar to the loss in GAPDH activity. Therefore, the cells’
metabolic energy appears to slow down before cell lysis occurs; after 9 hours incubation,
as measured by LDH release.
The NAD+ level in control cells remained stable over the 12 hours (Figure 5.6a). In
oxLDL-treated cells the NAD+ level had dropped by 52% after 3 hours. The NAD+ level
continued to decline, reaching a level 57% lower than the corresponding control after 6
hours, 63% lower after 9 hours and 65% lower after 12 hours (Figure 5.6a).
The NADP+ level in control cells remained stable during the incubation time (Figure
5.6b). In comparison, in oxLDL-treated cells, the NADP+ level dropped by 34% during
the initial 3 hours. The NADP+ level continued to decline and reached levels that were
37%, 40% and 46% lower than their corresponding controls after 6, 9 and 12 hours,
respectively (Figure 5.6b).
Therefore, oxLDL caused a decrease in the NAD+ and NADP+ levels in the first 3 hours,
before cell lysis occurred. Cell lysis was after 9 hours, as measured by LDH release. This
data was very similar to that observed with U937 cells described in chapter 4.
Unfortunately we were unable to measure NADH and NADPH as they were found to be
highly labile in the mobile phase used in this analysis.
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Figure 5.6 Time course showing the effect of oxLDL on NAD+ and NADP+ levels in
HMDM cells.
15.0 x106 HMDM cells were incubated with 2.0 mg/ml oxLDL over a 12 hour period. (a)
NAD+; (b) NADP+. All concentrations were determined by HPLC analysis. Mean protein
content was 0.5 mg/well. Significance is indicated as *** P < 0.001 vs respective control
of each time point. Results shown are the mean ± SEM of triplicate samples.
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5.2.5 Effect of different concentration of 7,8-dihydroneopterin on
lactate production in cell culture media of oxLDL-treated
HMDM cells
The antioxidant effect of 7,8-dihydroneopterin on lactate production in cell culture media
was studied by pre-incubated HMDM cells for 10 minutes with increasing concentrations
of 7,8-dihydroneopterin (0, 50, 100, 150 and 200 M) in RPMI-1640 (no phenol red)
media containing 10% HIHS before incubation with and without 2.0 mg/ml oxLDL for
12 hours (Figure 5.7).
The presence of 7,8-dihydroneopterin alone, up to a concentration of 200 M did not
affect the lactate level in HMDM cells (Figure 5.7), while the presence of 2.0 mg/ml
oxLDL alone caused a 44% decrease in the lactate level of the cell culture media (Figure
5.7). The presence of 7,8-dihydroneopterin caused a significant concentration dependent
protection against oxLDL-induced loss of lactate production. This only occurred at 7,8-
dihydroneopterin concentrations above 50 M. At 100 M 7,8-dihydroneopterin the
lactate production increased by approximately 20% compared to the oxLDL only control.
With 200 μM 7,8-dihydroneopterin the lactate output by the cells was fully protected
such there was no significant effect due to the presence of oxLDL (Figure 5.7). The data
shows 7,8-dihydroneopterin has a protective effect against oxLDL-induced damage to
HMDM cells glycolytic activity, as measured by the lactate levels measured in the cell
culture media.
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Figure 5.7 Effect of 7,8-NP concentration on lactate production in cell culture media
of oxLDL-treated HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with different concentrations of 7,8-
dihydroneopterin (0, 50, 100, 150 and 200 µM) before incubation with or without 2.0
mg/ml oxLDL for 12 hours. The lactate released to culture media was measured. Mean
protein content was 0.5 mg/well. Results shown are the mean ± SEM of triplicate
samples. Significant of results was examined by comparing the lactate concentration with
each 7,8-dihydroneopterin concentration with the positive control containing cells with
just oxLDL; Significance is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001.
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5.2.6 Effect of 7,8-dihydroneopterin concentration on GAPDH
activity in oxLDL-treated HMDM cells
The antioxidant effect of 7,8-dihydroneopterin on GAPDH activity was studied by pre-
incubated HMDM cells for 10 minutes with various concentrations of 7,8-
dihydroneopterin (0, 25, 50, 100, 150 and 200 M) in RPMI-1640 (no phenol red) media
containing 10% HIHS before incubation with and without 2.0 mg/ml oxLDL for 24 hours
(Figure 5.8).
The presence of 7,8-dihydroneopterin alone, up to a concentration of 200 M, did not
affect the GAPDH activity in HMDM cells (Figure 5.8), while the presence of 2.0 mg/ml
oxLDL alone caused a 72% decrease in the GAPDH activity (Figure 5.8). In the presence
of 25 and 50 M 7,8-dihydroneopterin, there was an increased GAPDH activity from the
oxLDL alone controls but this increase was not significant until 100 μM 7,8-
dihydroneopterin or greater was added to the media. In the presence of 150 and 200 M
7,8-dihydroneopterin, GAPDH activity 50% and 70% greater than the oxLDL only
control, respectively (Figure 5.8). This shows that at concentrations of 100 μM and
greater, 7,8-dihydroneopterin protects GAPDH from the oxidative stress induced by
oxLDL.
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Figure 5.8 Effect of 7,8-NP concentration on GAPDH activity of oxLDL-treated
HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with different concentrations of 7,8-
dihydroneopterin (0, 25, 50, 100, 150 and 200 µM) before incubation with or without 2.0
mg/ml oxLDL for 24 hours. The GAPDH activity was measured. Mean protein content
was 0.5 mg/well. Results shown are the mean ± SEM of triplicate samples and significant
was tested between the positive control of cells with just oxLDL and cells with 7,8-
dihydroneopterin and oxLDL. Significance is indicated as * P < 0.05, *** P < 0.001.
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5.2.7 Effect of 7,8-dihydroneopterin on GAPDH activity in oxLDL-
treated HMDM cells
A time course study of the antioxidant effect of 7,8-dihydroneopterin on HMDM cell
GAPDH activity was conducted by pre-incubated HMDM cells for 10 minutes with 200
M 7,8-dihydroneopterin in RPMI-1640 media containing 10% HIHS with and without
2.0 mg/ml oxLDL for 24 hours (Figure 5.9). In the presence of 2.0 mg/ml oxLDL alone,
the GAPDH activity dropped by 28% during the initial 3 hours and 53% less than the
control after 6 hours. Only 9% of the original HMDM GAPDH activity remained after 24
hours with oxLDL (Figure 5.9). In the presence of 200 M 7,8-dihydroneopterin and 2.0
mg/ml oxLDL, the GAPDH activity remained the same over time compared to the
corresponding control of each time point (with oxLDL alone) (Figure 5.9).
5.2.8 Effect of 7,8-dihydroneopterin on oxLDL uptake by HMDM
cells
It was possible that the observed protective effect of 7,8-dihydroneopterin was simply
due to this compound affecting the uptake of oxLDL and therefore preventing the oxLDL
having a toxic effect on the cells. This was examined by measuring the uptake of labelled
oxLDL. DiI was chosen because we were concerned about possible protein oxidation
effects with other labelling systems and the stability of the label. DiI is a fluorescent
lipophilic dye which is rapidly absorbed into the lipid layer of the oxLDL and becomes
trapped within the cells once the oxLDL is taken up (Stephan & Yurachek, 1993).
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Figure 5.9 Time course showing the effect of 7,8-NP on GAPDH activity in oxLDL-
treated HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with or without 200 µM 7,8-
dihydroneopterin before incubation with 2.0 mg/ml oxLDL over a 24 hour period. The
GAPDH activity was measured at various time points. Mean protein content was 0.5
mg/well. Significance is indicated as *** P < 0.001 vs respective control at each time
point. Results shown are the mean ± SEM of triplicate samples.
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5.2.8.1 Standardisation of fluorescence for DiI and DiI-oxLDL
concentrations
The main fluorescence intensity (MFI) of DiI and DiI-oxLDL (oxLDL which had been
labelled with fluorescent DiI at 37C) was measured at different concentrations in order
to generate a standard curve and measure the range of linearity of both free and bound
label. With free DiI in isopropanol there was a direct liner relationship between the DiI
concentration and fluorescence intensity between 1 to 10 µg/ml (Figure 5.10a). Above 10
µg/ml the fluorescence intensity reached a maximal level. When absorbed into oxLDL
there was some change in the fluorescent intensity. The concentration-dependent
fluorescence of DiI-oxLDL is shown in Figure 5.10b. There was a linear correlation
between DiI-oxLDL concentration and fluorescence between 0.05 and 200 µg/ml; above
this concentration the fluorescence intensity reached a maximal level. Therefore, DiI and
DiI-oxLDL up to a concentration of 10 and 200 µg/ml, respectively, must be used in
order to obtain a true reading of fluorescence intensity. Any fluorescence intensities
above this concentration may give an inaccurate result.
5.2.8.2 Effect of DiI-oxLDL and 7,8-dihydroneopterin on HMDM cell
viability and morphology
The effect of DiI-oxLDL with and without 7,8-dihydroneopterin, on HMDM cell
viability and morphology were studied by pre-incubated HMDM cells for 10 minutes
with or without 200 µM 7,8-dihydroneopterin in RPMI-1640 media plus 10% HIHS for
12 hours (Figure 5.11 and Figure 5.12). However, preliminary studies suggested that the
DiI was acting as an antioxidant and so was affecting the oxLDL cytotoxicity. This was
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Figure 5.10 Concentration-dependent fluorescence of DiI and DiI-oxLDL.
(a) Free DiI concentration range from 1 to 25 µg/ml. The correlation remained linear up
to a concentration of 10 µg/ml. (b) DiI-oxLDL concentration range from 0.5 to 500
µg/ml. The correlation remained linear up to a concentration of 200 µg/ml.
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confirmed when it was shown that 2.0 mg/ml DiI-oxLDL was not cytotoxic (bar e, Figure
5.11) while oxLDL (bar b, Figure 5.11) was cytotoxic and only 49% of cells were still
viable. The addition of 0.2 mg/ml DiI-oxLDL did not reduce the toxicity of the 2.0 mg/ml
oxLDL on the HMDM cells (bar c, Figure 5.11). The DiI-oxLDL at 0.2 mg/ml as
expected was also not cytotoxic (bar d, Figure 5.11). The addition of 7,8-
dihydroneopterin to the DiI combination still prevented the loss of cell viability showing
that the DiI did not interfere with the action of the 7,8-dihydroneopterin (bars f-i, Figure
5.11). HMDM cell morphology was photographed before the MTT viability assay after
12 hour incubation (Figure 5.12).
Control cells showed a typical, round shape (Figure 5.12a) but in the presence of 2.0
mg/ml oxLDL (Figure 5.12b) and 0.2 mg/ml DiI-oxLDL with 2.0 mg/ml oxLDL (Figure
5.12c), there appeared to be more cell lysis compared to the control cells but the presence
of 200 μM 7,8-dihydroneopterin prevented the loss of normal cell morphology (Figure
5.12f & g). There was no change in cell morphology in the presence of the 0.2 mg/ml
DiI-OxLDL (Figure 5.12d) or 2.0 mg/ml DiI-oxLDL (Figure 5.12e) or in the presence of
200 μM 7,8-dihydroneopterin (Figure 5.12h & i) compared to the control cells. The cell
morphology was in agreement with that measured by the MTT viability reduction assay.
Therefore, the presence of the DiI was not masking changes measured by the MTT
reduction.
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Figure 5.11 Effect of DiI-oxLDL and 7,8-NP on HMDM cell viability.
HMDM cells (5.0 x106 cells/ml) were incubated for 12 hours before cell viability
measurement by MTT reduction. The figure shows cells alone (a), cells with 2.0 mg/ml
oxLDL (b), cells with 0.2 mg/ml DiI-oxLDL and 2.0 mg/ml oxLDL (c), cells with 0.2
mg/ml DiI-oxLDL (d), cells with  2.0 mg/ml DiI-oxLDL (e), cells with  200 µM 7,8-
dihydroneopterin and 2.0 mg/ml oxLDL (f), cells with 200 µM 7,8-dihydroneopterin, 0.2
mg/ml DiI-oxLDL and 2.0 mg/ml oxLDL (g), cells with 200 µM 7,8-dihydroneopterin
and 0.2 mg/ml DiI-oxLDL (h), cells with 200 µM 7,8-dihydroneopterin and 2.0 mg/ml
DiI-oxLDL (i). Results shown are the mean ± SEM of triplicate samples. Significance
was determined between the control of cell without oxLDL (a) and the other conditions
and shown as *** P < 0.001.
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(a) Control (b) 2.0 mg/ml OxLDL (c) 0.2 mg/ml DiI-oxLDL +
2.0 mg/ml oxLDL
(d) 0.2 mg/ml DiI-oxLDL (e) 2.0 mg/ml DiI-oxLDL (f) 200 μM 7,8-NP + 2.0
mg/ml oxLDL
(g) 200 μM 7,8-NP + 0.2
mg/ml DiI-oxLDL +
2.0 mg/ml oxLDL
(h) 200 μM 7,8-NP + 0.2
mg/ml DiI-oxLDL
(i)200 μM 7,8-NP + 2.0
mg/ml DiI-oxLDL
Figure 5.12 HMDM cell morphology during incubation with DiI-oxLDL.
HMDM cells at 5.0 x106 cells/ml were incubated with 2.0 mg/ml oxLDL, or 0.2 mg/ml
DiI-oxLDL, or 0.2 mg/ml DiI-oxLDL, or 2.0 mg/ml DiI-oxLDL without or with 200 M
7,8-dihydroneopterin for a 12 hours. (a) HMDM cells; (b) 2.0 mg/ml oxLDL; (f) 7,8-
dihydroneopterin and 2.0 mg/ml oxLDL; (d) 0.2 mg/ml DiI-oxLDL; (c) 0.2 mg/ml DiI-
oxLDL and 2.0 mg/ml oxLDL; (e) 2.0 mg/ml DiI-oxLDL; (h) 200 μM 7,8-
dihydroneopterin and 0.2 mg/ml DiI-oxLDL (g) 7,8-dihydroneopterin, 0.2 mg/ml DiI-
oxLDL and 2.0 mg/ml oxLDL; (i) 200 μM 7,8-dihydroneopterin and 2.0 mg/ml DiI-
oxLDL.
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Overall the data shows that 0.2 mg/ml DiI-oxLDL can be used to measure oxLDL uptake
under non-cytotoxic conditions. In cytotoxic conditions, a mixture of 0.2 mg/ml DiI-
oxLDL with non-labelled 2.0 mg/ml oxLDL can be used to measure the oxLDL uptake
also, because both are taken up equally by the same mechanism. The 2.0 mg/ml DiI-
oxLDL cannot be used for the uptake studies because it is not cytotoxic.
5.2.8.3 Effect of 7,8-dihydroneopterin on HMDM cell uptake of DiI-
oxLDL at non-cytotoxic levels
The death of the HMDM cells with cytotoxic levels of oxLDL makes the uptake data
difficult to interpret. As a result, the first uptake studies were conducted with the 0.2
mg/ml DiI oxLDL. HMDM cells were then pre-incubated for 10 minutes with or without
200 µM 7,8-dihydroneopterin in RPMI-1640 media containing 10% HIHS with 0.2 DiI-
oxLDL (non-cytotoxic level) at 37°C (to measure cell association) over a 10 hour period
(Figure 5.13). In control cells, the uptake of DiI-oxLDL by HMDM cells increased
during the initial 3 hours, before it slowed and uptake stopped at 6 hours. The presence of
200 μM 7,8-dihydroneopterin significantly slowed the rate of uptake. The final
concentration of DiI in the cells was 35% of the control cells without 7,8-
dihydroneopterin (Figure 5.13). Therefore, 7,8-dihydroneopterin decreased the uptake of
oxLDL when a non-toxic concentration of DiI-oxLDL was used.
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Figure 5.13 Time course showing the effect of 7,8-NP on the uptake of non-cytotoxic
level of DiI-oxLDL by HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with or without 200 M 7,8-
dihydroneopterin before incubation with 0.2 mg/ml DiI-oxLDL at 37°C (to measure cell
association) over a 10 hour period. Mean protein content was 0.5 mg/well. Significance is
indicated as ** P < 0.01 vs respective control at each time point. Results shown are the
mean ± SEM of triplicate samples.
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5.2.8.4 Effect of 7,8-dihydroneopterin on HMDM cell uptake of a non-
cytotoxic level of DiI-oxLDL mixed with cytotoxic level of
oxLDL
There was the possibility that oxLDL and DiI-oxLDL might be treated differently by the
cell. Though difficult to explore this was examined by mixing 50 ug/ml DiI-oxLDL with
non-labelled oxLDL at 2.0 mg/ml and giving this to the HMDM cells. HMDM cells were
pre-incubated for 10 minutes with or without 200 µM 7,8-dihydroneopterin in RPMI-
1640 containing 10% HIHS with 0.05 mg/ml DiI-oxLDL mixed with 2.0 mg/ml oxLDL
(cytotoxic level) at 37°C over a 10 hour period (Figure 5.14). There was a time dependent
uptake of DiI-oxLDL by HMDM cells. In control cells, the uptake of DiI-oxLDL by
HMDM cells increased during the initial 3 hours, and then the rate decreased during the
following 6 hours before stopping after 6 hours. The same trend was recorded in 7,8-
dihydroneopterin treated cells, but the DiI-oxLDL uptake in the presence of 7,8-
dihydroneopterin was reduced by 22%, 42% and 40% after 3, 6 and 10 hours,
respectively, as compared to the respective control at each time point (Figure 5.14).
Therefore, 7,8-dihydroneopterin was able to slow uptake of Di-oxLDL into the cell in the
presence of a toxic oxLDL concentration. Examination of the cells at 12 hours (Figure
5.12) shows that in the absence of 7,8-dihydroneopterin there was considerable cell
damage which may explain the lack of DiI-oxLDL uptake after 6 hours. In contrast the
7,8-dihydroneopterin appears to have stopped the oxLDL uptake after 3 hours and the
cells have remained healthy.
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Figure 5.14 Time course showing the effect of 7,8-NP on the uptake of non-cytotoxic
level of DiI-oxLDL mixed with cytotoxic level of oxLDL by HMDM cells.
HMDM cells at 5.0 x106 cells/ml were incubated with or without 200 M 7,8-
dihydroneopterin before incubation with 0.05 mg/ml DiI-oxLDL and 2.0 mg/ml oxLDL
at 37°C (to measure cell association) over a 10 hour period. Mean protein content was 0.5
mg/well. Significance is indicated as ***P < 0.001 vs respective control at each time
point. Results shown are the mean ± SEM of triplicate samples.
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5.3 Discussion
5.3.1 Lactate release and metabolic activity
The cytotoxicity of oxLDL in HMDM cells has been clearly demonstrated in chapter 3;
as a loss in cell viability after 6 hours, measured using MTT reduction, which concluded
with extensive cell lysis. In this chapter 5, the cytotoxicity of oxLDL to HMDM cells has
been further shown by measuring lactate and purine nucleotide concentrations in addition
to measuring lactate dehydrogenase and GAPDH activity. As discussed in chapter 4, the
effects on U937 cells and on HMDM, in this chapter, are very similar to what has
previously been described for smooth muscle cells (SMCs) in vitro (Sukhanov et al.,
2006).
Lactate is the end product of anaerobic glycolysis, which is one of the major metabolic
pathways in macrophage cells (Loike et al., 1993, Nelson & Cox, 2005). As was
observed with the U937 cells in chapter 4, there was no overall loss in LDH activity.
When cell lysis started to occur, the LDH enzyme began to leak from the intracellular
space into the cell culture media. The changes in lactate levels are therefore a
consequence in the change in metabolism of the HMDM cells. In HMDM cells, time
course studies indicated that lactate production and release-into the cell culture media
dropped after 6 hours yet significant LDH loss from the cell did not occur till 9 hours
showing that cell metabolism slowed before cell lysis occurred in HMDM cells.
As previously described, GAPDH is a critical enzyme in glycolysis as it contains
oxidatively sensitive thiol. Net ATP production in glycolytic cells, such as macrophages,
results mainly from substrate level phosphorylation reactions catalysed by enzymes
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below GAPDH in glycolysis (phosphoglycerate kinase and pyruvate kinase). In HMDM
cells, oxLDL caused a decrease in GAPDH activity and in ATP, ADP, NAD+ and
NADP+ levels from the initial 3 hours. This occurred faster than the loss in cell viability
and in lactate levels, which happened after 6 hours. Therefore, in HMDM cells the
metabolic energy production slowed down before cell lysis occurred, which was after 9
hours as measured by LDH release. In HMDM cells, the reduction in GAPDH activity
and in ATP, ADP, NAD+ and NADP+ levels happened at the same time as in U937 cells,
as discussed in a previous chapter 4 of this study.
This delay in time between LDH enzyme loss to the cytoplasm and lactate production
suggests that the LDH enzyme was still active after the shutdown of glycolysis but
pyruvate synthesis from glycolysis and pentose phosphate had decreased. The loss of
GAPDH will have decreased glycolysis production of pyruvate. The decrease in NADP+
(Figure 5.6b) before cell lysis suggests that much of the lost NADP+ was converted to
NADPH. Pentose phosphate activity is controlled by the enzyme glucose-6-phosphate
dehydrogenase which is inhibited by NADPH. The drop in lactate production after
treatment with oxLDL dose suggests both glycolysis and the pentose phosphate pathway
were inhibited at 6 hours. Unfortunately, with our high performance liquid
chromatography (HPLC) method NADPH and NADH were extremely labile and
therefore cannot be measured so we are unable to confirm this hypothesis. The same
finding was found in U937 cells in this study and in other study (Caruso et al., 2004) as
discussed in a previous chapter 4.
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Interestingly, inflammation plays an important role in the elevation of lactate
concentration by macrophages (Leppänen et al., 2006, Loike et al., 1993, Samuvel et al.,
2009). Increased lactate concentration affects gene expression and cell function (Hunt et
al., 1978). Lactate enhances lipopolysaccharide (LPS)-induced inflammation by
stimulating cytokine expression by macrophages (Samuvel et al., 2009, Nareika et al.,
2005). As discussed in detail in the previous chapter 4, macrophages transported lactate
to the extracellular space and utilised it as source of energy (Loike et al., 1993, Drake et
al., 1980). The extracellular activity of the LDH enzyme increases under the condition of
oxidative stress (Jovanovic et al., 2010). This is very different to what we have observed;
we have measured a cell death process rather than an activation or inflammation process.
The results of oxidative stress are lipid peroxidation of the cell membrane, enzyme
inactivation through sulfydryl groups (-SH), protein aggregation, polysaccharide
polymerisation and the damage of nucleic acids. It occurs in the chain of acute processes,
such as in some inflammatory reactions (Ames et al., 1993). With HMDM cells, oxLDL
triggered a large oxidative stress, causing the rapid loss of cellular glutathione (GSH),
GAPDH inhibition and eventual loss of viability, without caspase-3 activation (Gieseg et
al., 2010). As discussed in detail in chapter 4, many studies have shown that inactivation
of GAPDH is a marker of oxidative stress, which results in a decrease in intracellular
ATP levels (Ralser et al., 2007, Mckenzie et al., 1996, Schraufstatter et al., 1990).
OxLDL has been shown to decrease GAPDH activity, which causes inhibition of
glycolysis and decreases ATP levels in HASMCs, which in turn plays an important role
in the mechanisms of atherogenesis (Sukhanov et al., 2006). In addition, GAPDH
inactivation by another oxidant, nitric oxide (NO) has been shown to reduce GAPDH
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activity and ATP content in macrophages (Albina et al., 1999). In a previous study in our
laboratory, hypochlorite (HOCl)-treated HMDM cells showed a concentration-dependent
decrease in intracellular ATP when a concentration above 50 μM of HOCl was used. The
time course study showed that 100 μM HOCl induced a rapid decrease in intracellular
ATP. HOCl mediated intracellular ATP loss in HMDM cells, which contributes to
necrotic cell death (Yang, 2009).
Surprisingly, the AMP levels in HMDM cells did not significantly differ from the
controls over time (Figure 5.5c). This was also found with U937 cells in this study and in
other studies (Pelzmann et al., 2003, Emerling et al., 2009) as discussed in chapter 4. We
would have expected the cellular AMP levels to increase as cells can regenerate ATP by
substrate level phosphorylation of ADP by adenylate-kinase, producing ATP and AMP
(Solaroli et al., 2009). This reaction does not appear to have been significant within the
oxLDL treated macrophages.
5.3.2 7,8-Dihydroneopterin protection of metabolic function
In this study, the potential antioxidant effect of 7,8-dihydroneopterin against the damage
caused by oxLDL was investigated in HMDM cells. The influence of 7,8-
dihydroneopterin was assessed by measuring the lactate level and the activity of  the
GAPDH enzyme in the presence of 7,8-dihydroneopterin and oxLDL. In the previous
chapters, 7,8-dihydroneopterin was shown to be very effective at preventing the loss of
metabolic function in U937 cells. In this chapter, we examine if HMDM cells, which
unlike U937 cells, are found in the artery wall, will respond in the same way. With the
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related THP-1 cell line, 7,8-dihydroneopterin had no protective effect against oxLDL or
peroxyl-radicals. The reason behind this difference remains unresolved.
In HMDM cells, there was a concentration-dependent protection by 7,8-dihydroneopterin
against oxLDL-induced loss of lactate production and in the loss of GAPDH activity. A
maximum protective effect was established with 200 M 7,8-dihydroneopterin.
Therefore, 7,8-dihydroneopterin has a protective effect against oxLDL-induced damage
by maintaining metabolic activity as measured by lactate levels in the cell culture media
of HMDM cells and glycolytic GAPDH activity. In HMDM cells, time course studies
indicated that 7,8-dihydroneopterin protects GAPDH activity loss against oxLDL-
induced damage in HMDM cells from the initial 3 hours. The protective effect of 7,8-
dihydroneopterin against the damage caused by oxLDL in HMDM cells occurred with
the same timing as that measured in U937 cells in this study (as discussed in a previous
chapter).
7,8-Dihydroneopterin appears to decrease the cytotoxicity of oxLDL in HMDM cells and
protects the cellular GSH and GAPDH activity by scavenging oxidants generated in
response to oxLDL (Gieseg et al., 2010). Previous studies found that during
inflammation, 7,8-dihydroneopterin has a protective effect against oxidants (Gieseg et al.,
1995, Gieseg et al., 2000, Gieseg et al., 2001b, Duggan et al., 2002, Firth et al., 2008b)
as discussed in detail before in Chapters 3 and 4.
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5.3.3 OxLDL uptake
There is a possibility that the protective effect of 7,8-dihydroneopterin-against oxLDL-
induced damage is established by influencing the uptake of oxLDL. In the present study,
it was found that 7,8-dihydroneopterin was able to inhibit oxLDL uptake when used at a
non-cytotoxic level of DiI-oxLDL alone or mixed with cytotoxic level of oxLDL. The
non-cytotoxic concentration of DiI-oxLDL did not affect cell viability, while mixed with
a cytotoxic level of oxLDL did cause cell viability loss. Although, the high concentration
of DiI-oxLDL (2.0 mg/ml), which is supposed to be cytotoxic, did not affect the cell
viability and so appeared to have acted as protectant.
This finding is consistent with previous studies in this laboratory, which have shown a
time-dependent uptake of Di-oxLDL by HMDM cells, and a significant inhibitory effect
of 7,8-dihydroneopterin on the uptake of oxLDL when non-toxic oxLDL concentrations
were used (Amit, 2008). Later studies have now shown a down regulation of HMDM cell
plasma membrane CD36 receptor by 7,8-dihydroneopterin which may cause a decrease in
oxLDL uptake by HMDM cells (Gieseg et al., 2010). The ability of 7,8-dihydroneopterin
to protect HMDM cells from oxLDL-induced death provides further evidence that this
antioxidant may be secreted by HMDM cells to provide protection against oxidative
damage in the highly oxidative environment of atherosclerotic plaque.
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6 General discussion and conclusion
6.1 Hypothesis
The primary hypothesis of this research was that oxidised low density lipoprotein
(oxLDL) causes human monocyte-like cell line U937 and human monocyte-derived
macrophage (HMDM) cells to undergo necrotic cell death, via oxidative loss of key
metabolic enzymes causing the loss of glycolytic activity and the shutdown of
metabolism. This was tested by examining the effect of oxLDL on the U937 and HMDM
cells glycolytic activity through measuring glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and lactate dehydrogenase (LDH) enzyme activity, lactate production, the rate
of oxygen consumption (VO2) and intracellular adenosine triphosphate (ATP) levels. The
study showed that oxLDL caused a progressive, time-dependent shutdown of glycolytic
metabolism. Study of the GAPDH enzyme showed that the loss of this enzyme activity
was due to oxidative inactivation. It was also hypothesised that the antioxidant 7,8-
dihydroneopterin (7,8-NP) would protect cells from this oxidative stress. The addition of
7,8-dihydroneopterin did prevent the loss of intracellular glutathione (GSH) and the
various enzyme markers studied.
The findings of this PhD research are summarised in Figure 6.1. OxLDL interacts with
the cell via an as yet, undetermined mechanism to produce an intracellular oxidative
stress. This oxidative stress is thought to be in the initial form of superoxide (O2●-)
generated via NADPH-oxidase (NOX) (Selemidis et al., 2007). The resulting reactive
oxygen species (ROS) generated within the cell cause the loss of GSH. In the absence of
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Figure 6.1 Events lead to metabolic activity loss, GSH loss and necrotic cell death in
oxLDL-treated U937 and HMDM cells.
The addition of oxLDL to the cells triggers a series of events starting with the loss of
GSH. The loss of GSH allows the oxidative loss of caspase and GAPDH activity. 7,8-
Dihydroneopterin protecting U937 and HMDM cells’ metabolic activity by preventing
the loss of GSH so preventing cell death.
1
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GAPDH-inhibition
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Loss of ATP
Necrosis
No apoptosis effected
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the GSH, the oxidative stress then is able to oxidise and inactivate the GAPDH, so
causing the glycolysis pathway to fail, resulting in decreased lactate production and loss
of oxygen consumption. The lack of ATP production means the cell can no longer
maintain normal function and goes into cell death. The oxidative stress also causes the
inactivation of the caspase enzymes, causing the failure of the apoptosis system and the
cell defaults to a necrotic cell death. 7,8-Dihydroneopterin protecting U937 and HMDM
cells’ metabolic activity by preventing the loss of GSH so preventing cell death.
6.2 Effect of oxLDL on the cells’ metabolic functions in U937 cells and
HMDM cells
OxLDL caused a rapid decrease in GAPDH activity during the first 3 hours of incubation
in both U937 and HMDM cells. This suggests that GAPDH, which is the key enzyme in
glycolysis, shows similar susceptibility towards oxLDL toxicity in both cell types. It is
known that GAPDH is extremely sensitive to thiol modification because of the oxidation
of cysteinyl sulfydryl (Cys149) located in the active site of the enzyme. This oxidation is
responsible for the loss of GAPDH activity during oxidative stress (Schuppe-Koistinen et
al., 1994, Cuddihy et al., 2009a). The sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) results of U937 cells in this study showed that a number of
proteins had lost their thiol groups within 3 hours of oxLDL addition. This finding is
consistent with reported data from human aortic smooth muscle cells (HASMCs) where
oxLDL, after 3 hours of exposure, caused the down regulation of GAPDH expression and
a decrease in GAPDH thiol (Sukhanov et al., 2006). This GAPDH activity results
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supported the theory of the importance of GAPDH to sustain glycolysis and provide
substrates for the Krebs cycle and electron transport chain (ETC) (Nelson & Cox, 2005).
In both cell types, the loss of GAPDH by the oxLDL occurred when there was a decrease
in ATP and adenosine diphosphate (ADP). The oxLDL also caused a decrease in the VO2
in U937 cells during this time period. These finding are consistent with studies on rabbit
macrophages (Leppänen et al., 2006), where an impaired supply of oxygen and nutrients
resulted in ATP depletion and lead to the shutdown of cell function and ultimately cell
death. In HASMCs (Sukhanov et al., 2006), oxLDL caused the down regulation of
GAPDH, inhibition of glycolysis and ATP depletion. Inhibition of glucose uptake caused
inactivation of GAPDH and suppression of ATP levels (Schraufstatter et al., 1990). ATP
is important in the maintenance of cell membrane integrity (Halliwell & Gutteridge,
2007). Inhibition of  GAPDH and ATP productions by peroxynitrite and S-nitrosothiols
caused necrotic cell death and rupture of the plasma membrane (Brown, 2010). As
macrophage foam cells, with high oxygen and glucose consumption, accumulate within
the intima, the metabolic demands increase. During the later stages of the development of
the lesions, the VO2 of a proportion in the cells of the arterial wall becomes reduced. This
might eventually cause ischemia in the arterial wall, which in turn might lead to
decreased viability and reduced metabolic activity (Bjornheden & Bondjers, 1987).
In cells where glucose metabolism is the main source of energy, the glycolytic pathway is
a primary source of carbon (as pyruvate) for the Krebs cycle. In tissue culture, U937 and
HMDM cells also generate large amounts of lactate suggesting either an impaired Krebs
cycle or ETC, or simply an oversupply of pyruvate by both glycolysis and the pentose
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phosphate pathway. This pyruvate is converted to lactate for removal from the cells. In
oxLDL treated U937 cells, the lactate production decrease occurred at the same time as
GAPDH loss, but in the HMDM cells there was a significant lag of 3 hours where lactate
was still generated. The source of this pyruvate most likely was the pentose phosphate
pathway which is not affected by oxidative stress (Kruger & Von Schaewen, 2003).
NADH generated in the Krebs cycle is a possible source of the reducing equivalents
required for the lactate production. This NAD+ regeneration via LDH would have
allowed the Krebs cycle and pentose phosphate pathway to continue for some time, even
with the loss of mitochondrial activity. Why this was different to the U937 cells is
uncertain but it mainly reflects the level of oxidative stress and the possible oxidative
inhibition of aconitase in the U937 cells (Gumieniczek et al., 2011, Gupta et al., 2012).
Also, the U937 cell lysis followed soon after GADPH loss so the loss of the LDH
enzyme from the cells may also explain the loss of lactate generation in the U937 cells.
LDH was released to the cell culture media after 3 hours in U937 cells and after 6 hours
in HMDM cells. The experimental data supports the proposal that the observed lag time
in decreased metabolic function could be a reflection on the HMDM cells ability to
maintain membrane function and hold onto the LDH within the cytoplasm. The loss of
ATP in the U937 cells was faster than the HMDM cells so the loss of membrane function
could be expected to be faster as ATP is required to maintain the various ion channels
within the membrane.
This correlated to cell viability loss, which occurred from the initial 3 hours in U937 cells
and after 6 hours in HMDM cells. Overall, there is a slowing of cell metabolism before
cell lysis occurred in HMDM cells while the processes were very rapid in the U937 cells.
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6.3 GSH and oxidative stress
Oxidative stress caused by oxLDL in U937 cells, resulted in loss of GSH level within the
first 3 hours. Cellular GSH is a very potent antioxidant and can efficiently neutralise ROS
such as nitric oxide (NO), O2●-, and hydrogen peroxide (H2O2), and hypochlorite (HOCl).
Previous studies in this laboratory have shown that oxLDL induces intracellular GSH loss
in HMDM cells immediately from the initial 3 hours. This GSH loss was faster than the
loss of cell viability at all time points, which showed 20% reduction after 3 hours and by
60% after 24 hours (Amit, 2008). This could indicate that the gradual collapse of the
GSH level induced by oxLDL preceded macrophage death. This could also suggest that
GSH depletion was required for oxLDL-induced macrophage toxicity (Amit, 2008,
Gieseg et al., 2009b). These observations are in agreement with results demonstrating
that depletion of reduced GSH enhances oxLDL cytotoxicity in human macrophages
(Darley-Usmar et al., 1991, Gotoh et al., 1993, Wang et al., 2006). The most likely
explanation for this is that the depletion of reduced GSH by oxLDL (Wang et al., 2006)
alters the GSH thiol redox state (GSH/GSSG ratio). Since GSH/GSSG ratio is one of the
principal determinants of the cellular redox environment, any alteration in the redox
environment can lead to cellular dysfunction and cell death (Schafer & Buettner, 2001).
Loss of glutathione may exacerbate the oxidative stress effect of the oxLDL on HMDM
cells.
6.4 OxLDL uptake and Cytotoxicity
OxLDL appears to cause U937 and HMDM cells to undergo a rapid necrotic cell death
due to failure of metabolism and loss of cell membrane integrity after 6 and 12 hours,
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respectively. The cell death with oxLDL occurred with the loss of GSH but no caspase-3
activation. All morphological characteristics were of necrosis in the presence of oxLDL.
The rapid loss of the enzyme GADPH was not unexpected as previous studies (Baird et
al., 2004) had shown the oxidative stress induced by oxLDL was sufficient to inhibit
capsase-3 which blocks the apoptotic process leaving necrosis as the default.
Caspases have been shown to be inactivated through the oxidative loss of the key
catalytic thiol within the active site (Hampton et al., 2002b). This inactivation has been
demonstrated with hydrogen peroxide (H2O2), a key ROS within cells during oxidative
stress, and protein hydroperoxides of Trp and Tyr, hypothesised products of the ROS
(Hampton et al., 2002a). These studies suggest that oxidative stress can inactivate
caspases so driving dying cells into necrosis rather than apoptosis. OxLDL causes ROS
generation by cells, leading to oxidative stress, shutdown of metabolism and breakdown
of mitochondrial ETC and escape of its components such as cytochrome c through
mitochondrial membrane pores. OxLDL induced cytochrome c released from
mitochondria into the cytosol and causes caspase-3-inactivation leading to cell death by
necrosis (Gieseg et al., 2009a). Examination of plaque necrotic core does show a
considerable amount of extra cellular debris (Stocker & Keaney, 2004) suggesting that
necrosis is a major process occurring with the plaque.
6.5 Protective effect of 7,8-dihydroneopterin on cell viability and
metabolic function
In some plaques there are regions of high 7,8-dihydroneopterin level, the average is
55.59±5.19 nM (Gieseg et al., 2008, Firth et al., 2008a, Genet, 2010) and up to 18 µM
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(personal communication in our laboratory). 7,8-Dihydroneopterin is hypothesised to be
synthesised to protect macrophages and other cells formed in the plaque from the
oxidants such as  HOCl, NO and peroxyl radicals released during inflammation (Gieseg
et al., 2008, Gieseg et al., 1995). This research clearly shows 7,8-dihydroneopterin, in
vitro, effectively protects human monocyte-like U937 and  HMDM cells from oxLDL-
induced loss of glycolytic function and cell death. 7,8-Dihydroneopterin also appears to
slow the uptake of oxLDL suggesting it may also be able to modulate or slow foam cell
formation if produced at micromolar levels.
It is possible that if 7,8-dihydroneopterin is generated in the intracellular spaces at
concentrations exceeding 100 μM then there would be a considerable stabilising of the
macrophage cells viability. It is possible that necrotic core regions may be associated
with regions of low 7,8-dihydroneopterin level. This is however very difficult to
demonstrate for a number of fundamental reasons. The production of 7,8-
dihydroneopterin and neopterin is likely to be a transitory processes, triggered by specific
inflammatory events within the plaque. As the neopterin and 7,8-dihydroneopterin appear
to readily diffuse out of the plaque, what is measured in advanced plaque, removed
during surgery, is a snap shot of the plaque state at the time of removal. Also, only
advanced human plaques are available for study, so it is not possible to study early stage
plaques. Classical animal models cannot give any information of this process as mice,
rats and rabbit macrophages do not make 7,8-dihydroneopterin.
This argument also assumes that cell death is bad as it promotes further inflammation.
However 7,8-dihydroneopterin, destabilising the cell metabolism may allow foam cells to
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reach a level of stability which promotes further plaque grow. It is difficult to determine
where the balance is, especially as there is a strong correlation between plasma neopterin,
atherosclerosis and poor clinical outcomes (Gieseg et al., 2008, Adachi et al., 2007). This
correlation shows that atherosclerosis is an inflammatory disease. What is missing from
the data is a measure of 7,8-dihydroneopterin vs neopterin in atherosclerotic patients
which may indicate the level of oxidative inflammation occurring within the plaques.
6.6 Further studies
This study focused on only one enzyme, glycolytic enzyme GAPDH due to its reported
susceptibility to oxidative stress. The loss of this enzyme would effectively knock out
glycolysis and the flow of carbon into the mitochondria from sugar metabolism, the
almost complete loss of ATP production was observed. OxLDL also caused a major loss
in the VO2 suggesting that other enzymes within mitochondria were affected by the
oxidative stress. The protection of the VO2 by 7,8-dihydroneopterin supports this
hypothesis. The Krebs cycle enzyme aconitase is found both in the cytoplasm and
mitochondria and is known to be oxidised by ROS. Loss of this enzyme would also be a
key event in oxLDL-mediated cell death.
The source of the oxidative stress has not been fully confirmed and most studies have
focused on endothelium cells. Macrophages generate superoxide (O2●-) during
inflammation via the membrane-bounded NADPH-oxidase enzyme (NOX). It is possible
that over stimulation of NOX is the source of the oxidative stress causing GAPDH
inactivation and cell death. In addition to measuring the timing of NOX activation,
measuring whether it is cytoplasmic or mitochondrial aconitase which is inactivated may
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show where the ROS is generated. Isolating the location of the ROS generation using
ROS scavenging dyes such as dihydroethidium (DHE) and red mitochondrial superoxide
indicator (MitoSox) would be a key investigation.
Assuming NOX is activated, the role of calcium in activating this enzyme would be of
interest. Previous work in this laboratory using HOCl has shown the opening of Ca+2
channels is important to the cell death process, so should be examined. Whether 7,8-
dihydroneopterin can prevent a calcium influx into the cytoplasm would need to be
examined. The down regulation of the scavenger receptor CD36 and lipid uptake by 7,8-
dihydroneopterin does not appear to affect the ROS production (Gieseg et al., 2010). 7,8-
Dihydroneopterin is likely to affect foam cell formation needs to be explored by
measuring cholesterol ester accumulation in macrophages by high performance liquid
chromatography (HPLC) analysis.
In this project, the VO2 was measured using suspension cell line U937 cells but not the
adherent HMDM cells. It was assumed that U937 cells would responded the same as
HMDM cells but this is only an assumption. There is very little data on HMDM cells
VO2 or how these cells metabolise different substrates, especially triglycerides vs
glucose. The establishment of protocols to measure adherent, or at least human blood
derived monocytes, VO2 would provide valuable information on these cells metabolism,
especially in the oxygen and possibly nutrient restricted environment of the
atherosclerotic plaque.
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